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Abstract 
NF-κB is a key transcription factor involved in the regulation of inflammation. 
The transcriptional activity of NF-κB is regulated by a number of post-
translational modifications, including phosphorylation. Phosphorylation of NF-κB 
subunits may regulate transcription in a gene selective manner. The NF-κB p50 
subunit is an important dual regulator of inflammatory responses, which can 
either promote or repress gene expression depending on the formation of 
heterodimer or homodimer complexes, respectively. Although p50 is a critical 
regulator of the immune system, phosphorylation of this subunit is largely 
understudied. In this thesis, the role of phosphorylation of NF-κB p50 on serine 
80 (S80) in regulating transcriptional responses is investigated, using two human 
NFKB1S80A knock-in cell lines generated by CRISPR/Cas9 genome editing 
techniques. Transcriptomic analyses reveal a critical role for S80 in selectively 
regulating the expression of a subset of NF-κB target genes in response to TNFα 
and LPS, including pro-inflammatory chemokines and cytokines. DNA binding 
analyses demonstrate that S80 regulates the binding of p50 to NF-κB binding 
sites in a sequence-specific manner. Specifically, phosphorylation of S80 reduces 
the affinity of p50 for κB sites that have an adenine at the -1 position. These 
data indicate that p50 S80 phosphorylation predominantly regulates transcription 
through the p50:p65 heterodimer, where S80 phosphorylation acts in trans to 
limit the NF-κB mediated transcription of pro-inflammatory genes. This advances 
our understanding of the regulation of transcriptional programmes by the NF-ĸB 
p50 subunit. 
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1 Introduction 
1.1 General introduction 
Nuclear factor-κB (NF-κB) proteins are a family of structurally related 
transcription factors that regulate the expression of over 500 genes involved in 
many important biological processes including the regulation of cell cycle, 
proliferation, differentiation and cell death. However, the most fundamental 
role that NF-κB plays is to regulate inflammation. The importance of NF-κB in 
these physiological processes is evident from its dysregulation in a number of 
disease states such as chronic inflammation, immunodeficiency and cancer 
(Courtois and Gilmore, 2006, Hayden and Ghosh, 2012). Due to its ability to 
regulate such a large number of genes, the activity of NF-κB is tightly regulated 
at multiple levels, including mechanisms of gene specific transcriptional 
regulation by NF-κB that ensure specificity of gene expression. 
1.2 Components of the NF-κB pathway 
1.2.1 NF-κB 
The NF-κB transcription factor family is composed of five subunits: RelA (p65), 
RelB, c-Rel, p50 and p52. The p50 and p52 subunits are generated from the 
limited proteasomal processing of the precursor proteins p105 and p100, 
respectively, while p65, RelB and c-Rel are translated directly. The p50 and p52 
subunits lack the transactivation domain (TAD) found in the C-terminal regions 
of the RelA, c-Rel and RelB subunits, while all NF-κB subunits contain a highly 
conserved Rel homology domain (RHD) (Figure 1.1A). The RHD facilitates DNA 
binding, dimerisation, nuclear localisation, and interaction with inhibitor of κB 
(IκB) proteins (Oeckinghaus and Ghosh, 2009). 
The NF-κB subunits can hetero- and homo-dimerise to form dimer complexes 
(Figure 1.1B). While theoretically 15 combinations are possible, only 12 dimer 
complexes have experimentally identified in vivo (Huxford and Ghosh, 2009). 
NF-κB can promote or repress transcription depending on the subunit 
composition of dimer complexes. Although the p50 and p52 subunits lack a TAD, 
they can positively regulate transcription by forming a heterodimer with TAD 
22 
 
containing subunits p65, RelB and c-Rel. Alternatively, p50 and p52 homodimers 
function as transcriptional repressors by competing with TAD containing NF-ĸB 
dimers for the same DNA binding sites in target gene promoters (Carmody et al., 
2007). While the abundance of particular NF-κB dimers is cell type-specific, the 
p50:p65 heterodimer represents the most abundant dimer complex, and is 
expressed in most cell types (Oeckinghaus and Ghosh, 2009). Various studies 
using knockout cell lines and knockout mouse models have elucidated both 
unique and overlapping biological functions of NF-κB dimers (Hoffmann et al., 
2003, Gerondakis et al., 2006). For example, expression of NF-κB target gene 
leukemia inhibitory factor (Lif) was abolished in Nfkb1-/- and Rela-/- single 
knockout cells, and was not expressed by c-Rel containing dimers, suggesting 
that only the p50:p65 heterodimer is functional on this promoter (Hoffmann et 
al., 2003). In contrast, expression of chemokine C-X-C motif ligand 10 (Cxcl10), 
colony stimulating factor 1 (Csf1) and C-C chemokine ligand 5 (Ccl5) requires a 
dimer containing p65, with either p50 or p52. Furthermore, double NF-κB 
subunit knockout mice have more severe phenotypes compared to single subunit 
knockouts (Gerondakis et al., 2006). 
23 
 
 
 
Figure 1.1: NF-κB family of transcription factors 
(A) Schematic representation of the five members of the NF-κB transcription factor family: p65, 
RelB, c-Rel, p100/p52 and p105/p50. The principal structural domains are indicated and labelled. 
Amino acid residue numbering corresponds to human protein sequence. (B) 15 possible homo- 
and heterodimers formed by different combinations of NF-κB subunits. 
 
NF-κB dimers bind to specific DNA sequences called κB sites in the enhancers 
and promoters of target genes. Most κB sites are 10 base pairs (bp) in length, 
with the consensus sequence 5’-G-5G-4G-3R-2N-1W0Y+1Y+2C+3C+4-3’ (R represents a 
purine, N represents any nucleic acid, W represents an A or T and Y represents a 
pyrimidine). A number of structural studies have revealed that p50 and p52 bind 
to the 5bp 5′-GGGRN-3′ half-site of the consensus sequence, while p65, RelB and 
c-Rel bind to the 5′-YYCC-3′ half-site (Chen et al., 1998, Cramer et al., 1997, 
Ghosh et al., 1995, Huang et al., 2001). These studies suggested that NF-κB 
dimers follow a rule of cognate half-site recognition, separated by a 1bp spacer: 
p50 and p52 homodimers bind to 11bp κB site consisting of two 5bp half-sites, 
whereas p65 and c-Rel homodimers bind to 9bp sites consisting of two 4bp half-
sites. Heterodimers on the other hand, bind to a 10bp κB site, consisting of a 
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5bp and 4bp half-site. DNA binding analyses utilising electrophoretic mobility 
shift assays and large-scale protein-binding microarrays (PBMs) have confirmed 
the 3 distinct classes of NF-κB DNA binding-specificity (Kunsch et al., 1992, 
Siggers et al., 2011). Despite this classification, NF-κB dimers have overlapping 
DNA binding specificities. For example, p65 and c-Rel bind to the same class of 
κB site, however p65 and c-Rel can elicit distinct biological functions (Hoffmann 
et al., 2006). By measuring DNA dissociation rates, Siggers et al. (2011) showed 
that c-Rel homodimers have much higher affinity to specific κB sites in 
comparison to p65 homodimers, contributing to the specific regulation of c-Rel-
dependent functions. In addition, the NF-κB p50:p65 heterodimer has been 
shown to bind to a consensus κB site with an affinity of ~10nM, whereas p50 and 
p65 homodimers bind to the same κB site with 5- and 15-fold lower affinity, 
respectively (Phelps et al., 2000). These studies suggest that κB site sequences 
are a pre-requisite for NF-κB-DNA binding specificity. However, many of the 
mechanisms which regulate NF-κB affinity to particular κB sites, contributing to 
specificity of target gene expression, remain unknown. 
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1.2.2 IκB 
The primary mechanism by which NF-κB activity is regulated is through 
interaction with IκB proteins. In unstimulated cells, NF-κB dimers are 
sequestered in the cytoplasm by association with an IκB family member. The IκB 
family of proteins can be classified into three groups: typical, precursor and 
atypical ( 
Figure 1.2). All IκB proteins are characterised by the presence of ankyrin repeat 
domains, which interact with the RHD of NF-κB proteins. Much like the NF-κB 
protein family, the IκB proteins have different affinities for particular subsets of 
NF-κB dimers, are regulated in different manners, and are expressed in a tissue-
specific manner (Hinz et al., 2012). 
 
 
 
Figure 1.2: IκB protein family members 
Schematic representation of the typical (A), precursor protein (B), and atypical (C) IκB proteins. 
The principal structural domains are indicated and labelled. Amino acid residue numbering 
corresponds to human protein sequence. 
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The typical or classical IκB proteins IκBα, IκBβ and IκBε are present in the 
cytoplasm of unstimulated cells. All 3 classical IκB proteins share 6 ankyrin 
repeats, and a conserved signal response region containing phosphorylation sites 
required for stimulus-induced degradation. IκBα and IκBβ share an acidic region, 
rich in proline (P), glutamic acid (E), serine (S) and threonine (T), also referred 
to as PEST sequences (Figure 1.2A). PEST sequences are implicated in regulating 
IκB protein half-life (Rogers et al., 1986, Rodriguez et al., 1995), and are 
thought to provide a structural mechanism for the divergent functions of IκBα 
and IκBβ (Malek et al., 2003). 
The typical IκB proteins preferentially interact with p65 and c-Rel containing NF-
κB dimers, where IκBα has a higher affinity for p50:p65 heterodimers than for 
p65 homodimers (Malek et al., 2003). In fact, IκBα bound to p50:p65 was the 
first NF-κB:IκB complex to be discovered, and is the best characterised IκB 
protein. The IκBα:p50:p65  complex defines the general mechanism by which NF-
κB dimers are inhibited (Müller and Harrison, 1995, Ghosh et al., 1995). Crystal 
structures of IκBα:p50:p65 revealed that IκBα masks the nuclear localisation 
sequence (NLS) of p65, but not p50 (Huxford et al., 1998, Jacobs and Harrison, 
1998). The combination of the nuclear export sequence (NES) of IκBα and 
exposed p50 NLS results in shuttling of the NF-κB:IκB complex between the 
nucleus and cytoplasm (Johnson et al., 1999, Huang et al., 2000, Malek et al., 
2001). However due to the strength of the IκBα NES, rate of nuclear export 
exceeds that of nuclear import, resulting in a steady-state cytoplasmic 
localisation (Ghosh and Karin, 2002, Huang et al., 2000). Rapid degradation of 
IĸBα during NF-κB activation exposes the previously masked NLS of p65, 
facilitating nuclear translocation of the NF-κB dimer, where it can bind to 
specific κB sites. While IκB degradation is the primary mechanism for activation 
of NF-κB activity, the IκB proteins are also important for the termination of NF-
κB transcriptional responses. This mechanism depends on the NF-κB dependent 
re-synthesis of IκB proteins. Shortly after its degradation, IκBα is rapidly re-
synthesised and functions to restore the cell to its resting state by binding to NF-
κB dimers in the nucleus, via a negative feedback loop (Arenzana-Seisdedos et 
al., 1995). 
27 
 
The roles of IκBβ and IκBε are less well understood. Although IκBβ has similar 
NF-κB dimer binding preferences to IκBα, in contrast, IκBβ masks the NLS of 
both NF-κB subunits. Therefore IκBβ:NF-κB complexes do not shuttle between 
the nucleus and the cytoplasm, and have a strict cytoplasmic localisation in 
unstimulated cells (Malek et al., 2001). IκBβ degradation and re-synthesis occur 
with delayed kinetics compared to IκBa. IκBε is lesser studied, however it is 
known that IκBε associates with p65 and c-Rel containing dimers. High levels of 
expression are seen in tissues such as spleen and lung, indicating that IκBε 
function appears to be limited to cells of the hematopoetic lineage (Hinz et al., 
2012). In addition, like IκBβ, IκBε degradation and re-synthesis occurs at a much 
slower rate in comparison to IκBa. Differences in dimer preference, degradation 
and re-synthesis rates suggest that the typical IκB proteins have distinct roles in 
NF-κB inhibition. 
The p100 and p105 proteins serve as both NF-κB subunit precursors, and also as 
IκB proteins. Both p100 and p105 undergo limited proteolysis, generating the p52 
and p50 subunits, respectively. Processing can either occur constitutively, or be 
induced by phosphorylation by an IκB kinase (Christian et al., 2016). p100 and 
p105 also contain 7 ankyrin repeat domains in their C-terminus (Figure 1.2B). 
Therefore, p100 and p105 can bind to NF-κB in a both an NF-κB-like and IκB-like 
manner, via their RHD and ankyrin repeat domains, respectively. Not only does 
inducible processing of p100 and p105 generate NF-κB subunits, it also functions 
to liberate NF-κB dimers bound in this inhibitory complex, much like the typical 
IκB proteins. p105 is capable of binding to and inhibiting p50, p65 and c-Rel 
containing dimers, maintaining them in the cytoplasm (Rice et al., 1992, 
Naumann et al., 1993). While p100 is also capable of binding to and inhibiting 
many NF-κB dimers (Ishimaru et al., 2006), it is most well-known for its 
interaction with RelB. Inducible processing of p100 generates p52:RelB 
heterodimers, an important step in the non-canonical NF-κB activation pathway 
(Senftleben et al., 2001) (described in section 1.3.1). More recently, it was 
discovered that p100 and p105 also form large molecular weight complexes, 
defined by both NF-κB:RHD and NF-κB:ankyrin interactions which function to 
inhibit NF-κB activity (Savinova et al., 2009). 
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The atypical IκB members B-cell lymphoma 3 (BCL-3), IκBζ, IκBNS and IκBη 
contain 7 ankyrin repeats facilitating their ability to bind to NF-κB dimers 
(Figure 1.2C). The atypical IκB proteins are predominantly nuclear, and are 
generally not expressed in unstimulated cells with the exception of IκBη, which 
is constitutively expressed (Hinz et al., 2012). Upon induction, atypical IκB 
proteins function to modulate the activity of NF-κB dimers in the nucleus. BCL-3 
was the first atypical IκB protein to be discovered, however its precise function 
as an NF-κB regulator remained unclear for many years. BCL-3 specifically 
associates with p50 and p52 homodimers, and is thought to be capable of both 
enhancing and repressing their transcriptional activity (Wulczyn et al., 1992, 
Bours et al., 1993, Fujita et al., 1993, Nolan et al., 1993). However, BCL-3 has 
been well characterised as an inhibitor of NF-κB, by stabilising repressive NF-κB 
p50 homodimers to DNA, preventing TAD containing dimers from binding 
(Carmody et al., 2007, Wessells et al., 2004) (described in section 1.4.3.1.1). 
IκBζ shares structural and functional homology with BCL-3. IκBζ preferentially 
associates with and modulates the activity of p50 homodimers. IκBζ binds p50 
homodimers at κB sites, most notably on the interleukin 6 (Il6) promoter. 
Expression of Il6 is not induced in IκBζ-deficient cells, indicating that IκBζ is a 
co-activator of p50 homodimers (Yamamoto et al., 2004). In addition, IκBNS has 
been shown to preferentially associate with p50 (Fiorini et al., 2002). It is 
therefore assumed that IκBNS functions in a similar manner to BCL-3, stabilising 
p50 homodimers on DNA. However, negative regulation of NF-κB activity by 
IκBNS was shown to be selective since production of IL-6, but not tumour 
necrosis factor α (TNFα), was increased following stimulation of IκBNS knockout 
cells (Kuwata et al., 2006). More recently, IκBη was identified as an atypical IκB 
with high homology to IκBβ (Yamauchi et al., 2010). IκBη associates with the p50 
subunit of NF-κB, and was shown to be important for regulating a subset of pro-
inflammatory genes. Knockdown of IκBη by siRNA suppressed the transcription of 
Cxcl2, Il6 and Il1b in stimulated RAW264.7 cells, suggesting that IκBη might 
function as a co-activator of NF-κB gene expression (Yamauchi et al., 2010). 
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1.2.3 IKK complex 
A key regulatory step in the NF-κB activation pathway is the phosphorylation of 
IκB proteins by the IκB kinase (IKK) complex. The IKK complex is a large protein 
structure (700-900 kDa) consisting of two kinase subunits IKKα and IKKβ, and a 
regulatory subunit IKKγ (NEMO). IKKα and IKKβ share 50% sequence identity, and 
contain a kinase domain, leucine zipper, and helix-loop-helix domain. These 
domains are responsible for phosphorylation of substrates, homo- or hetero-
dimerisation of the kinases, and kinase activity, respectively (Israel, 2010). The 
IKK complex is the core component of NF-κB signalling, with most NF-κB 
activation signals converging on this enzymatic complex. The significance of the 
IKK complex has been demonstrated using mouse knockout models, whereby 
Ikka-/-, Ikkb-/- and Nemo-/- mice all have lethal phenotypes (Gerondakis et al., 
2006). Activation of the IKK complex is dependent on phosphorylation of serine 
residues (IKKα S176 and S180; IKKβ S177 and S181) located in an activation loop 
within the kinase domain (Mercurio et al., 1997, Delhase et al., 1999). Following 
activation, the IKK complex is capable of phosphorylating a number of 
substrates, many of which are involved in the NF-κB pathway [as reviewed by 
(Chariot, 2009)]. However, the complex is best characterised for the 
phosphorylation of IκB proteins, targeting them for degradation in order to 
liberate NF-κB dimers (described in section 1.3). However, IKKα and IKKβ have 
been shown to directly phosphorylate NF-κB subunits (Christian et al., 2016). 
IKKα and IKKβ phosphorylate multiple serine residues on p100 and p105, required 
for processing to p52 and p50, respectively. IKKα and IKKβ have also been 
implicated in phosphorylation of the p65 subunit, regulating NF-κB dependent 
gene expression (Christian et al., 2016). For example, serine 536 (S536) of the 
p65 subunit can be phosphorylated by both IKKα and IKKβ, which have distinct 
functional outcomes. Phosphorylation of S536 by IKKβ enhances p65 
transactivation (Sakurai et al., 1999). In contrast, phosphorylation of the same 
residue by IKKα leads to ubiquitination of p65, targeting it for proteasomal 
degradation by the proteasome, therefore limiting p65 driven transcription 
(Lawrence et al., 2005). These studies indicate that the IKK complex has distinct 
roles in the regulation of the NF-κB pathway. 
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1.3 Signalling to NF-κB 
1.3.1 NF-κB activation overview 
NF-κB is activated by a wide variety of extracellular stimuli, involving several 
signalling pathways which converge on the IKK complex. Given the similarity 
between IKKα and IKKβ, it was presumed that they would have overlapping 
functions. However, divergent roles have been outlined for each of the kinases, 
leading to the identification of two different NF-κB activation pathways: the 
canonical or classical pathway, and the non-canonical pathway (Figure 1.3). 
Each pathway is distinct with respect to the inducing stimuli, particular IKK 
subunit involved, and NF-κB/IκB substrates targeted. 
The canonical or classical pathway is considered to be representative of the 
general mechanisms by which NF-κB is regulated. In this pathway, IKKβ is 
activated by phosphorylation as a result of the engagement of various receptors 
such as Toll-like receptors (TLRs), tumour necrosis factor receptors (TNFRs), B-
cell receptors (BCR) and T-cell receptors (TCR) (Hayden and Ghosh, 2012). 
Activation of IKKβ leads to the specific phosphorylation of IκBα on S32 and S36, 
targeting IκBα for ubiquitination. In turn, ubiquitination leads to proteasomal 
degradation of IκBα, which frees sequestered NF-κB dimers such as the p50:p65 
heterodimer, allowing translocation to the nucleus (Figure 1.3A). The non-
canonical pathway is dependent on NF-κB-inducing kinase (NIK) induced 
activation of IKKα. NIK is activated by signals from receptors such as CD40, 
lymphotoxin β receptor (LTβR) and B-cell activating factor (BAFF) receptor 
(Hayden and Ghosh, 2012). Activated NIK phosphorylates IKKα, and through a 
series of NIK/IKKα dependent phosphorylations, p100 is ubiquitinated and 
targeted for limited proteolysis. This generates the p52 subunit, which typically 
forms heterodimers with RelB. p52:RelB heterodimers are then able to 
translocate to the nucleus (Figure 1.3B). 
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Figure 1.3: Canonical and non-canonical NF-κB signalling 
(A) The canonical pathway is induced by a diverse range of stimuli, which activates a number of 
receptors such as Toll-like receptors (TLRs), B-cell receptors (BCR), T-cell receptors and tumour 
necrosis factor receptors (TNFRs). These receptors utilise a number of signalling adaptors to 
activate the IKK complex. Phosphorylation (yellow octagons) of specific serine residues of classical 
IκBs such as IκBα by IKKβ leads to IκB ubiquitination and subsequent proteosomal degradation. 
This results in the release of NF-κB dimers, which are free to translocate to the nucleus and induce 
transcription of target genes. (B) The non-canonical pathway depends on the activation of NIK by a 
number of receptors including B-cell activating factor (BAFF), CD40 receptor and lymphotoxin β 
receptor (LTβR). Activation of NIK leads to subsequent activation of IKKα. IKKα phosphorylation of 
the p100 NF-κB subunit (yellow octagons) leads to proteosomal processing of p100 to p52. This 
results in the activation of p52:RelB heterodimers, which are free to translocate to the nucleus to 
induce transcription of target genes. 
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1.3.2 NF-κB activation by specific receptors 
Although a number of NF-κB activation signals converge on the IKK complex, 
there are fundamental differences which precede IKK activation dependent on 
the stimulus received, leading to specific NF-κB responses. Many receptor-
induced activation pathways of IKK have been elucidated for TLR and TNFR 
families, which are outlined below. 
1.3.2.1 Toll-like receptors (TLRs) 
Toll-like receptors are a class of transmembrane proteins which belong to a 
family of pattern recognition receptors, which play a key role in the innate 
immune system. TLRs function to recognise pathogen-associated molecular 
patterns (PAMPs), defined as conserved molecular motifs associated with 
microbial pathogens. Following PAMP recognition, TLRs induce signal cascades of 
downstream effectors to activate innate immune responses. To date, the 
mammalian TLR family consists of 13 members, each detecting distinct PAMPS 
derived from a range of microbial pathogens such as bacteria, viruses and fungi. 
Of the 13 members, only TLR1-10 have been identified in humans (Kawasaki and 
Kawai, 2014). While each TLR varies with regards to PAMP recognition, all TLRs 
share a conserved Toll/IL-1R (TIR) domain, which mediates downstream 
signalling by recruiting TIR domain containing adapter molecules. These include 
the myeloid differentiation primary-response protein (MYD88), TIR-containing 
adaptor protein/MYD88-adaptor-like (TIRAP), TIR-domain-containing adaptor 
protein inducing IFNβ (TRIF), TRIF-related adaptor molecule (TRAM) and sterile 
alpha- and armadillo-motif-containing protein (SARM) (O'Neill and Bowie, 2007). 
TLRs use different combinations of adaptor proteins in order to mediate 
downstream signals. TLR signalling can be divided into two pathways based on 
the requirement of the MYD88 adapter (Medzhitov et al., 1998). 
1.3.2.2 TLR4 
TLR4 was one of the first TLRs identified, and was found to be involved in NF-κB 
activation and inflammatory gene expression by inducing transcription of IL1 and 
IL8 (Medzhitov and Janeway, 1997). Subsequent studies using Tlr4 null mice 
revealed an essential role for TLR4 in lipopolysaccharide (LPS) induced signalling 
(Poltorak et al., 1998). LPS is the outer membrane component of gram negative 
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bacteria, and is an extremely potent PAMP, inducing the release of critical pro-
inflammatory factors to activate the immune response. While TLR4 primarily 
responds to LPS, TLR4 can recognise other PAMPS derived from fungi, viruses, 
parasites and host, highlighting the importance of TLR4 for the innate immune 
response (Kawasaki and Kawai, 2014). In addition, TLR4 is the only TLR which 
can signal through both MYD88-dependent and MYD88-independent pathways. 
The MYD88-dependent pathway is responsible for pro-inflammatory cytokine 
production through activation of NF-κB and mitogen activated protein kinase 
(MAPK) gene expression, while the MYD88-independent pathway activates 
interferon regulatory transcription factor (IRF) families, mediating the induction 
of interferon regulatory factors (IFNs) (Lu et al., 2008). 
1.3.2.2.1 MYD88 dependent pathway 
Upon ligand binding, TLR4 receptors heterodimerise and recruit adaptor 
molecules via interactions with their TIR domains. MYD88 recruitment is 
facilitated by the bridging adaptor molecule TIRAP. In addition to the TIR 
domain, MYD88 also contains a death domain (DD) through which it can recruit 
other DD containing proteins. MYD88 recruits and activates IL-1 receptor 
associated kinase 4 (IRAK4), a DD containing kinase. IRAK4 recruits and 
phosphorylates IRAK1 and IRAK2. IRAK1 undergoes auto phosphorylation which in 
turn recruits tumour necrosis factor receptor-associated factor 6 (TRAF6), an E3 
ubiquitin ligase. Together with ubiquitin conjugating enzymes UBC13 and UEV1A, 
TRAF6 promotes ubiquitination of itself, which recruits a kinase complex 
consisting of transforming growth factor-β-activated kinase 1 (TAK1) and TAK1 
binding proteins (TABs) 2 and 3 (Figure 1.4A). TAK1 is capable of activating both 
NF-κB and MAPK signalling pathways, leading to pro-inflammatory gene 
expression (Lu et al., 2008). TAK1 binds to the regulatory subunit of the IKK 
complex NEMO via ubiquitin chains, which allows it to phosphorylate and 
activate IKKβ. TAK1 phosphorylation of IKKβ, leads to IκBα degradation, and 
subsequent NF-κB activation gene expression. TAK1 phosphorylation of MAPKs 
leads to the activation of extracellular signal-regulated kinases (ERK), c-Jun N-
terminal kinase (JNK) and p38 pathways, and subsequent gene expression, 
regulated by a number of transcription factors, including AP-1 (Kawasaki and 
Kawai, 2014) (Figure 1.4A). However, studies have demonstrated that TAK1 
activation of MAPK pathways is cell type-specific. TAK1 can activate ERK1/2, p38 
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and JNK in fibroblasts and B-cells (Sato et al., 2005), but does not induce ERK1/2 
activation in monocytes (Lee et al., 2000). 
TLR4 is also capable of utilising the TIR adaptor protein SARM. In unstimulated 
cells, SARM and TRIF interact with each other weakly. However, following TLR4 
activation by LPS, SARM expression is upregulated and the interaction between 
SARM and TRIF is stabilised (Carty et al., 2006). This complex prevents TRIF from 
interacting with other TLR adapter proteins, thus reducing TRIF mediated TLR 
signalling. It has been shown that SARM inhibits the TRIF-mediated, but not 
MYD88-mediated, activation of NF-κB (Carty et al., 2006). It is hypothesised that 
this negative regulation may function to prevent excessive activation in response 
to LPS by limiting pro-inflammatory gene expression. 
1.3.2.2.2 MYD88 independent pathway 
TLR4 is able to signal without MYD88 by utilising the adaptor molecule TRIF, 
through association with bridging adaptor TRAM. Through the TIR domain, TRIF 
recruits TRAF6. In addition, TRIF contains a receptor-interacting protein (RIP) 
interaction motif, which mediates its interaction with RIP1. The 
serine/threonine kinase RIP1 is required for the activation of TAK1, which leads 
to subsequent activation of the IKK complex resulting in NF-κB and MAPK 
activation (Lu et al., 2008). TRIF signalling also induces interferon response 
genes through the IRF3 transcription factor. TRIF recruits TRAF3, which is 
responsible for activating TANK binding kinase 1 (TBK1) and IKKε. TBK1 and IKKε 
catalyse the dimerisation and nuclear translocation of IRF3 (Oganesyan et al., 
2006). IRF3, together with NF-κB, activate transcription of type 1 interferons 
(Honda et al., 2006) (Figure 1.4B). 
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Figure 1.4: MYD88 dependent and MYD88 independent TLR4 signalling 
Engagement of TLR4 by ligands such as LPS induces receptor dimerisation, activating signalling 
through both MYD88 dependent (A) and MYD88 independent (B) pathways. (A) TIR domains in the 
cytoplasmic portion of TLR4 receptors recruit bridging adaptor TIRAP, which in turn recruits 
MYD88. MYD88 recruits members of the IRAK family (IRAK1, IRAK2 and IRAK4) and TRAF6. 
Ubiquitination (Ub) of this complex recruits and activates the TAK1 complex (TAK1, TAB2 and 
TAB3). TAK1 binds to NEMO and phosphorylates IKKβ, leading to subsequent activation of NF-κB 
signalling through the canonical pathway. TAK1 also activates MAPK signalling pathways JNK, 
ERK and p38, inducing transcription factors such as AP-1. (B) TLR4 TIR domains also facilitate 
binding of bridging adaptor molecule TRAM, which recruits TRIF. TRIF interacts with RIP1, which is 
required for the activation of TAK1 signalling. In addition, TRIF recruits TRAF3, which activates 
TBK1 and IKKε kinases that phosphorylate IRF3. Phosphorylation induced IRF3 dimerisation and 
nuclear translocation, activating the expression of type 1 interferons. 
 
1.3.2.3 Tumour necrosis factor receptors (TNFRs) 
TNFRs are a superfamily of transmembrane receptors that play key roles in 
innate and adaptive immunity. The superfamily contains 29 members, 
characterised by the presence of cysteine-rich domain (CRD) in the extracellular 
region, responsible for binding 19 different tumour necrosis factor (TNF) ligands, 
including the potent inflammatory cytokine TNFα (Li et al., 2013). TNFRs can be 
divided into those containing a DD and those without, known as death receptors 
and activating receptors, respectively. The signalling cascades triggered by 
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TNFRs are diverse, and are determined by which proteins are recruited to their 
intracellular domains. The main pathways induced by TNFRs include the 
activation of NF-κB and MAPK, and apoptosis (Li et al., 2013). 
TNFα binds to two receptors TNFR1 and TNFR2. TNFR1 is expressed ubiquitously 
in almost all cell types, whereas TNFR2 is limited to specific cell types, and 
expressed at lower levels in the resting state (Naude et al., 2011). A number of 
in vivo studies have demonstrated the significant role that TNFR1 plays in the 
immune response. TNFR1 has been shown to be primarily responsible for 
initiating inflammatory responses induced by TNFα (Loetscher et al., 1993, van 
der Poll et al., 1996). Furthermore, a study using Tnfr1 and Tnfr2 deficient mice 
revealed that Tnfr1 deficient mice die from infection, whereas Tnfr2 deficient 
mice are unaffected (Deckert-Schlüter et al., 1998). In addition, while NF-κB 
activation can be induced by both TNFR1 and TNFR2, is has been shown that 
TNFα-induced NF-κB activation occurs predominantly through TNFR1 (McFarlane 
et al., 2001). 
TNFR1 exists in trimeric complexes as a pre-requisite to ligand binding and to 
prevent spontaneous receptor autoactivation (Chan et al., 2000). Upon ligand 
binding, TNFR1 oligomers undergo conformational change, which recruits TNF 
receptor-associated death domain (TRADD) mediated through DD interactions. 
TRADD subsequently recruits RIP1 kinase and TRAF2, where TRAF2 forms strong 
interaction with cellular inhibitor of apoptosis protein (cIAP) 1 and cIAP2. The 
formation of this signalling complex results in ubiquitination of RIP1. The exact 
mechanism utilised by this TNFR1-induced signalling complex to activate NF-κB 
remains unclear, and is the subject of ongoing research [as reviewed by (Wajant 
and Scheurich, 2011)]. However, a number of studies have highlighted the 
importance of RIP1 ubiquitination. Polyubiquitination of RIP1 was shown to be 
critical for IKK activation, and that polyubiquitin chains serve to bind IKK 
regulatory subunit NEMO (Ea et al., 2006, Wu et al., 2006). This led to the 
proposed model that RIP1 polyubiquitin chains provide a scaffold to recruit the 
TAK/TAB complex, allowing TAK1 to phosphorylate IKKβ through its close 
proximity to the IKK complex. Therefore TNFα-induced phosphorylation of IKKβ 
results in the degradation of IκBα, leading to the activation of NF-κB (Figure 
1.5). 
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Figure 1.5: TNFα-induced TNFR1 signalling 
Upon binding of TNFα, TNFR1 oligomers recruit TRADD via interaction with death domains. 
TRADD recruits RIP1 kinase and TRAF2, forming a strong interaction with cIAP1 and cIAP2. As a 
result of the formation of this complex, RIP1 is ubiquitinated (Ub). It is proposed that RIP1 binds to 
NEMO via polyubiquitin chains, bringing the IKK complex in close proximity with the TAK1 
complex, facilitating IKKβ phosphorylation. Phosphorylation of IKKβ leads to subsequent activation 
of NF-κB signalling through the canonical pathway. 
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1.4 NF-κB p50 subunit 
1.4.1 Importance of NFKB1 
The NFKB1 gene encodes the precursor protein p105, which undergoes limited 
proteasomal processing to generate the NF-κB p50 subunit. The NF-κB p50 
subunit is an important dual regulator of inflammation, which can either 
activate or repress inflammatory gene expression depending on the formation of 
heterodimer or homodimer complexes, respectively. Although p50 forms the 
ubiquitously expressed p50:p65 heterodimer complex, p50 is often considered as 
an “accessory” subunit, and is consequently understudied. Research on the 
dynamic regulation of NF-κB function has focussed mainly on the p65 subunit. 
The p65 subunit has received most attention due to the lethal phenotype of 
Rela-/- mice (Gerondakis et al., 2006). Although Nfkb1-/- mice are viable, they 
display a number of complex inflammatory phenotypes, indicating the 
importance of p105/p50 in both innate and adaptive immune responses 
(Gerondakis et al., 2006). 
Studies using Nfkb1-/- mice have shown that p105/p50 is essential for lymphocyte 
function. Mice lacking p105/p50 are defective for B-cell proliferation in response 
to LPS (Sha et al., 1995). In addition, B-cells from Nfkb1-/- mice are also 
defective for differentiation and isotype switching (Snapper et al., 1996). 
Therefore, Nfkb1-/- mice display impaired humoral immune responses (Sha et al., 
1995). Follicular B-cell populations are turned over rapidly in vivo, leading to 
accelerated rates of B-cell apoptosis (Grumont et al., 1998). In addition, 
marginal zone and CD5+ peritoneal B-cells are reduced in Nfkb1-/- mice (Cariappa 
et al., 2000, Pohl et al., 2002). Lack of p105/p50 also impairs T helper (Th) cell 
function. Both Th1 and Th2 cells from Nfkb1-/- mice are impaired in their ability 
to produce effector cytokines such as IFN-γ and IL-4, respectively (Artis et al., 
2005, Artis et al., 2003). It has also been shown that p105/p50 is required for 
granulocyte-macrophage colony-stimulating factor (GM-CSF) production by CD4+ 
T-cells (Campbell et al., 2011). Furthermore, Nfkb1-/- dendritic cells fail to 
promote Th2 differentiation (Artis et al., 2005). Mice lacking p105, but not p50 
have shown the importance of p105 as a suppressor of inflammation. Deletion of 
the p105 C-terminal domain of ankyrin repeats (Nfkb1ΔCT/ΔCT) leads to the 
development of enlarged spleens and lymph nodes, and inflammation of the 
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lungs and livers of Nfkb1ΔCT/ΔCT mice (Ishikawa et al., 1997). Nfkb1-/- mice studies 
have also revealed that p105/p50 is essential for monocyte function. 
Macrophages taken from Nfkb1−/− mice show impaired expression of immune 
effectors IL-6, IL-10 and cyclo-oxygenase 2 (COX2) when stimulated with TLR 
ligands, indicating the importance of p105/p50 in innate immune response (Sha 
et al., 1995, Waterfield et al., 2003, Banerjee et al., 2006). 
Nfkb1-/- mice have been utilised for models of a number of diseases. An 
experimental model mimicking chronic liver disease revealed that Nfkb1-/- mice 
suffer severe chronic inflammation and fibrosis compared to WT mice (Oakley et 
al., 2005). The role of p50 in the resolution of LPS-induced renal inflammation 
was demonstrated, whereby Nfkb1-/- mice expressed elevated levels of 
chemokines, had prolonged renal inflammatory cell infiltration, and reduced 
survival rates (Panzer et al., 2009). Similar results were observed in a model of 
hippocampal inflammation, where Nfkb1-/- mice showed enhanced neutrophil 
infiltration and increased levels of pro-inflammatory gene expression in response 
to LPS (Rolova et al., 2014). Furthermore, during pulmonary infection with 
Escherichia coli, Nfkb1-/- mice expressed elevated levels of chemokines, 
increased inflammation of the lung, and had reduced survival rates, 
demonstrating the role of p105/p50 in a pneumonia model (Mizgerd et al., 
2003). In contrast, Nfkb1-/- mice were shown to be resistant to chronic and acute 
models of arthritis, and mounted a weaker inflammatory response than WT 
mice, showing the importance of p105/p50 in the pathogenesis of inflammatory 
arthritis (Campbell et al., 2011). In addition to acting as suppressor of 
inflammation, p105/p50 has also been reported to have roles as a tumour 
suppressor in a model of hepatocellular carcinoma (HCC) using Nfkb1-/- mice. 
Loss of p105/p50 promotes the development of age-associated chronic liver 
disease, characterised by steatosis, neutrophilia, fibrosis, hepatocyte telomere 
damage and HCC (Wilson et al., 2015). In particular, development of HCC was 
attributed to lack of p50 by utilising an Nfkb1S340A/S340A mouse, carrying a 
mutation which disrupts the formation of p50 homodimers. Wilson et al. (2015) 
showed that p50 homodimers were important for repressing chemokine 
expression in neutrophils. 
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Functional polymorphisms in NFKB1 are significant risk factors for the 
development of a number of human diseases such as inflammatory bowel disease 
(Karban et al., 2004), acute respiratory distress syndrome (Bajwa et al., 2011), 
systemic lupus erythematosus (Cen et al., 2013), chronic obstructive pulmonary 
disease (Huang et al., 2013), common variable immune deficiency (Tuijnenburg 
et al.), as well as a number of cancers (Sun and Zhang, 2007). 
Despite the obvious roles that NFKB1 plays in inflammatory responses and human 
disease, there is a lack of knowledge of the fundamental biochemistry of 
p105/p50. Therefore, understanding p105/p50 function is essential for providing 
insight into how NF-κB activity regulates the immune response. 
1.4.2 p105 processing 
p105 undergoes limited proteasomal processing to generate the p50 subunit, 
however the precise molecular mechanisms involved remain unclear. p105 
processing to p50 occurs in both a constitutive and inducible manner, which 
require prior ubiquitination. Limited proteolysis is an example of a rare case in 
which the proteasome does not completely destroy its target, but only partially 
degrades it. The proteasome requires a glycine-rich region in the N-terminal half 
of p105 (amino acids 376–404) thought to be a poor substrate for the 
proteasome, which acts as a stop signal (Lin and Ghosh, 1996, Orian et al., 
2000). Constitutive processing of p105 may occur co-translationally (Lin et al., 
1998) and post-translationally (Fan and Maniatis, 1991). Signal induced 
processing requires site-specific phosphorylation of the C-terminal region 
(Fujimoto et al., 1995, Heissmeyer et al., 1999, Heissmeyer et al., 2001, 
Salmeron et al., 2001, Lang et al., 2003). In addition, complete degradation of 
p105 may be induced without the generation of p50 (Orian et al., 2000, 
Heissmeyer et al., 2001). 
Initial studies identified phosphorylation of S893 and S907 residues by an 
unknown kinase as important for the proteasomal processing of p105. However, 
it is not clear whether p50 is generated as a result of p105 phosphorylation at 
these sites (Fujimoto et al., 1995). Stimulus induced phosphorylation of S923 by 
IKKβ has been reported to cause complete degradation of p105. However, there 
are conflicting reports as to the contribution of each of these phosphorylations 
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to p105 degradation, which may be cell type-specific (Heissmeyer et al., 1999, 
Heissmeyer et al., 2001, Salmeron et al., 2001, Lang et al., 2003). 
Phosphorylation of p105 at S927 and S932 by IKKβ is well studied (Orian et al., 
2000, Salmeron et al., 2001, Heissmeyer et al., 2001, Lang et al., 2003). 
However, these reports are conflicting as to whether IKKβ-induced 
phosphorylation of S927 and S932 results in complete degradation of p105 or 
limited processing to generate p50. A study by Cohen et al. (2004) suggested 
that IKKβ has two distinct functions: stimulation of degradation and stimulation 
of processing, mediated by two different E3 ligases (Cohen et al., 2004). Indeed 
recruitment of β-transducin repeat-containing (β-TrCP) E3 ligase (Orian et al., 
2000, Lang et al., 2003) results in complete degradation of p105 (Heissmeyer et 
al., 2001), whereas recruitment of Kip1 ubiquitylation-promoting complex 1 
(KPC1) E3 ligase results in p105 processing (Kravtsova-Ivantsiv et al., 2015). In 
addition, KPC1 was shown to also regulate constitutive p105 processing 
(Kravtsova-Ivantsiv et al., 2015). Furthermore, p105 is phosphorylated at S903 
and S907 by glycogen synthase kinase 3β (GSK3β) (Demarchi et al., 2003). In 
resting cells, phosphorylation of these residues by GSK3β stabilises p105, and 
cells lacking GSK3β undergo a higher rate of constitutive p105 processing to p50. 
S903 and S907 are also required for signal induced p105 processing in response to 
TNFα (Demarchi et al., 2003). 
It is important to note that p105 processing does not exclusively function to 
generate the p50 subunit or to liberate bound NF-κB dimers. p105 is also an 
important negative regulator of MAPK activation downstream of a number of 
receptors including the TLRs and TNFRs. A small but distinct pool of p105 is 
bound to TPL-2 (MAP3K8), a serine/threonine kinase belonging to the MAP3K 
family. p105 serves to stabilise TPL-2 in an inactive form and blocks the 
activation of the MAP kinase cascade (Belich et al., 1999, Beinke et al., 2003). 
Activation of TPL-2 is dependent on p105 processing induced by IKKβ 
phosphorylation of p105 S927 and S932. Following phosphorylation, subsequent 
proteasomal degradation of p105 liberates TPL-2 kinase (Beinke et al., 2003, 
Waterfield et al., 2003). Free TPL-2 phosphorylates and activates MEK1/2 and 
triggers a cascade of MAP kinase activity including ERK1/2 (Beinke et al., 2003, 
Waterfield et al., 2003). 
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1.4.3 Regulation of NF-κB p50 activity 
Since NF-κB is involved in such a diverse range of biological processes, strict 
regulation of NF-κB signalling is essential. In particular, NF-κB regulates a large 
number of pro-inflammatory genes such as chemokines (e.g. TNFα, IL6, IL8) 
cytokines (e.g. CXCL1, CXCL2, CCL2) immunoreceptors (e.g. C-C chemokine 
receptor 5 (CCR5), CCR7, CD40) and adhesion molecules (e.g. vascular cell 
adhesion protein 1 (VCAM1), intercellular adhesion molecule 1 (ICAM1), CD44). 
Aberrant or dysregulated NF-κB signalling can result in inappropriate 
inflammatory responses, which can be detrimental to the host. Therefore 
transcriptional activity must be regulated tightly. Given that the NF-κB p50 
subunit is involved in both activating and repressing inflammatory gene 
expression, its activity is regulated through interaction with co-factors and post-
translational modifications (PTMs), in particular phosphorylation. 
1.4.3.1 Regulation of transcriptional activity by interacting proteins 
1.4.3.1.1 BCL-3 
Although rapid induction of the innate immune system is essential for mounting 
the appropriate response to pathogens, the magnitude and duration of pro-
inflammatory genes expression must be limited in some manner. Studies using 
Nfkb1-/- mice revealed that both p105 and p50 have a clear role in the negative 
regulation of inflammation. BCL-3 has been shown to be an essential regulator of 
p50 homodimers, and is required to limit the expression of pro-inflammatory 
genes in a number of immune cells such as macrophages, dendritic cells, and B-
cells (Carmody et al., 2007). BCL-3 functions to stabilise p50 homodimers on DNA 
by preventing their ubiquitination and degradation by the proteasome, therefore 
occupying the promoters of target genes. Although p50 homodimers negatively 
regulate expression by competing with TAD containing dimers for κB sites, p50 
homodimers are ineffective in the absence of BCL-3 interaction (Collins et al., 
2014). The BCL-3 mediated stability of p50 homodimers on gene promoters is 
also crucial for establishing TLR tolerance in macrophages (Carmody et al., 
2007). TLR tolerance is defined as a state of altered responsiveness to TLR 
stimulation, which reduces expression of deleterious pro-inflammatory genes, 
while maintaining expression of pro-resolution effectors (Yan et al., 2012). 
Promoter tolerance is generated by stabilising the p50:p50:DNA inhibitory 
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complex and requires the presence of both BCL-3 and p50 (Carmody et al., 
2007). 
1.4.3.1.2 HDAC-1 
In addition to BCL-3, histone deacetylase 1 (HDAC-1) has been shown to be an 
important regulator of p50 homodimers. HDAC-1 is an abundant mammalian 
histone deacetylase, responsible for chromatin remodelling. Studies utilising 
chromatin immunoprecipitation (ChIP) assays revealed that HDAC-1 is recruited 
to the promoters of pro-inflammatory genes in a p50 dependent manner (Zhong 
et al., 2002, Elsharkawy et al., 2010). These findings provide a mechanism to 
explain the immunosuppressive properties of the p50 subunit: p50:p50:HDAC-1 
complexes repress pro-inflammatory gene expression by condensing chromatin, 
rendering gene promoters inaccessible for transcription. Recently, Cartwright et 
al. (2018) have reported that HDAC-1 directly interacts with p50 homodimers 
bound to the promoters of a subset of NF-κB target genes to repress their 
expression. Mutation of the interaction site altered histone acetylation, and 
resulted in elevated chemokine expression and enhanced neutrophil chemotaxis. 
HDAC-1 interacts with p50 at its NLS, extending the list of NLS-interacting 
factors that regulate p50 activity, alongside BCL-3 and IκBα. (Cartwright et al., 
2018). 
1.4.3.2 Regulation of transcriptional activity by phosphorylation 
The activity of NF-κB subunits is dynamically regulated by a number of PTMs, in 
particular phosphorylation. Phosphorylation controls interaction of NF-κB with 
other co-factors, and the stability, degradation and transcriptional activity of 
NF-κB dimers. Importantly, research is beginning to reveal that certain 
phosphorylation events contribute to the selective regulation of NF-κB 
transcriptional activity in a gene specific manner. Phosphorylation of NF-κB 
subunits function to either enhance or downregulate target gene expression, or 
to modulate transcriptional responses, rather than acting as a simple on/off 
switch for gene transcription. Site-specific phosphorylations regulating 
transcriptional activity can be a consequence of signalling from upstream 
components of the NF-κB pathway, such as IKKα and IKKβ. NF-κB can also be 
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phosphorylated by kinases from other signalling pathways, providing crosstalk 
with multiple signalling networks (Christian et al., 2016). 
To date, research of NF-κB subunit phosphorylation has focussed mainly on the 
p65 subunit. A number of studies have identified and functionally described 22 
phosphorylation sites (www.phosphosite.org). Two of the most well 
characterised p65 phosphorylation sites are S276 and S536. S276 and S536 are 
phosphorylated by a number of different kinases, which have distinct outcomes 
for p65 regulation (Christian et al., 2016). These include transcriptional 
activation or inhibition, enhanced DNA binding, regulation of interaction with 
other modulators or further modification of the subunit by additional PTMs. In 
particular, studies have shown evidence of selective gene expression regulated 
by phosphorylation. Anrather et al. (2005) showed that phosphorylation of p65 at 
multiple residues including S276 regulates p65 transcriptional activity in a κB 
site-specific manner, using reporter constructs (Anrather et al., 2005). 
Furthermore, Hochrainer et al. (2013) demonstrated that S276 phosphorylation 
regulates the expression of a distinct subset of NF-κB target genes in the context 
of endogenous gene promoters (Hochrainer et al., 2013). In addition, Moreno et 
al. (2010) revealed that phosphorylation of S536 selectively regulates the 
induction and repression of NF-κB target genes, demonstrated by using a S536A 
phospho-mutant. This led to the proposal of the NF-κB barcode hypothesis which 
suggests that post-translational modifications of NF-ĸB subunits, either alone or 
in combination, generate distinct functional states that direct transcription in a 
gene specific manner (Moreno et al., 2010). 
To date, the majority of the p105/p50 phosphorylation sites identified are 
located in the C-terminal region of p105 and regulate the processing of p105 by 
the proteasome (described in section 1.4.2) (Christian et al., 2016) (Figure 1.6). 
Phosphorylation of the p50 subunit is much less well understood, and to date 
only 4 p50 phosphorylation sites have been studied in detail: S337, S242, S20 and 
S328 (positions highlighted in Figure 1.6). 
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Figure 1.6: Phosphorylation of NFKB1 
Schematic representation of human NFKB1 protein, highlighting the positions of experimentally 
identified phosphorylation sites known to regulate activity (yellow octagons). Principal structural 
motifs are indicated, including a Rel homology domain (RHD) consisting of a DNA binding and 
dimerisation region; a glycine rich region (GRR); an ankyrin repeat domain (ANK) and a death 
domain (DD). Amino acid residue numbering corresponds to human protein sequence. 
 
The phosphorylation of p50 at S337 is critical for DNA binding. S337 lies in a 
protein kinase A (PKA) consensus site and PKA has been demonstrated to 
phosphorylate p50 at S337 in vitro and in vivo (Hou et al., 2003). It was also 
reported that p50 S337 is constitutively phosphorylated by PKA (Guan et al., 
2005). Substitution of serine residues S65 and S342 with alanine (A) also abolish 
p50 DNA binding but there is, as of yet, no demonstration that these sites are 
phosphorylated (Hou et al., 2003). Recently, S242 was identified by mass 
spectrometry as a phosphorylation site for checkpoint protein kinase 1 (Chk1) 
(Vonderach et al., 2018). Phosphorylation of S242 by Chk1 is key for p50 
homodimer binding. S242 lies in the DNA binding interface of p50, close to a 
critical lysine residue required for interacting with DNA. A phosphomimetic 
mutant, where p50 S242 was substituted to aspartate (D), p50 exhibited a >10-
fold reduction in DNA binding affinity compared to wild type p50 (Vonderach et 
al., 2018). In addition, this study reported that phosphorylation of S337 by both 
Chk1 and PKA is critical for the regulation of p50 homodimer formation. 
Specifically, phosphorylation of S337 by both kinases disrupted p50 
homodimerisation (Vonderach et al., 2018). These findings are in contrast with 
Hou et al. (2003), who report that mutation of S337 does not affect 
dimerisation. Phosphorylation of human p50 at S20 by DNA-dependent protein 
kinase (DNA-PK) is critical for expression of VCAM1 in response to TNFα (Ju et 
al., 2010). However, this serine residue is not conserved in mouse p50 and so it 
appears that the regulation of p50 function by phosphorylation at this site is 
specific to human. 
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The phosphorylation of S328 by Chk1 is triggered by DNA damage and regulates 
the interaction of p50 with specific NF-κB binding elements based on the κB site 
nucleotide sequence (Crawley et al., 2013). S328 phosphorylation reduces the 
affinity of p50 for κB sites with a cytosine (C) at the -1 position, without 
affecting binding to κB sites containing a -1 adenine (A). The differential 
interaction between phospho-p50 and specific κB sequences regulates the 
transcriptional response following DNA damage by inhibiting the expression of 
anti-apoptotic genes. As a consequence, p50 S328 phosphorylation promotes DNA 
damage induced cytotoxicity (Crawley et al., 2015). In genes with multiple κB 
sites, the presence of a single κB site with a C at the -1 position is sufficient to 
inhibit NF-κB-dependent activity. The studies of p50 S328 phosphorylation 
provide the strongest evidence to date that p50 phosphorylation can selectively 
regulate p50 transcriptional activity by modulating DNA binding in a sequence 
specific manner. The inhibition of gene specific transcription by p50 S328 
phosphorylation presumably occurs through altered DNA binding of p50 
containing heterodimers (e.g. p50:p65). Given that p50 has been shown to be an 
important negative regulator of inflammatory gene expression (Carmody et al., 
2007, Collins et al., 2014) S328 phosphorylation of p50 homodimers may also 
have an important and distinct impact on transcriptional outcomes. 
An additional serine residue of p50, S340, has been recently shown to be 
important for the formation of p50 homodimers (Wilson et al., 2015). The 
mutation of S340 to alanine leads to a loss of p50 homodimers. S340A knock-in 
mice recapitulate the Nfkb1-/- phenotype in the hepatocellular carcinoma model 
(described previously in section 1.4.1). However, to date, there is no direct 
evidence that S340 is phosphorylated. Although, given the recent findings by 
Vonderach et al. (2018), who report that phosphorylation of p50 S337 by Chk1 
and PKA destabilises p50 dimerisation, it is plausible that p50 S340 
phosphorylation may regulate dimer formation. 
It is clear that phosphorylation of NF-κB subunits plays an important role in 
regulating transcriptional activity. In particular, site-specific phosphorylation of 
NF-κB subunits regulates gene expression in a selective manner. However, there 
is still a considerable gap in our mechanistic understanding of how 
phosphorylation events coordinate NF-κB transcriptional specificity. There is 
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evidence to suggest that the sequence of NF-κB binding sites in DNA contributes 
to the selective effects of certain phosphorylation events. However, it is equally 
clear that the phosphorylation of NF-κB subunits may also regulate the 
interaction with other factors which in turn may determine transcriptional 
outcome. Understanding gene-specific regulatory mechanisms will be key to 
elucidating distinct transcriptional profiles that are regulated by NF-κB 
phosphorylation. 
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1.5 Thesis aims 
The NF-κB subunit p50 is an essential dual regulator of inflammation, playing 
important roles in human health and disease. Despite its importance, the 
regulation of p50 transcriptional activity is understudied. Site-specific 
phosphorylation has been shown to be a key regulator of p65 mediated 
inflammatory gene expression, however there is a lack of research investigating 
the importance of p50 phosphorylation. A novel phosphorylation site at S80 on 
the p50 subunit has been identified, and is phosphorylated by IKKβ. It is 
hypothesised that S80 phosphorylation regulates inflammation in a gene specific 
manner. The aims of this thesis were to: 
1. Generate NFKB1S80A human cell lines utilising CRISPR/Cas9 genome editing 
techniques to create tools to investigate the role of NF-κB p50 S80 
phosphorylation in vitro. 
2. Investigate the transcriptomic profile regulated by p50 S80 
phosphorylation utilising RNA sequencing analysis. 
3. Investigate the mechanism of S80 phosphorylation in the regulation of 
inflammatory gene expression. 
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Chapter 2 
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2 General materials and methods 
2.1 Materials 
2.1.1 Antibodies 
Antibody Clone Supplier (Catalogue No.) 
α-Tubulin B-5-1-2 Sigma Aldrich (T6074) 
β-Actin ac-15 Sigma Aldrich (A5441) 
HDAC1 H-51 Santa Cruz (sc-7872) 
HDAC1 Polyclonal Sigma Aldrich (AV 38530) 
IκBα  44D4 Cell Signaling (4821) 
Phospho–IκBα (Ser32/36) 5A5 Cell Signaling (9246) 
NF-κB1 p105/p50 D7H5M Cell Signaling (12540) 
NF-κB1 p50 C-19 Santa Cruz (sc-1190) 
p38 MAPK Polyclonal Cell Signaling (9212) 
Phospho-p38 MAPK Thr180/Tyr182 Cell Signaling (9211) 
p44/42 MAPK(ERK1/2)  p44/42 Cell Signaling (9102) 
Phospho-p44/42 
MAPK(ERK1/2) 
Thr202/Tyr204 Cell Signaling (9101) 
NF-κB p65 C-20 Santa Cruz (sc-372) 
RelA Polyclonal Bethyl Laboratories (A301-
824A) 
Xpress XP Invitrogen (R910-25) 
Table 2.1: Primary antibodies 
 
Antibody Clone Supplier (Catalogue No.) 
Anti-mouse IgG HRP Whole Ab Amersham (NA931) 
Anti-rabbit IgG HRP Whole Ab Amersham (NA934) 
Rabbit-anti-goat IgG-HRP Whole Ab Santa Cruz (sc-2354) 
Mouse-anti-goat IgG-HRP Whole Ab Santa Cruz (sc-2768) 
Table 2.2: Secondary antibodies 
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2.1.2 Reagents 
All general salts and chemicals were purchased from Sigma Aldrich UK unless 
otherwise stated, and were stored and prepared according to the manufacturer’s 
instructions. 
2.1.3 Buffers 
2.1.3.1 Electrophoresis buffers 
0.5X Tris-borate-EDTA (TBE) buffer 
5.4g Tris (Fisher Scientific) 
2.75g boric acid 
2ml 0.5M EDTA 
Table 2.3: Agarose gel electrophoresis buffer 
 
1X Running buffer 1X Transfer buffer 
25mM Tris 
250mM glycine (Fisher Scientific) 
0.1% SDS 
48mM Tris 
39mM glycine 
0.0375% SDS 
20% methanol (Fisher Scientific) 
Table 2.4: Western blot electrophoresis buffers 
 
2.1.3.2 Electrophoresis gels 
Agarose gel 
1.5% agarose (Bio-Rad) 
0.5X TBE buffer 
1X GelRed (Biotum) 
Table 2.5: Agarose gel recipe 
 
 Gel 
Reagent 5% Stacking (total 1ml) 10% Resolving (total 5ml) 
H2O 0.68ml 1.9ml 
30% acrylamide 0.17ml 1.7ml 
1.0M Tris-HCl (pH6.8) 0.13ml - 
1.5M Tris-HCl (pH8.8) - 1.3ml 
10% SDS 0.01ml 0.05ml 
10% APS 0.01ml 0.05ml 
TEMED 0.001ml 0.002ml 
Table 2.6: SDS-PAGE gel recipes 
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2.1.3.3 Sample buffers 
2X SDS Sample buffer 5X SDS Sample buffer 
100mM Tris-HCl (pH6.8) 
4% (w/v) SDS  
0.2% (w/v) bromophenol blue 
20% (w/v) glycerol 
200mM β-mercaptoethanol 
250mM Tris-HCl (pH6.8) 
10% (w/v) SDS 
0.02% (w/v) bromophenol blue 
30% (w/v) glycerol 
5% β-mercaptoethanol 
Table 2.7: SDS-PAGE sample buffers 
 
2.1.3.4 Assay buffers 
Radioimmunoprecipitation assay (RIPA) buffer 
50mM Tris-HCl pH7.4 
150mM NaCl 
0.25% Na Deoxycholate 
1mM EDTA pH8.0 
1% Nonidet P-40 
1mM NaF* 
1mM Na3VO4* 
1mM PMSF* 
1µg/ml leupeptin* 
2µg/ml aprotinin* 
2µg/ml pepstatin* 
Table 2.8: RIPA buffer 
*Added fresh on day of use 
 
DNA affinity purification assay (DAPA) buffer 
10mM Tris-HCl pH7.5 
50mM NaCl 
1mM DTT* 
5% glycerol 
1mM EDTA 
1mM NaF* 
1mM Na3VO4* 
1mM PMSF* 
1µg/ml leupeptin* 
2µg/ml aprotinin* 
2µg/ml pepstatin* 
Table 2.9: DAPA buffer 
*Added fresh on day of use 
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2.1.4 Plasmids 
Plasmid Source 
pPGKpuro A gift from Rudolf Jaenisch (Addgene plasmid # 
11349) 
pSpCas9(BB)-2A-GFP 
(PX458) 
A gift from Feng Zhang (Addgene plasmid # 
48138) 
gRNA/Cas9 This study 
pTAL-Luc Purchased from Clontech (Catalogue no. 631909) 
pTAL-Luc-NFKB-AA This study 
pTAL-Luc-NFKB-AC This study 
pTAL-Luc-NFKB-GA This study 
pTAL-Luc-NFKB-GC This study 
pRL-TK Purchased from Promega (Catalogue No. E2241) 
pEF4a p50WT Xpress Carmody lab stocks 
pEF4a p50S80A Xpress Carmody lab stocks 
Table 2.10: Plasmids sources 
 
2.2 Methods 
2.2.1 Cell culture 
2.2.1.1 Maintenance 
Human embryonic kidney 293T (HEK293T) cells were cultured in high glucose 
Dulbecco’s Modified Eagle Medium (DMEM), supplemented with 10% heat-
inactivated fetal bovine serum (FBS) (Invitrogen), 2mM L-glutamine, and 100 
units/ml of streptomycin and penicillin. Cells were sub-cultured by enzymatic 
detachment with 0.05% Trypsin-EDTA solution (Invitrogen). THP-1 cells were 
cultured in Roswell Park Memorial Institute (RPMI) 1640 media, supplemented 
with 10% heat-inactivated FBS, 2mM L-glutamine, and 100 units/ml of 
streptomycin and penicillin. All cells were maintained at 37°C in a humidified 
environment with 5% CO2. 
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2.2.1.2 Plating 
Tissue culture plating conditions used for endogenous assays are described in 
Table 2.11. 
Cell type Assay Plate/dish Cell number 
HEK293T Endogenous protein 6-well plate 1x106 
Nuclear translocation 6cm dish 2x106 
DAPA 10cm dish 7.5x106 
Endogenous IP 10cm dish 7.5x106 
RNA-seq/qPCR 6-well plate 1x106 
THP-1 Endogenous protein 24-well plate 0.45x106 
Nuclear translocation 6-well plate 1.5x106 
RNA seq/qPCR 24-well plate 0.45x106 
Table 2.11: Plating conditions for endogenous assays 
 
2.2.1.3 Transfection 
2.2.1.3.1 Functional assays 
Transfection conditions for functional assays are described in Table 2.12. WT 
HEK293T cells were transfected with Turbofect (ThermoFisher Scientific), 
according to the manufacturer’s instructions. 
Assay Cell number Plate/dish Plasmid concentration 
Dual luciferase assay 1x105 24-well plate 100ng Firefly: 10ng Renilla 
Limited proteolysis 2x106 6-well plate 1µg of each plasmid 
Table 2.12: Transfection conditions for functional assays 
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2.2.1.3.2 CRISPR/Cas9 genome editing 
Transfection conditions used for CRISPR/Cas9 genome editing are described in 
Table 2.13. 
Cell type Buffer Cell number Electroporation 
parameters  
DNA 
concentration 
HEK293T R 5x107 cells/ml 
(5x106 
cells/transfection) 
2 pulses 
1100v 
20ms 
2µg pPGKpuro: 
4µg pX458 sgRNA: 
4µg ssODN 
THP-1 T 4x107 cells/ml 
(4x105 
cells/transfection) 
2 pulses 
1400v 
20ms 
20pmol Cas9: 
20pmol sgRNA: 
10pmol ssODN 
Table 2.13: Transfection conditions for CRISPR/Cas9 genome editing 
 
2.2.1.4 THP-1 differentiation 
THP-1 cells were resuspended at a density of 1x106/ml before plating as 
described in Table 2.11. THP-1 cells were treated with 25ng/ml PMA for 72 
hours. Following differentiation, PMA-containing media was removed, cells were 
washed once in THP-1 culture media, and cells were replaced with fresh THP-1 
culture media. Cells were either treated immediately, or were rested in culture 
for 4 days before treatment. 
2.2.2 Protein analysis 
2.2.2.1 Protein extraction 
2.2.2.1.1 Non-denaturing whole cell extracts 
Cell culture media was aspirated from tissue culture plates or dishes, and cells 
were washed gently with cold PBS. HEK293T cells and differentiated THP-1 cells 
were detached with cold PBS or cold PBS/5mM EDTA, respectively. Cells were 
pelleted by centrifugation at 11,000g for 45 seconds, and supernatants were 
removed. Cell pellets were resuspended in radioimmune precipitation assay 
(RIPA) buffer. Cells were incubated on ice for 30 minutes, and were vortexed 
every 5 minutes to lyse cells. Lysates were cleared by centrifugation at 16,000g 
for 10 minutes at 4°C. Supernatants were collected and analysed immediately, 
or stored at either -20°C or -80°C for long term storage. 
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2.2.2.1.2 Nuclear/cytoplasmic extracts 
Nuclear and cytoplasmic extracts were isolated from cells utilising the Nuclear 
Extract Kit (Active Motif) according to the manufacturer’s instructions with one 
additional step: nuclear pellets were washed with 1X hypotonic buffer before 
resuspension in complete lysis buffer for nuclear extraction. 
2.2.2.2 Quantification 
Protein concentrations for whole cell, cytoplasmic and nuclear extracts were 
quantified using a Bradford protein assay (Bio-Rad), where 1µl of extract was 
diluted in 1ml 1X Bradford reagent. A 6-point standard curve between 0-9µg/ml 
of bovine serum albumin (BSA) was utilised to determine unknown protein 
concentrations. The absorbance of each sample was measured in triplicate at 
595nM using a spectrophotometric 96-well plate reader. 
2.2.2.3 Western blotting 
Protein samples were resolved by sodium dodecyl sulphate (SDS) polyacrylamide 
gel electrophoresis (PAGE) using the Mini-PROTEAN Tetra Cell System (Bio-Rad). 
Samples were diluted in either 2X or 5X SDS sample buffer (Table 2.7) and were 
resolved on 10% acrylamide gels (Table 2.6) at 100-120V for 90 minutes in 1X 
Tris-glycine running buffer (Table 2.4). Resolved proteins were subsequently 
transferred to Amersham Protran 0.45µM NC nitrocellulose Western blotting 
membranes (GE healthcare) in 1X Tris-glycine transfer buffer (Table 2.4) using 
the Mini Trans-Blot Electrophoretic Transfer System (Bio-Rad). To block non-
specific binding, membranes were incubated in 5% fat free milk (Marvel)/PBS-
Tween 20 (0.05%) (PBS-T) solution. 
Membranes were probed with primary antibodies in 5% fat free milk/PBS-T 
solution or 5% BSA/PBS-T solution overnight at 4°C, and with secondary 
antibodies in 5% fat free milk/PBS-T solution for 1 hour at room temperature. 
Washed 3 times in PBS-T for 5 minutes. After each antibody incubation, 
membranes were washed in PBS-T 3 times for 5 minutes. To detect bound 
proteins, Western Bright ECL or Western Bright Sirius (Advansta) 
chemilumiescent substrates were used according to the manufacturer’s 
instructions. Membranes were scanned using C-DiGit Blot Scanner (LI-COR) on 
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either standard or high sensitivity settings. Protein size was determined using a 
pre-stained molecular weight ladder (ThermoFisher Scientific), marked on 
membranes using a chemiluminescent marker (LI-COR). Western blot images 
were visualised and quantified using Image Studio Lite Version 5.2 (LI-COR). If 
proteins of interest were of similar or identical size, membranes were stripped 
using Restore Plus Western Blot Stripping Buffer (ThermoFisher Scientific) 
according to manufacturer’s instructions, before re-blocking and re-probing the 
membrane. 
2.2.3 Functional assays 
2.2.3.1 Immunoprecipitation (IP) 
For endogenous immunoprecipitation assays, cells were plated as described in 
Table 2.11. Cells were treated with 10ng/ml TNFα prior to harvest. Whole cell 
lysates were prepared as described in section 2.2.2.1.1. Equivalent 
concentrations of whole cell lysates were resuspended in a total of 1ml RIPA 
buffer. Samples were pre-cleared for 30 minutes at 4°C with 20µl protein G 
agarose beads (Millipore). Pre-cleared lysates were immunoprecipitated with 
primary antibody (5µl NF-κB1 p105/p50) overnight at 4°C with 20µl of fresh 
agarose beads. Beads were pelleted at 11,000g for 10 seconds and supernatant 
was discarded. Pellets were washed three times in RIPA buffer were and 
resuspended in equal volumes of 2X SDS loading dye. Samples were boiled for 5 
minutes at 95°C and were centrifuged at 16,000g for 2 minutes. Denatured 
eluates were resolved by SDS-PAGE and analysed by western blot. 
2.2.3.2 DNA affinity purification assay (DAPA) 
5’-biotinylated and unlabelled single-stranded oligonucleotides were purchased 
from Eurofins Genomics (Table 2.14). Single-stranded oligonucleotides were 
dissolved in sterile deionised water to a final concentration of 1µg per 1 to 2µl. 
Equal quantities of either 5’-biotinylated sense and unlabelled antisense, or 
unlabelled sense and antisense single-stranded oligonucleotides were annealed 
by heating to 95°C for 5 minutes and allowed to cool to room temperature (>1 
hour). 
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Oligo-
nucleotide 
name 
Sense (5’-3’) Antisense (5’-3’) 
AA AGTTGAGGGGAATTTCCCAGGC GCCTGGGAAATTCCCCTCAACT 
AC AGTTGAGGGGACTTTCCCAGGC GCCTGGGAAAGTCCCCTCAACT 
GA AGTTGAGGGGGATTTCCCAGGC GCCTGGGAAATCCCCCTCAACT 
GC AGTTGAGGGGGCTTTCCCAGGC GCCTGGGAAAGCCCCCTCAACT 
Table 2.14: DAPA oligonucleotides 
 
Cells were plated as described in Table 2.11. Cells were left untreated or 
treated with 10ng/ml TNFα for 30 minutes. Nuclear extracts were prepared as 
described in section 2.2.2.1.2. DAPA reactions were prepared by mixing 1.5µg of 
5’-biotinylated double-stranded oligonucleotides with 150µg of nuclear extract 
and 15µl streptavidin-agarose beads in a total of 500µl DAPA buffer. Unlabelled 
double-stranded oligonucleotides were added in 10-fold excess to confirm 
binding specificity. Reactions were incubated at room temperature on a rotator 
for 1 hour. Beads were pelleted by centrifugation at 550g for 10 seconds, and 
the supernatant was discarded. Beads were washed in 500µl DAPA buffer by 
inverting reaction tubes 10 times. The wash step was repeated twice. To elute 
DNA-bound proteins, beads were resuspended in 20µl of 2X SDS sample buffer, 
and incubated at 95°C for 5 minutes. Samples were vortexed for 10 seconds, 
then centrifuged at 16,000g for 2 minutes. Eluates were resolved on SDS-PAGE 
gels and analysed by Western blot. 
2.2.3.3 Dual luciferase assay 
Four different luciferase reporter constructs that contained four κB site repeats 
that vary at either the -2 or the -1 position immediately upstream of a minimal 
promoter and firefly luciferase reporter gene were generated. Oligonucleotides 
purchased from Eurofins Genomics (Table 2.15) were annealed by heating to 
95°C for 5 minutes and allowed to cool to room temperature (>1 hour). Annealed 
oligonucleotides were ligated into pTAL-Luc plasmid backbone via NheI and BglII 
restriction site cloning, using techniques described in section 2.2.7. 
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Oligonucleotide name Forward (5’-3’) Reverse (5’-3’) 
NFKB_AA CTAGCGGGAATTTCCGGG
AATTTCCGGGAATTTCCG
GGAATTTCCA 
GCCCTTAAAGGCCCTTAA
AGGCCCTTAAAGGCCCTT
AAAGGTCTAG 
NFKB_AC CTAGCGGGACTTTCCGGG
ACTTTCCGGGACTTTCCG
GGACTTTCCA 
CTAGCGGGTGTTTCCGG
GTGTTTCCGGGTGTTTCC
GGGTGTTTCCA 
NFKB_GA CTAGCGGGGATTTCCGG
GGATTTCCGGGGATTTCC
GGGGATTTCCA 
CTAGCGGGCTTTTCCGGG
CTTTTCCGGGCTTTTCCG
GGCTTTTCCA 
NFKB_GC CTAGCGGGGCTTTCCGG
GGCTTTCCGGGGCTTTCC
GGGGCTTTCCA 
CTAGCGGGCGTTTCCGG
GCGTTTCCGGGCGTTTCC
GGGCGTTTCCA 
Table 2.15: κB site repeat oligonucleotides 
 
Luciferase assays were performed using the Dual-Luciferase® Reporter Assay 
System (Promega). Cells were transiently transfected as described in Table 2.12 
for 24 hours. Co-transfection of Renilla luciferase expression vector pRL-TK was 
used as an internal control for all reporter assays. Cells were cultured with or 
without 10ng/ml TNFα for an additional 8 hours before harvest. Cells were 
washed once in cold PBS and lysed in 100µl passive lysis buffer. 15µl of lysate 
was added to 75µl LAR II buffer, and firefly luciferase activity was determined. 
75µl of Stop & Glo® buffer was then added, and Renilla luciferase activity was 
determined. All measurements were performed for 2 seconds on a Microbeta 
Luminescence Counter (PerkinElmer). To normalise the transfection efficiency 
across all samples, firefly luciferase activity was divided by that of Renilla. 
2.2.3.4 Limited proteolysis 
For analysis of overexpressed p50, cells were transiently transfected with either 
p50WT-XP or p50S80A-XP plasmids as described in Table 2.12 for 24 hours. For 
analysis of endogenous p50, cells were plated as described in Table 2.11. Cell 
were treated with 10ng/ml TNFα for 30 minutes prior to harvest. Harvested and 
washed cells were lysed in RIPA buffer lacking protease inhibitors to extract 
whole cell lysates. Limited proteolysis was performed by adding varying ratios of 
trypsin to 50µg of protein, and incubating the reaction mixture for 30 minutes at 
37°C. Proteolysis was terminated by adding 5X SDS sample buffer to the reaction 
and boiling for 5 minutes at 95°C. Samples were resolved by SDS-PAGE and 
analysed by western blot. 
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2.2.4 CRISPR/Cas9 genome editing 
CRISPR/Cas9 genome editing was carried out with the technical assistance of Mr 
David Kerrigan. 
2.2.4.1 Design and synthesis of CRISPR/Cas9 materials 
The guide RNA (gRNA) (5’-ACAAACTTACTTTGACCTGA-3’) used to target the S80 
codon was designed using the Broad Institue sgRNA Designer: CRISPRko design 
tool (https://portals.broadinstitute.org/gpp/public/analysis-tools/sgrna-design). 
Off-target effects of the gRNA were predicted using the Benchling gRNA Design 
and Analysis tool (https://benchling.com/crispr). Design of the single-stranded 
DNA oligonucleotide (ssODN) homology directed repair (HDR) template was 
assisted by using the HR Template Design tool (https://benchling.com/crispr). 
For generation of the gRNA/Cas9 plasmid for genome editing in HEK293T cells, 
complementary oligonucleotides with overhangs required for cloning were 
purchased from Eurofins Genomics (Table 2.16). Complementary gRNA oligos 
were annealed, phosphorylated and cloned into PX48, according to the Zhang 
Lab General Cloning Protocol (http://www.addgene.org/crispr/zhang/). Sense 
and antisense ssODNs (Table 2.16) were ordered from IDT as 4 nmole ultramer® 
DNA oligos. For genome editing in THP-1 cells, a synthetic gRNA (5’-
ACAAACTTACTTTGACCTGA-3’) and purified Cas9 protein were purchased from 
Synthego. 
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Oligonucleotide 
name 
Description Sequence (5’-3’) 
gRNA 1F Guide RNA CACCGACAAACTTACTTTGACCTGA 
gRNA 1R Guide RNA AAACTCAGGTCAAAGTAAGTTTGTC 
HEK293T_F Primer (PCR and 
sequencing) 
ACCTGGCTTTTTAGCCATATCT 
HEK293T_R Primer (PCR and 
sequencing) 
TTCAGCTTAGGAGCGAAGGC 
THP1_F Primer (PCR and 
sequencing) 
TGTATGTACCTTTGTTGCCGT 
THP1_R Primer (PCR and 
sequencing) 
CTCCAAAGAGTCAAAATCAACCA 
THP1_R2 Primer (PCR) CTTTGACCTGAGGGTAAGACT 
S80A sense ssODN HDR 
template 
AGAGGATTTCGTTTCCGTTATGTATGTGAAG
GCCCATCCCATGGTGGACTACCTGGTGCCTC
TAGTGAAAAGAACAAGAAAGCTTATCCTCAG
GTCAAAGTAAGTTTGTGGTAGCTCTCCTTCT
ATTTGAATTCTGGAAATTTTGATTTCCTACG
ATTTCCAAGGAATT 
S80A antisense ssODN HDR 
template 
AATTCCTTGGAAATCGTAGGAAATCAAAATT
TCCAGAATTCAAATAGAAGGAGAGCTACCAC
AAACTTACTTTGACCTGAGGATAAGCTTTCT
TGTTCTTTTCACTAGAGGCACCAGGTAGTCC
ACCATGGGATGGGCCTTCACATACATAACGG
AAACGAAATCCTCT 
1F1R OffTar-1 F Primer (PCR and 
sequencing) 
TGGCTAGTTGCACATTGCTC 
1F1R OffTar-1 R Primer (PCR and 
sequencing) 
TTTGGCAGAATTTCTCAGACTGC 
1F1R OffTar-2 F Primer (PCR and 
sequencing) 
TGCAGTGTAGTCCACACAAACT 
1F1R OffTar-2 R Primer (PCR and 
sequencing) 
TCGTTGAGTGCCTTCCAAGT 
1F1R OffTar-3 F Primer (PCR and 
sequencing) 
GTTAATCCTGCCCCTCGCTC 
1F1R OffTar-3 R Primer (PCR and 
sequencing) 
ACCCCAATTTTCATGCAGTGG 
1F1R OffTar-4 F Primer (PCR and 
sequencing) 
ACCAAAGGTAGCAGGTAGAACC 
1F1R OffTar-4 R Primer (PCR and 
sequencing) 
CCCCAGGAGTCAGCAGACATA 
1F1R OffTar-5 F Primer (PCR and 
sequencing) 
GCTTCTGAGCACAGTTCCTTC 
1F1R OffTar-5 R Primer (PCR and 
sequencing) 
GGGCATGTTCCTCTCATGGC 
Table 2.16: Oligonucleotides used for CRISPR/Cas9 genome editing 
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2.2.4.2 CRISPR/Cas9 editing of HEK293T cells 
A T150 flask of HEK293T cells (~80% confluent) were treated with 200ng/ml 
nocodazole for 16 hours. Following treatment, cells were washed twice with 
tissue culture media, trypsinised and cell density was determined. Cells were 
centrifuged at 300g for 5 minutes and supernatant was discarded. Cells were 
washed with Mg2+ and Ca2+ free PBS, centrifuged at 300g for 5 minutes and 
supernatant was discarded. HEK239T cells were transfected using the NEON® 
Transfection System 100µl kit (ThermoFisher Scientific), according to the 
manufacturer’s instructions. Specific transfection conditions and parameters are 
described in Table 2.13. Electroporated cells were plated into a 10cm dish 
containing 10ml tissue culture media and were left to recover overnight. 
Transfected cells were selected for 3 days with 3µg/ml of puromycin. After 
selection, puromycin media was removed and HEK293T cells were washed and 
replaced with fresh tissue culture media. Selected cells were grown until 
confluent, and used for serial dilution in 96-well plates to isolate single cell 
clones. 
2.2.4.3 CRISPR/Cas9 editing of THP-1 cells 
The density of THP-1 cells grown in T75 flasks was determined before being 
pelleted by centrifugation at 300g for 5 minutes. Supernatant was discarded, 
and cells were washed with Mg2+ and Ca2+ free PBS. Cells were centrifuged at 
300g for 5 minutes, and supernatant was discarded. THP-1 cells were 
transfected using the NEON® Transfection System 10µl kit (ThermoFisher 
Scientific), according to the manufacturer’s instructions. Specific transfection 
conditions and parameters are described in Table 2.13. Cas9 nuclease protein 
and the synthetic gRNA were mixed and incubated at room temperature for 10 
minutes to facilitate formation of ribonucleoprotein complexes (RNPs) before 
addition to the transfection reaction mixture. Electroporated cells were plated 
into a 24-well plate containing 500µl tissue culture media and were left to 
recover for 72 hours. To increase efficiency of identifying single cell clones, 
transfected cells were treated with 20µM CellTracker™ Green CMFDA dye 
(ThermoFisher Scientific) 24 hours prior to single cell sorting into 96-well plates 
by flow cytometry using a BD FACSAria III cell sorter. 
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2.2.4.4 Screening CRISPR/Cas9 clones 
To screen single cell clones, genomic DNA was extracted from HEK293T and THP-
1 cells using the DNeasy Blood & Tissue Kit (QIAGEN) according to the 
manufacturer’s instruction. The target region of DNA was first analysed by PCR 
amplification using primers shown in Table 2.16 and methods described in 
section 2.2.7. Clones were screened for homology directed repair (HDR) by 
restriction digest with HindIII restriction enzyme, using methods described in 
2.2.7. Clones positive for HDR were sent for Sanger sequencing (GATC-Biotech, 
Germany). NFKB1S80A positive clones were expanded and cryopreserved in FBS 
supplemented with 10% DMSO. 
2.2.5 Transcriptomic analysis 
2.2.5.1 RNA sequencing (RNA-seq) 
WT and NFKB1S80A HEK293T or THP-1 cells were left untreated or were treated 
for 3 hours with 10ng/ml TNFα or LPS, respectively. Total RNA was extracted 
from cells using the RNeasy kit (QIAGEN), according to the manufacturer’s 
instructions. Triplicate samples of each condition were submitted to the 
University of Glasgow Polyomics Facility for sample QC, polyA library preparation 
(Truseq stranded mRNA kit). Illumina NextSeq™ 500 platform was used to 
sequence single-end 75bp reads to a depth of 20 million. 
2.2.5.2 Quantitative PCR (qPCR) 
WT and NFKB1S80A HEK293T or THP-1 cells were left untreated or were treated 
with 10ng/ml TNFα or LPS, respectively. Total RNA was extracted from using the 
RNeasy kit (QIAGEN), according to the manufacturer’s instructions. Isolated RNA 
was primed with random hexamer oligonucleotides and reverse transcribed using 
Primer Design precision nanoScript2 reverse transcription kit to generate cDNA, 
according to the manufacturer’s instructions. qPCR was performed with 
PerfeCTa® SYBR®Green FastMix®, ROX™ (Quantabio) and QuantiTect primers 
(QIAGEN) shown in Table 2.17. All data were normalised to TBP. Gene expression 
changes were calculated using the 2-ΔΔCT method (Livak and Schmittgen, 2001). 
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Gene Catalogue No. 
BCL3 QT00012404 
CCL2 QT00212730 
CSF1 QT00035224 
CXCL2 QT00013104 
IL6 QT00083720 
IL8 QT00000322 
MAP3K8 QT00051730 
NFKB1 QT00063791 
TBP QT00000721 
TNF QT00029162 
Table 2.17: QuantiTect primers used for qPCR 
 
2.2.6 Bioinformatics 
2.2.6.1 RNA-seq analysis 
2.2.6.1.1 CuffDiff pipeline 
Quality control of raw sequence reads was determined using the Fast QC tool. 
Reads were aligned to human reference sequence iGenome NCBI GRCh38 using 
HISAT (v 2.0.3.2) (Kim et al., 2015). Aligned reads were assembled into 
transcripts using Stringtie (v 1.2.3) (Pertea et al., 2015). Significant differential 
fragments per kilobase per million reads (FPKM) values were calculated using 
CuffDiff (v. 2.2.1.3) (adjusted p-value <0.05) (Trapnell et al., 2010). The above 
analyses were performed using Glasgow University Galaxy server 
(http://heighliner.cvr.gla.ac.uk/). Clustering analysis was performed with 
default options (K-means clustering with Jensen-Shannon distance) using the 
Bioconductor package CummeRbund. Visualisation of RNA-seq data was 
performed using Papillon (v 0.1.1) developed by Dr Domenico Somma (University 
of Glasgow) (https://github.com/domenico-somma/Papillon). 
2.2.6.1.2 DESeq2 pipeline 
Quality control and read alignment was performed as described above 
(2.2.6.1.1). Aligned reads were counted using HTseq-count (v 0.6.1) (Anders et 
al., 2015) using Glasgow University Galaxy server. Read counts were used as 
input to SearchLight (Beta), an automated pipeline for analysis and visualisation 
of RNA-seq data, developed by Mr John Cole and colleagues (GLAZgo Discovery 
Centre, University of Glasgow). Significant differential gene expression was 
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calculated using DESeq2 (adjusted p-value <0.05 and <0.01 for HEK293T and 
THP-1 data sets, respectively) (Love et al., 2014). 
2.2.6.1.3 Accession Numbers 
RNA-seq data is available in the NCBI Gene Expression Omnibus database with 
the following accession numbers: HEK293T: GSE117279; THP-1: GSE120212 
2.2.6.2 Transcription factor binding site (TFBS) analysis 
2.2.6.2.1  Motif analysis 
Motif analysis was based on the GREAT approach (McLean et al., 2010), which 
incorporates both proximal and distal regulatory regions for enrichment 
analyses. Regulatory regions for genes were obtained from the Ensembl 
Regulatory Build (Zerbino et al., 2015). Genomic locations were obtained using 
the “fetch closest non-overlapping feature” tool. JASPAR Position Weight Matrix 
MA0105.1 was used to identify the best matching NFKB1 binding sites in 
regulatory regions using the “FIMO” tool. These analyses were performed using 
the University of Glasgow Galaxy server (http://heighliner.cvr.gla.ac.uk/). 
Sequence logos were generated using WebLogo 
(http://weblogo.berkeley.edu/logo.cgi) (Crooks et al., 2004). 
De novo motif searches were performed using the motif search program HOMER 
developed by C. Benner (Heinz et al., 2010), using the findMotifs.pl command 
with default parameters (promoter region 300bp upstream 50bp downstream of 
transcription start site). Custom motifs were generated using the seq2profile.pl 
command. 
2.2.6.2.2 TFBS shape analysis 
Transcription factor binding site shape analysis was performed using the 
TFBSshape online tool available at http://rohslab.cmb.usc.edu/TFBSshape/ 
(Yang et al., 2014). Minor grove width and propeller twist define base-pair 
parameters whereas roll and helix twist represent base pair step parameters. 
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2.2.6.3 Gene set enrichment analysis (GSEA) 
Gene set enrichment analysis was performed using GSEA software in conjunction 
with the Molecular Signatures database (MSigDB) (Subramanian et al., 2005, 
Liberzon et al., 2011). Differentially expressed genes calculated by CuffDiff were 
ranked by adjusted p value, then by log2 fold change. The ranked gene list was 
analysed using GSEA Preranked with enrichment score set to “classic”. 
2.2.7 Molecular biology techniques 
2.2.7.1 Agarose gel electrophoresis 
DNA samples were resolved by agarose gel electrophoresis, using the Mupid-One 
electrophoresis system (Eurogentect). Samples were diluted in 6X loading dye 
[New England Biolabs (NEB)] and were resolved on GelRed stained 1.5% agarose 
gels (Table 2.5) at 100-135V for 30 minutes in 0.5X TBE buffer (Table 2.3). Gels 
were visualised using a UV transilluminator (Alpha Innotech). DNA size was 
determined using 100bp ladder (Promega). If DNA was required for subsequent 
cloning steps, DNA was excised and purified using QIAquick gel extraction kit 
(QIAGEN), according to the manufacturer’s instructions. 
2.2.7.2 Polymerase chain reaction (PCR) 
Primers for PCR were designed using Primer3 software. Genomic DNA was 
amplified using HotStarTaq Master Mix Kit (QIAGEN) according to the 
manufacturer’s instructions. If amplified DNA was required for subsequent 
restriction digest DNA, PCR products were purified using QIAquick PCR 
purification kit (QIAGEN) according to the manufacturer’s instructions. The 
concentration of purified PCR products were measured using a NanoDrop 
spectrophotometer (ThermoFisher Scientific). 
2.2.7.3 Restriction digest 
Restriction digests were prepared by mixing either 1µg plasmid DNA or 500ng 
purified PCR product with the required enzymes (NEB), according to 
manufacturer’s instructions, in a total of volume of 20µl. 
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2.2.7.4 Ligation 
Ligation reactions were prepared by mixing insert DNA and plasmid backbone 
and at a molar ratio of 5:1 with T4 DNA ligase (NEB) according to manufacturer’s 
instructions, in a total of volume of 20µl. Ligation reactions were incubated for 1 
hour at room temperature. 
2.2.7.5 Plasmid preparation 
2.2.7.5.1 DNA transformation 
XL-1 Blue competent cells (Agilent technologies) were thawed on ice. Either 
10ng of plasmid DNA or with 1µl of ligation reaction was mixed with 10µl cells, 
and incubated for 15 minutes on ice. Following incubation, cells were heat-
shocked for 45 seconds at 42°C, and were returned to ice immediately. Cells 
were incubated on ice for a further 15 minutes before the addition of 100µl L-
broth. Cells were plated onto lysogeny broth (LB) agar plates containing 
100µg/ml ampicillin and were incubated overnight at 37°C. 
2.2.7.5.2 Midiprep 
A single bacterial colony was inoculated in 5ml L-broth containing 100µg/ml 
ampicillin to generate a starter culture. Starter cultures were incubated at 37°C 
shaking for ~8 hours. 100µl starter culture was used to inoculate 100ml L-broth 
containing 100µg/ml ampicillin, which was then incubated at 37°C shaking 
overnight. Plasmid DNA was extracted using Pure Yield Plasmid Midiprep System 
(Promega) according to the manufacturer’s instructions. Plasmid concentration 
was measured using a NanoDrop spectrophotometer (ThermoFisher Scientific). 
Plasmid midipreps were utilised for transfection of cells. 
 
2.2.7.5.3 Miniprep 
A single bacterial colony was inoculated in 5ml L-broth containing 100µg/ml 
ampicillin and was incubated at 37°C shaking overnight. Plasmid DNA was 
extracted using QIAprep Spin Miniprep Kit (QIAGEN) according to the 
manufacturer’s instructions. Plasmid miniprep DNA was utilised to check for 
successful cloning by DNA sequencing. 
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2.2.7.6 DNA sequencing 
DNA sequencing of purified PCR products and plasmids were carried out by GATC 
Biotech, using either common universal primers provided by the company or 
custom primers (Table 2.16). 
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Chapter 3 
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3 Generation of knock-in NFKB1S80A cell lines 
using CRISPR/Cas9 genome editing techniques 
3.1 Abstract 
The CRISPR/Cas9 system originally identified as a microbial adaptive immune 
system has been adapted to be used as a programmable tool for precision 
genome editing. Introducing targeted mutations into the genome provides means 
to generate effective models used to study molecular function. Here, 
CRISPR/Cas9 genome editing technology was utilised to generate knock-in 
NFKB1S80A cell lines to investigate the role of NF-κB p50 S80 phosphorylation in 
the regulation of inflammatory gene expression. Plasmid-based and 
ribonucleoprotein complex methodologies were employed to efficiently deliver 
CRISPR/Cas9 components into HEK293T and THP-1 cells, respectively. NFKB1S80A 
knock-in cells were confirmed by homology directed repair assays and Sanger 
sequencing. 
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3.2 Introduction 
The ability to introduce specific targeted mutations into the genome has 
facilitated the rapid generation of animal and cell-based models used to study 
human disease. Although a number of genome editing techniques exist, such as 
zinc-finger nucleases (ZFN) (Kim et al., 1996, Bibikova et al., 2001) and 
transcription activator-like effector nucleases (TALENs) (Christian et al., 2010, Li 
et al., 2011), the CRISPR/Cas9 system is fast becoming the most utilised 
technique due to its simplicity, specificity, and ease of customisation. 
The CRISPR-Cas9 system is a microbial adaptive immune system that protects the 
host against foreign nucleic acids such as plasmids or viruses (Mojica et al., 
2005, Pourcel et al., 2005). Fragments from invading nucleic acids, called 
“protospacers” are incorporated into the bacterial genome in between clustered 
regularly interspaced short palindromic repeats (CRISPR). The large arrays 
formed are used to “remember” the DNA of foreign nucleic acids. When CRISPR 
arrays are transcribed, the transcripts are processed to generate small CRISPR 
RNAs (crRNAs), which contain sequences complementary to the invading DNA, 
derived from the protospacers (Brouns et al., 2008). Each crRNA must hybridise 
with a transactivating CRISPR RNA (tracrRNA) which acts as a scaffold for 
complex formation with Cas9 nuclease. The crRNA portion of the complex guides 
Cas9 to the complementary target DNA sequences. The endonuclease activity of 
Cas9 is dependent on a short conserved protospacer-associated motif (PAM) 
sequence NGG, where N is any base (Bolotin et al., 2005). Once bound to its 
target, the crRNA-tracrRNA-Cas9 complex cleaves the DNA 3bp upstream from 
the PAM site, destroying the invading DNA (Barrangou et al., 2007). 
In 2013, multiple groups adapted the CRISPR/Cas9 system to enable its use as a 
programmable tool to facilitate genome engineering in eukaryotic cells (Cong et 
al., 2013, Jinek et al., 2012, Mali et al., 2013). The adapted system consists of 
two components: a “guide” RNA (gRNA) and Cas9 endonuclease. The gRNA is a 
fusion between the essential components of a tracrRNA and a crRNA. A 20bp 
sequence at the end of the gRNA (which corresponds to the protospacer portion 
of the crRNA) is responsible for directing Cas9 to its target site. Therefore, Cas9 
endonuclease activity can be directed to any location in the genome which has 
the sequence N20-NGG. 
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The schematic shown in Figure 3.1 depicts how programmable Cas9 activity can 
be utilised for genome editing. Using a gRNA, Cas9 is targeted to a user defined 
region of the genome, where it creates double-strand breaks (DSBs) in the DNA. 
DSBs can induce two distinct DNA repair pathways: non-homologous end joining 
(NHEJ) or homology directed repair (HDR). During CRISPR/Cas9 genome editing, 
NHEJ is more frequently used by cell to repair DNA (Maruyama et al., 2015). 
While NHEJ is a highly efficient repair mechanism, it is error-prone, leading to a 
high frequency of insertion or deletion (indel) mutations. Indels within the 
coding region of a gene could potentially cause frameshift or nonsense 
mutations, resulting in a functional gene knockout. Alternatively, if a repair 
template is provided, DSBs can be processed via HDR. By designing a repair 
template containing desired sequence, specific genome editing can be achieved, 
including the creation of targeted knock-ins. 
For small edits in the genome (<50bp), the optimal repair template is a single-
stranded DNA oligonucleotide (ssODN) (Ran et al., 2013). The ssODN contains 
homology arms between 40-90bp which flank the desired mutation to be 
incorporated into the genome. Asymmetric homology arms have been shown to 
be slightly more efficient at facilitating HDR (Richardson et al., 2016). ssODNs 
can either be sense or antisense in orientation, relative to the target locus. A 
recent study has proposed that once Cas9 has been released from DNA, both 
sides of the double-strand break are recognised and resected by DNA repair 
machinery equally (Liang et al., 2017). This means that both sense and antisense 
ssODNs can facilitate HDR, with no preference towards a particular ssODN 
orientation. However, the precise mechanisms of Cas9 interaction with target 
DNA is not fully understood, and requires further study. 
It has been reported that the efficiency of HDR-mediated genome editing can be 
increased by synchronising cells in the G2/M phase of the cell cycle, where 
eukaryotic cells undergo homologous recombination (Heyer et al., 2010). The 
antimitotic agent nocodazole has been shown to effectively synchronise cells, 
increasing HDR efficiency and donor template integration into the genome (Yang 
et al., 2016). 
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Figure 3.1: Overview of CRISPR/Cas9 genome editing 
A target region is selected for genome editing. gRNAs (red) made up of a user defined 20bp 
protospacer (dotted red line) and a tracrRNA scaffold (solid red line) form a complex with Cas9 
(yellow) which guides the endonuclease to the desired region of the genome. Cas9 induces 
double-strand breaks (DSBs) in the DNA, which can be repaired in one of two ways. In the error 
prone NHEJ pathway, DNA ends are re-joined which can result in indel mutations (orange). Indels 
within the coding region can cause a functional gene knockout. Alternatively, if a repair template is 
provided, DSBs can be processed via HDR. By designing a repair template with desired sequence 
(blue lines), specific genome editing can be achieved, including the creation of targeted knock-ins. 
 
Although the CRISPR/Cas9 system presents a simple and robust method for 
targeted genome editing, there are a number of factors which can limit its 
efficiency and reliability in practise. One such factor is the delivery method of 
CRISPR components. Each model system has its own set of considerations to 
achieve efficient delivery of CRISPR components into the nucleus of cells. A 
common approach is the use of a mammalian expression vector, in which a 
promoter (typically U6), drives gRNA expression. This method is efficient for 
cells that are easy to transfect, such as HEK293Ts. However, not all cells 
efficiently take up plasmids required to express CRISPR components. For 
example, DNA transfection is not an effective method for expressing proteins in 
cells such as monocytes. Monocytic cells, such as THP-1 cells, are capable of 
sensing and degrading double-stranded DNA in the cytosol via the cGAS-STING 
and AIM2 inflammasome pathways (Cai et al., 2014). Therefore, CRISPR 
components are degraded before they reach the nucleus, inhibiting their ability 
to perform genome editing. To circumvent this, alternative methods have been 
developed for CRISPR/Cas9 editing of cells sensitive to nucleic acid transfection. 
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One example is the Cas9-gRNA ribonucleoprotein (RNP) complex method. Cas9 
RNPs consist of purified Cas9 protein complexed with a gRNA which are delivered 
as functional complexes that evade cytosolic nucleic acid sensing pathways. 
Another potential limiting factor affecting the CRISPR/Cas9 system is off-target 
activity. Although the targeting specificity of Cas9 is to the 20 nucleotide gRNA 
sequence, it has been shown that potential off-target cleavage can occur at DNA 
sequences similar to the gRNA (Jinek et al., 2012, Cong et al., 2013, Fu et al., 
2013, Hsu et al., 2013, Mali et al., 2013). Cas9 can tolerate up to 3-5bp 
mismatches, however it is dependent on where the mismatches are in the gRNA 
sequence. Typically, if the mismatches are within the first 10-12bp adjacent to 
the PAM site, called the “seed sequence”, off-target cleavage is less likely to 
occur. This is because the seed sequence determines Cas9 specificity (Jinek et 
al., 2012, Mali et al., 2013). It is therefore important to consider how off-target 
activity might affect the cell model that is to be generated. Off-target activity 
may cause unintended and unwanted mutations the genome. There are many 
tools available for predicting the most likely off-target sites for a given gRNA, 
which can easily be analysed by PCR amplification and DNA sequencing. 
The overall aim of this chapter was to generate NFKB1S80A human cell lines to 
investigate the role of NF-κB p50 S80 phosphorylation in the regulation of 
inflammation, by fulfilling the following objectives: 
1. Design and validate CRISPR/Cas9 genome editing technology in HEK293T 
cells, using a plasmid-based method. 
2. Utilise the Cas9-gRNA RNP method to generate NFKB1S80A knock-in THP-1 
cells. 
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3.3 Results 
3.3.1 NFKB1S80A knock-in genome editing strategy 
3.3.1.1 gRNA and ssODN repair template design 
In order to generate NFKB1S80A knock-in cell lines, the region of the human 
NFKB1 locus containing the codon for S80 (exon 5) was selected as the target 
region for CRISPR/Cas9 designs. Potential gRNA targets were generated using the 
Broad Institute gRNA Designer tool, available online 
(https://portals.broadinstitute.org/gpp/public/analysis-tools/sgrna-design). 
This tool calculates an on-target efficacy score for each gRNA, indicating the 
likelihood of Cas9 cleavage at the target sequence. Scores are between 0 and 1, 
with a higher score representing higher efficacy. The position of the top four 
scoring gRNAs relative to NFKB1 exon 5 are shown (Figure 3.2A). The sequence, 
orientation, PAM site and on-target score for each gRNA are shown (Figure 3.2B). 
Targeted homozygous mutations have been shown to occur more frequently if 
the distance of the gRNA cut site relative to the site of the desired mutation is 
<10bp (Paquet et al., 2016). For this reason, gRNA 1 was selected for 
CRISPR/Cas9 genome editing due to its proximity to the codon for S80, and 
highest on-target efficacy score. 
To analyse any potential off-target effects of the gRNA 1, the Broad Institute 
Benchling online tool was utilised (https://benchling.com/crispr). This tool 
identifies potential off-target cutting sites throughout the genome for a selected 
gRNA, which are ranked based on score. Scores are between 0 and 100, with a 
higher score representing higher Cas9 efficacy at a given sequence. The top 5 
off-target sites identified for gRNA 1 are shown in Figure 3.2C. It was found that 
the likelihood of Cas9 cleavage at off-target sites is low, indicated by the low 
scores. This is due to mismatches between the off-target site and the seed 
sequence region of gRNA 1, which reduces Cas9 recognition of these sites. In 
addition, off-target sites were found to be intergenic or intronic (Figure 3.2C). 
Despite low efficacy scores, if Cas9 nuclease were to cut at these sites, the 
mutations implemented would be unlikely to cause deleterious effects to cells. 
Screening for off-target mutations in both CRISPR/Cas9 cell lines is reported in 
section 3.3.2.4 and 3.3.3.2 for HEK293T and THP-1 NFKB1S80A cells, respectively. 
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A single-stranded DNA oligonucleotide (ssODN) was designed to act as a template 
for HDR to introduce synonymous codon changes into the genome. The codon 
changes were designed to mutate serine 80 to alanine; to introduce a unique 
HindIII restriction site to facilitate CRISPR/Cas9 clone screening and to mutate 
the PAM site to prevent further Cas9 cleavage after the desired mutations 
introduced (Figure 3.2D). The ssODN was designed in both sense and antisense 
orientation in order to optimise knock-in efficiency. 
 
 
Figure 3.2: CRISPR/Cas9 editing strategy 
(A) Schematic of human NFKB1 exon 5 showing the position of four gRNAs designed (highlighted 
yellow) relative to the S80 codon (highlighted red). (B) The sequence, strand, PAM site and on-
target efficacy score for each gRNA (score range 0-1) are shown. (C) The top five scoring off-target 
sites of gRNA 1 (score range 0-100) are shown. Mismatches between the sequence of gRNA 1 
and each off-target site are underlined. The strand orientation, PAM site and genomic coordinates 
(GRCh38/hg38) are indicated for each off-target site. (D) Schematic of the ssODN oligo design, 
relative to the S80 codon (red), the selected gRNA (yellow) and PAM site (blue). Homology arms 
(dotted lines) and synonymous codon changes (bold) are shown. The HindIII restriction site is 
indicated (green triangles). 
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3.3.2 CRISPR/Cas9 editing in HEK293T cells 
3.3.2.1 gRNA/Cas9 plasmid creation and validation 
A plasmid-based approach was utilised for CRISPR/Cas9 genome editing of 
HEK293T cells, due to the high transfection efficiency of these cells. The 
selected gRNA was synthesised as two complementary oligonucleotides which 
were annealed, and cloned into the CRISPR guide expression plasmid PX458, 
creating a Cas9/gRNA plasmid (Figure 3.3A). In order to determine the ability of 
the Cas9/gRNA plasmid to create targeted DSBs, a Surveyor assay was performed 
(schematic shown in Figure 3.3B). This assay detects and cleaves single base 
mismatches or small indels in DNA caused by DSBs created by Cas9. The 
Cas9/gRNA plasmid was co-transfected into HEK293T cells with a puromycin 
selection plasmid. Untransfected cells were used as a negative control. 
Transfected cells were selected in puromycin for 3 days. Following puromycin 
selection, cells were grown in culture with fresh media. DNA was extracted from 
selected cells, and the region flanking the cut site was amplified by PCR using 
primers HEK293T_F and HEK293T_R (Table 2.16 and Figure 7.1). PCR products 
were purified and incubated with Surveyor nuclease, and resolved on an agarose 
gel. DNA from untransfected HEK293T cells was used as a negative control. The 
gRNA/Cas9 plasmid was found to create DSBs at the target site, indicated by 
cleavage of the purified PCR product from transfected cells compared to 
untransfected cells (Figure 3.3C). Two digestion products are expected (310bp 
and 126bp). However, the low molecular weight fragment is too faint to be 
visualised at a low exposure. To visualise the second product, gel exposure was 
increased and the gel image has been cropped to show the 126bp fragment 
(Figure 3.3C). 
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Figure 3.3: Cas9/gRNA CRISPR plasmid cloning and validation 
(A) Cloning strategy for the creation of the gRNA/Cas9 plasmid used for CRISPR/Cas9 editing in 
HEK293T cells. Complementary gRNA oligonucleotides (highlighted yellow) were synthesised with 
5’-BbsI overhangs (underlined) to facilitate cloning into BbsI digested PX458. The U6 promoter 
requires a G base at the transcriptional start site, therefore an additional G base (bold) was added 
to the gRNA. (B) Surveyor assay schematic. DNA from gRNA/Cas9 transfected cells is denatured 
and reannealed, forming heteroduplexes due to mismatched DNA caused by indels (green). 
Heteroduplexes are cleaved by Surveyor nuclease, whereas homoduplexes are not. (C) DNA 
extracted from untransfected (-) and gRNA/Cas9 transfected cells (+) and was amplified by PCR 
and purified. Purified PCR products (436bp) were digested by Surveyor nuclease, and resolved on 
a 1.5% agarose gel. The 310bp and 126bp fragments visualised by different exposures are 
indicated by arrows. 
 
3.3.2.2 HDR efficiency optimisation 
Having confirmed gRNA/Cas9 successfully cleaves the target region, the next 
step was to determine the ability of the ssODN to mediate HDR. HEK293T cells 
were co-transfected with Cas9/gRNA plasmid, puromycin selection plasmid and 
either the sense or antisense ssODN. Transfected cells were selected for 3 days 
in puromycin. Following puromycin selection, cells were grown in culture with 
fresh media. DNA was extracted from puromycin selected cells and amplified by 
PCR. Purified PCR products were digested with HindIII restriction enzyme, and 
resolved on an agarose gel. Since the HindIII restriction site is unique to the 
repair template, digested PCR products indicate successful HDR facilitated by 
the ssODN. It was found that the antisense ssODN was able to facilitate HDR, 
indicated by HindIII digestion of the purified PCR product (Figure 3.4A). 
However, two digestion products are expected (307bp and 129bp). Due to the 
low abundance of the lower molecular weight product, the 129bp fragment is 
too faint to be visualised. 
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The sense ssODN did not appear to mediate HDR indicated by the lack of HindIII 
digestion products (Figure 3.4A). The efficiency of HDR is proportional to the 
amount of digested PCR product, determined by the intensity of gel bands. 
Although the antisense ssODN is capable of mediating HDR, HindIII digestion 
products are of low intensity, and are therefore not visible (Figure 3.4A). This 
suggests that HDR efficiency is low. It was therefore desirable to enhance the 
efficiency of HDR in order to increase the probability of identifying NFKB1S80A 
knock-in HEK293T cells. 
The use of nocodazole for synchronising HEK293T cells to improve HDR efficiency 
using the antisense ssODN was investigated. HEK293T cells were treated with 
nocodazole 16 hours prior to transfection. Treated cells were co-transfected 
with Cas9/gRNA plasmid, puromycin plasmid and antisense ssODN. Transfected 
cells were selected with puromycin for 3 days. Following puromycin selection, 
cells were grown in culture in fresh media. DNA was extracted from puromycin 
selected cells and amplified by PCR. Purified PCR products were digested with 
HindIII restriction enzyme to assay for HDR. DNA from untransfected cells was 
used as a negative control. This revealed that HEK293T cells treated with 
nocodazole increased HDR efficiency, indicated by the increased levels of HindIII 
digestion products (Figure 3.4B) compared to unsynchronised cells (Figure 3.4A). 
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Figure 3.4: ssODN validation and HDR optimisation 
(A) HEK293T cells were co-transfected with gRNA/Cas9 plasmid, puromycin plasmid and either 
sense or antisense ssODN as indicated. DNA was extracted and amplified by PCR. Purified PCR 
products (436bp) were digested with HindIII restriction enzyme, and resolved on a 1.5% agarose 
gel. One visible cleavage product (307bp) is indicated by an arrow. (B) HEK293T cells were treated 
with nocodazole 16 hours pior to transfection with gRNA/Cas9 plasmid and puromycin plasmid with 
or without antisense ssODN as indicated. DNA was extracted and amplified by PCR. Purified PCR 
products (436bp) were digested HindIII restriction enzyme, and resolved on a 1.5% agarose gel. 
Expected cleavage products (307bp and 129bp) are indicated by arrows. 
 
3.3.2.3 Generation of NFKB1S80A knock-in HEK293T cells 
Having increased the efficiency of antisense ssODN-mediated HDR, transfection 
of G2/M synchronised HEK293T cells was repeated as described in section 
3.3.2.2. Following puromycin selection for 3 days, serial dilution of transfected 
HEK293T cells was performed in order to isolate single clones. Single clones were 
expanded in culture. HEK293T clones were split for either maintenance in 
culture or were harvested for screening. To screen for potential NFKB1S80A 
knock-in clones, DNA was extracted and the region flanking the target site was 
amplified by PCR. An example of PCR results obtained from clone screening is 
shown in Figure 3.5A. Clones with PCR products that contain indels are excluded 
from knock-in screening, since Cas9 indels have not been corrected by HDR. 
Examples of excluded clones (10 and 16) are shown in Figure 3.5A. Clones 10 and 
16 are likely to be heterozygous for an insertion and deletion mutation, 
indicated by larger and smaller PCR products, respectively (Figure 3.5A). Clones 
with PCR products of expected size (463bp) are either unedited, or have been 
edited by HDR. These clones were screened for HDR by digesting purified PCR 
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products with HindIII. An example of the HDR assay results obtained from clone 
screening is shown in Figure 3.5B. Two clones (5 and 9) were found to be 
positive for HDR, indicated by HindIII digestion products of expected sizes 
(Figure 3.5B). PCR products from clones 5 and 9 are completely digested, 
indicating these clones are homozygous NFKB1S80A knock-ins. In order to confirm 
the targeted knock-in mutation, clones 5 and 9 were sent for Sanger sequencing. 
Although the HDR assay suggested clone 5 was positive for the S80A knock-in 
mutation (Figure 3.5B), Sanger sequencing revealed that this clone did not 
contain the intended mutations (Figure 3.5C). Sanger sequencing revealed 
mutliple peaks in the DNA sequence chromatogram, indicating that multiple 
sequences are present (Figure 3.5C). Although not visible on the DNA sequence 
chromatogram, it is possible that clone 5 contains an allele carrying the HindIII 
restriction site. Peaks may have been incorrectly called due to the presence of 
multiple sequences, masking the sequence of allele containing the restriction 
site. However, it is unknown why other alleles which do not contain the HindIII 
restriction site were not detected in the HDR assay (Figure 3.5B). Sanger 
sequencing revealed that clone 9 is homozygous for the targeted knock-in 
mutation, confirming the generation of NFKB1S80A knock-in HEK293T cells. 
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Figure 3.5: Screening and identification of NFKB1S80A positive HEK293T cells 
Clones marked with an asterisk in (A) identify which clones were shown to be homozygous for 
HDR in (B). (A) Example of PCR screening of clones. DNA was extracted from clones and 
amplified by PCR. PCR products were resolved on a 1.5% agarose gel. Clones 10 and 16 were 
excluded from HDR screening due to presence of indels. (B) Clones were screened for HDR by 
HindIII restriction digestion of purified PCR products (436bp). Digestion products were resolved on 
a 1.5% agarose gel. Clones 5 and 9 identified as potential NFKB1S80A positive clones are marked 
with asterisk. The expected cleavage products (307bp and 129bp) are indicated by arrows. (C) 
DNA sequencing chromatograms of WT, clone 5 and NFKB1S80A clone 9. The position of the codon 
for S80 is highlighted (black box). 
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3.3.2.4 Off-target analysis of NFKB1S80A HEK293T cells 
In order to detect any potential off-target mutations created during CRISPR/Cas9 
genome editing, the top 5 off-target sites identified during gRNA design (Figure 
3.2C) were analysed in NFKB1S80A knock-in HEK293T cells. PCR primers were 
designed (Table 2.16) to amplify each off-target site to detect any Cas9 
cleavage. DNA was extracted from WT and NFKB1S80A HEK293T cells, amplified by 
PCR, and was analysed by Sanger sequencing. The aligned DNA sequencing reads 
shown in  
Figure 3.6 demonstrate that no mutations were detected at the 5 potential off-
target sites tested. 
 
 
Figure 3.6: Off-target site analysis of knock-in NFKB1S80A HEK293T cells 
Each off-target site was amplified by PCR, and products were analysed by Sanger sequencing. 
Aligned DNA sequence reads from WT and NFKB1S80A HEK293T cells are shown with the off-
target site highlighted (yellow). (For genomic coordinates, refer to Figure 3.2C). 
  
84 
 
3.3.3 CRISPR/Cas9 editing in THP-1 cells 
3.3.3.1 Generation of NFKB1S80A knock-in THP-1 cells 
In order to create NFKB1S80A knock-in THP-1 cells, the Cas9/gRNA 
ribonucleoprotein (RNP) CRISPR/Cas9 delivery method was employed. A 
synthetic gRNA (sgRNA) with the same sequence gRNA selected in section 3.3.1 
was synthesised. In order to validate the Cas9/gRNA RNP method as a successful 
genome editing strategy for THP-1 cells, transfected THP-1 cells were assayed 
for HDR. Purified Cas9 protein was incubated with the sgRNA to form a 
Cas9/gRNA ribonucleoprotein complex. The RNP complex was co-transfected 
into THP-1 cells with either sense or antisense ssODN. DNA was extracted, and 
the region flanking the target site was amplified by PCR using primers THP1_F 
and THP1_R (Table 2.16 and Figure 7.1). Purified PCR products digested with 
HindIII restriction enzyme and resolved on an agarose gel. DNA from 
untransfected THP-1 cells was used as a negative control. It was found that the 
sense ssODN was able to facilitate HDR, indicated by the presence of a HindIII 
digestion product (Figure 3.7A). Two cleavage products are expected (351bp and 
154bp). However, due to the low abundance of the lower molecular weight 
product, the 154bp fragment is not visible on the agarose gel. The antisense 
ssODN did not appear to mediate HDR indicated by the lack of HindIII digestion 
products (Figure 3.7A). This result confirms that the Cas9/gRNA RNP method is 
capable of creating targeted knock-in mutations in THP-1 cells. 
Transfection of THP-1 cells using the sense ssODN was repeated, and single 
clones were isolated by flow cytometry, using a single cell sorter. Single clones 
were expanded in culture. THP-1 clones were split for either maintenance in 
culture or were harvested for screening. To screen for potential NFKB1S80A 
knock-in clones, DNA was extracted and the target region was amplified by PCR 
using primers HEK293T_F and THP1_R2 (Table 2.16 and Figure 7.1). The THP1_R2 
primer spans the region of exon 5 where synonymous codon changes would be 
introduced if targeted knock-in mutation was successful (Figure 7.1). Due to the 
introduced DNA mismatches, the THP1_R2 primer will not anneal to the target 
DNA, and no amplification of DNA will occur. Therefore, clones that do not give 
a PCR product are included for further HDR screening. An example of PCR results 
obtained from clone screening is shown in Figure 3.7B. Examples of clones 
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included for HDR screening are marked with an asterisk. Potential NFKB1S80A 
knock-in clones were screened for HDR by HindIII digest of purified PCR 
products, amplified by THP1_F and THP1_R primers (Table 2.16 and Figure 7.1). 
An example of the results obtained from HDR clone screening is shown in Figure 
3.7C. Clone 3 is likely to be heterozygous for the targeted knock-in mutation, 
indicated by presence of both WT and HindIII digested PCR products. Clone 10 is 
homozygous for the NFKB1S80A mutation, indicated by complete digestion of PCR 
products by HindIII (Figure 3.7C). The homozygous targeted knock-in mutation 
was confirmed by Sanger sequencing (Figure 3.7D). These results confirm the 
successful generation of NFKB1S80A knock-in THP-1 cells. 
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Figure 3.7: Screening and identification of NFKB1S80A positive THP-1 cells 
(A) THP-1 cells were co-transfected with Cas9/gRNA RNP complex, and either sense or antisense 
ssODN as indicated. DNA was extracted and amplified by PCR. Purified PCR products (505bp) 
were digested using HindIII restriction enzyme, and resolved on a 1.5% agarose gel. One expected 
cleavage product (351bp) is indicated by an arrow (B) Example of PCR screening of clones. DNA 
was extracted from clones and amplified by PCR (327bp). Products were resolved on a 1.5% 
agarose gel. Examples of clones included for HDR screening are marked with asterisk. (C) Clones 
were screened for HDR by HindIII restriction digestion of purified PCR products (505bp). Digestion 
products were resolved on a 1.5% agarose gel. The NFKB1S80A positive clone is labelled (clone 
10). The expected cleavage products (351bp and 154bp) are indicated by arrows. (D) DNA 
sequencing chromatograms of WT and NFKB1S80A THP-1 cells highlighting the position of the 
codon for S80 (black box). 
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3.3.3.2 Off-target analysis of NFKB1S80A THP-1 cells 
Off-target analysis was performed as described in section 3.3.2.4 with DNA 
extracted from WT and NFKB1S80A THP-1 cells. The aligned DNA sequencing reads 
shown in  
Figure 3.8 demonstrate that no mutations were detected at the 5 potential off-
target sites tested. 
 
 
Figure 3.8: Off-target site analysis of knock-in NFKB1S80A THP-1 cells 
Each off-target site was amplified by PCR, and products were analysed by Sanger sequencing. 
Aligned DNA sequence reads from WT and NFKB1S80A THP-1 cells are shown with the off-target 
site highlighted (yellow). (For genomic coordinates, refer to Figure 3.2C). 
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3.4 Discussion 
In this chapter, the successful generation of knock-in HEK293T and THP-1 
NFKB1S80A cell lines using utilising two different CRISPR/Cas9 genome editing 
methods is reported. The gRNA designed and selected to target Cas9 to exon 5 of 
the NFKB1 locus was shown to successfully introduce DSBs to the target region 
(Figure 3.3C). Although the ability of the gRNA/CRISPR plasmid to create DSBs 
was only assayed in HEK293T cells, it was assumed that it would be functional in 
THP-1 cells, since the target region is also human sequence. The ability of a 
sense and antisense ssODN repair template to fix Cas9-induced DSBs by HDR was 
assayed. Initially, the efficiency of HDR mediated by the antisense ssODN in 
HEK293T cells was low (Figure 3.4A). This was surprising, given that HEK293T 
cells are easily transfected and are a suitable model for plasmid-based 
CRISPR/Cas9 expression systems. HDR efficiency was increased by treating 
HEK293T cells with the G2/M phase synchroniser nocodazole, as measured by 
HDR assay (Figure 3.4B). DNA sequencing analysis of HDR positive clones 
revealed the successful incorporation of the targeted NFKB1S80A mutation in both 
HEK293T cells and THP-1 cells (Figure 3.5C and Figure 3.7D).  
Off-target site analysis for both NFKB1S80A cell lines was performed. No 
mutations were detected at the top 5 off-target sites selected for analysis. It is 
important to consider that there may be off-target mutation elsewhere in the 
genome that are not included on predicted lists. Full genome sequencing could 
be performed to completely verify the absence of off-target mutation. 
The generation of NFKB1S80A human cell lines has created novel tools for 
investigating the importance of p50 phosphorylation for NF-κB activity. Both 
NFKB1S80A HEK293T and THP-1 cells will be utilised to study the role of S80 
phosphorylation in the regulation of target gene expression in an endogenous 
manner. These cell lines provide ways to study NF-κB driven transcription in two 
different contexts: NFKB1S80A HEK293T cells provide a versatile model that can 
be utilised for a number of subsequent experiments due to their ease of culture, 
scalability and high transfection efficiency. NFKB1S80A THP-1 cells however, 
provide a human macrophage model to study S80 phosphorylation in an 
inflammatory context. NFKB1S80A HEK293T and THP-1 cells are utilised in Chapter 
4 and 5 respectively, to investigate the role of NF-κB p50 S80 phosphorylation.
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Chapter 4 
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4 The regulation of sequence specific NF-ĸB DNA 
binding and transcription by IKKβ 
phosphorylation of NF-ĸB p50 at serine 80 
4.1 Abstract 
Phosphorylation of the NF-ĸB transcription factor is an important regulatory 
mechanism for the control of transcription. Here we identify serine 80 (S80) as a 
novel phosphorylation site on the p50 subunit of NF-ĸB, and IKKβ as a novel p50 
kinase. Transcriptomic analysis of cells expressing a p50 S80A mutant reveal a 
critical role for S80 in selectively regulating the TNFα inducible expression of a 
subset of NF-ĸB target genes including pro-inflammatory cytokines and 
chemokines. S80 phosphorylation regulates the binding of p50 to NF-ĸB binding 
(ĸB) sites in a sequence specific manner. Specifically, phosphorylation of S80 
reduces the binding of p50 at ĸB sites with an adenine at the -1 position. Our 
analyses demonstrate that p50 S80 phosphorylation predominantly regulates 
transcription through the p50:p65 heterodimer, where S80 phosphorylation acts 
in trans to limit the NF-ĸB mediated transcription of pro-inflammatory genes. 
The regulation of a functional class of pro-inflammatory genes by the interaction 
of S80 phosphorylated p50 with a specific ĸB sequence describes a novel 
mechanism for the control of cytokine-induced transcriptional responses. 
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4.2 Introduction 
The transcription factor NF-ĸB plays an important role in a number of 
fundamental biological processes including cell cycle, proliferation, 
differentiation and cell death (Hayden and Ghosh, 2012). However, the primary 
role of NF-ĸB is as an essential regulator of the immune response through the 
transcriptional regulation of a large number of inflammatory genes, including 
chemokines, cytokines and immune effectors (Mitchell and Carmody, 2018). The 
NF-ĸB transcription factor family is comprised of five structurally related 
subunits: RelA (p65), RelB, c-Rel, p50 and p52. The p50 and p52 subunits are 
generated from the limited proteasomal processing of the precursor proteins 
p105 and p100 respectively, and lack the transactivation domain (TAD) found in 
the C terminal regions of the RelA, c-Rel and RelB subunits. All NF-ĸB subunits 
contain a highly conserved Rel homology domain (RHD) which facilitates 
dimerisation and DNA binding. NF-ĸB can promote or repress transcription 
depending on the subunit composition of dimer complexes. For example, 
although the p50 subunit lacks a TAD, it can positively regulate transcription by 
forming a heterodimer with a TAD containing subunit such as p65. Alternatively, 
p50 homodimers may function as transcriptional repressors by competing with 
TAD containing NF-ĸB dimers for the same DNA binding sites in target gene 
promoters (Carmody et al., 2007). 
The primary mechanism regulating NF-ĸB activity is the cytoplasmic 
sequestration of NF-ĸB dimers by the canonical IĸB proteins IĸB -α, -β and -ε, 
and the p105 and p100 precursor proteins. Activation of NF-ĸB requires the 
proteasomal degradation of the IĸB proteins triggered by IKK complex (IKKα and 
IKKβ) mediated phosphorylation IĸB. The degradation of IĸB proteins facilitates 
the nuclear translocation of NF-ĸB dimers where they bind to specific ĸB sites in 
DNA with the consensus sequence 5’-G-5G-4G-3R-2N-1W0Y+1Y+2C+3C+4-3’ (R 
represents a purine, N represents any nucleic acid, W represents an A or T and Y 
represents a pyrimidine) (Sen and Baltimore, 1986, Lenardo et al., 1989). 
Although the nuclear localisation of NF-ĸB is controlled by IĸB protein 
degradation, NF-ĸB transcriptional activity is regulated by a number of post-
translational modifications, including acetylation (Greene and Chen, 2004), 
ubiquitination (Collins et al., 2016) and phosphorylation (Christian et al., 2016). 
The importance of phosphorylation in regulating NF-ĸB transcriptional activity 
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has been revealed mainly by studies of the p65 subunit, where phosphorylation 
has been demonstrated to regulate transcription in a stimulus and gene specific 
manner through a variety of mechanisms including the modulation of p65 
interaction with IĸBα and other transcription factors, and regulating p65 
ubiquitination and stability (Christian et al., 2016). 
Although the NF-ĸB p50 subunit is a critical regulator of inflammatory gene 
expression, its regulation by phosphorylation is much less well understood. p50 is 
one of the most highly expressed transcription factors in macrophages, and is 
central to macrophage mediated inflammatory responses (Xue et al., 2014). p50 
homodimers are important repressors of inflammatory gene expression and the 
stability of p50 homodimers is crucial for limiting pro-inflammatory gene 
expression and establishing Toll-like Receptor tolerance in macrophages 
(Carmody et al., 2007, Yan et al., 2012). The phosphorylation of p50 at serine 
337 (S337) is required for DNA binding (Hou et al., 2003), while the 
phosphorylation of S242 inhibits p50 homodimer DNA binding (Vonderach et al., 
2018). Phosphorylation of S20 promotes DNA binding, and is required for VCAM1 
expression in response to TNFα (Ju et al., 2010). p50 phosphorylation at S328 
occurs in response to DNA damage and regulates the interaction of p50 with 
specific NF-ĸB binding sites to inhibit anti-apoptotic gene expression (Crawley et 
al., 2013, Schmitt et al., 2011). These studies indicate that transcriptional 
responses to specific stimuli may be shaped by the integration of signal induced 
NF-ĸB phosphorylation and binding site sequence in the regulatory elements of 
target genes. 
In this study, we describe serine 80 as a novel phosphorylation site on the NF-ĸB 
p50 subunit. We identify IKKβ as a S80 kinase and establish p50 as a novel 
substrate for this kinase. Our data reveals that TNFα-induced phosphorylation of 
S80 selectively regulates distinct subsets of NF-ĸB target genes, driven by 
differential binding of p50 and p65 at specific DNA sequences. Our analyses 
demonstrate that p50 S80 phosphorylation predominantly regulates transcription 
through p50:p65 heterodimers and shows that p50 phosphorylation may function 
in trans to inhibit gene transcription. Our analysis demonstrates that S80 
phosphorylation reduces the affinity of p50 for ĸB sites that have an adenine at 
the -1 position, limiting the expression of genes regulated by these binding sites. 
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Remarkably, the promoters of inflammatory cytokines and chemokines are 
enriched in ĸB sites containing a -1A and are thereby selectively regulated by 
phosphorylation of p50 at S80. Our data establishes IKKβ phosphorylation of p50 
S80 as a novel mechanism that shapes the TNFα-induced transcriptional 
programme and demonstrates the control of gene expression through the 
interaction of NF-ĸB phosphorylation and DNA binding site sequence. 
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4.3 Materials and methods 
4.3.1 Cell culture and transfection 
Human embryonic kidney 293T (HEK293T) cells were cultured in DMEM (Sigma), 
supplemented with 10% fetal bovine serum, 2mM L-glutamine, and 100 units/ml 
of streptomycin and penicillin. Cells were maintained at 37ºC in a humidified 
environment with 5% CO2 and sub-cultured by enzymatic detachment with 0.05% 
Trypsin-EDTA solution (Invitrogen). HEK293T cells were transiently transfected 
with Turbofect (ThermoFisher Scientific) according to manufacturer’s 
instructions. pFLAG-CMV2 IKKβ, pFLAG-CMV2 IKKβK44M, and pcDNA3 IKKβSSEE FLAG 
were kind gifts from Michael May, University of Pennsylvania. pEF4a-p50-XP and 
pEF4a-p50-Myc were generated by cloning murine cDNA into pEF4a empty 
vector. pEF4a-p50S80A-XP was generated by site directed mutagenesis using the 
Stratagene QuikChange II SDM kit according to the manufacturer’s instructions 
(Primers: 5'-CCTCTAGTGAGAAGAACAAGAAAGCCTACCCACAGG-3', 3'-
GGAGATCACTCTTCTTGTTCTTTCGGATGGGTGTCC-5'). For generation of 
CRISPR/Cas9 NFKB1S80A knock-in cells, HEK293Ts were transfected using the 
Neon® Transfection System 100µl kit (ThermoFisher Scientific) using 2 pulses at 
1100v for 20ms. 
4.3.2 Western blot analysis and immunoprecipitation 
Whole cell lysates were generated from cells suspended in radioimmune 
precipitation assay buffer (RIPA) containing 50mM Tris-HCl (pH 7.4), 1% Nonidet 
P-40, 0.25% deoxycholate,150mM NaCl, 1mM EDTA, 1mM PMSF, 1mM NaF, 1mM 
Na3VO4, 2µg/ml aprotinin, 1µg/ml pepstatin, and 1µg/ml leupeptin. Nuclear and 
cytoplasmic extracts were obtained using a nuclear extraction kit according to 
the manufacturer’s instructions (Active Motif). Protein concentration of lysates 
were determined using a Bradford assay (Bio-Rad). Immunoprecipitation (IP) 
assays employed equal concentrations of whole cell extracts, pre-cleared for 30 
min at 4°C with protein G-agarose beads (Millipore), and immunoprecipitated 
with antibody overnight at 4°C. Beads were washed three times in RIPA buffer, 
resuspended in equal volumes of 2X SDS loading dye and heated for 5 mins at 
95°C to elute immunoprecipitated protein. Denatured samples were resolved by 
SDS-PAGE, transferred to nitrocellulose membranes and blocked for 1 hour at 
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room temperature using 5% fat free milk powder in PBS-Tween 20. Membranes 
were immunoblotted with specific antibodies: p-IĸBα (cat. # 9246), IĸBα (cat. # 
4821) and p105/p50 (cat. # 12540) were purchased from Cell Signalling 
Technologies; antibodies against FLAG (cat. # F1804), HDAC-1 (cat. # AV38530), 
α-tubulin (cat. # T6074) and β-actin (cat. # A5441) were purchased from Sigma; 
anti-p65 (cat. # A301-824A) was purchased from Bethyl Laboratories, anti-Myc 
(cat. # SC-40) was purchased from Santa Cruz; and anti-Xpress (cat. # R910-25) 
was purchased from Invitrogen. A custom anti-p50 p-S80 antibody was designed 
and purchased from BioGenes GmbH. Antibody binding was visualised using 
WesternBright HRP ECL substrate (Advansta). 
4.3.3 Kinase assays 
For in vitro kinase assays utilising an immunoprecipitated kinase source, cells 
were transfected with plasmid encoding constitutively active or kinase inactive 
IKKβ and immunoprecipitations performed as described above. Protein-bound 
beads were used directly in the kinase assay by adding 800ng of substrate and 
10µl of kinase assay buffer (400mM HEPES (4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid) pH 7.5, 400mM MgCl2, 20mM EDTA, 40mM NaF, 
40mM β-glycerophosphate, 20mM DTT, 200μM cold ATP). 10μCi γ-32P labelled 
ATP was added to each sample and incubated at 30°C for 15 mins. Samples were 
made up to 500µl with ice cold PBS, incubated with glutathione beads for 30 
mins and agitated every 5 mins. Beads were washed 3 times with PBS followed 
by heating at 95°C for 5 mins in 40μl 2X SDS loading buffer. Samples were 
resolved by SDS-PAGE, and the gel was stained with GelCode Blue (Expedeon) 
reagent. The gel was fixed in fixation buffer (10% Glacial acetic acid/ 20% 
methanol/ 50% dH2O) for 30 mins followed by a 5 min incubation with 
rehydration buffer (20% methanol/3% glycerol). The gel was dried onto Whatman 
paper using a gel-dryer, exposed to phosphor imaging screen overnight and then 
visualised using the Storm phosphor-imager system (Molecular devices). For 
recombinant in vitro kinase assays, 400ng recombinant IKKβ kinase (Cell 
signalling technologies, #7458) was incubated with 400ng substrate following the 
protocol as described above. For the peptide array kinase assay, peptide 
libraries of murine p50 were generated by an automatic SPOT synthesis, as 
previously described (Frank, 2002) and synthesised on continuous cellulose 
membrane supports on Whatman 50 cellulose using Fmoc (N-(9-
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flurenyl)methoxycarbonyl) chemistry with AutoSpot-Robot ASS 222 (Intavis 
Bioanalytical Instruments). The array was used as a substrate for 
immunoprecipitated and recombinant IKKβ, carried out as described by (Kiely et 
al., 2009). 
4.3.4 Site directed mutagenesis and GST protein purification 
p50 was cloned into pGEX-6p1 in frame with the N terminal GST tag and 
transformed into BL21 CodonPlus Escherichia coli (Stratagene). Transformants 
were grown to an A600 of 1.0–2.0 at 37°C and induced with 1.0mM 1mM 
isopropyl β-D-1 thiogalactopyranoside (IPTG) for 16 h at 20°C. The bacteria were 
resuspended in a buffer containing 50mM Tris (pH 8.0), 150mM NaCl, and 1mM 
dithiothreitol, disrupted by sonication, and centrifuged to remove debris. 
Recombinant proteins were affinity-purified with GSH-agarose (Sigma) and 
eluted with 10mM glutathione (Promega) in 50mM Tris (pH 8.5) and 150mM NaCl. 
GST-p50 mutants were created by PCR based site-directed mutagenesis using the 
Stratagene QuikChange II SDM kit, according to manufacturer’s instructions and 
recombinant protein purified as above. 
4.3.5 CRISPR/Cas9 genome editing 
pSpCas9(BB)-2A-GFP (PX458) was a gift from Feng Zhang (Addgene plasmid # 
48138). gRNA oligonucleotides were purchased from Eurofins Genomics (5’-CACC 
GACAAACTTACTTTGACCTGA-3’, 3’-CTGTTTGAATGAAACTGGACTCAAA-5’) and 
were cloned into pSpCas9(BB)-2A-GFP. ssODN was purchased from Integrated 
DNA Technologies (5’-
AGAGGATTTCGTTTCCGTTATGTATGTGAAGGCCCATCCCATGGTGGACTACCTGGTGC
CTCTAGTGAAAAGAACAAGAAAGCTTATCCTCAGGTCAAAGTAAGTTTGTGGTAGCTCTC
CTTCTATTTGAATTCTGGAAATTTTGATTTCCTACGATTTCCAAGGAATT-3’). The 
ssODN contains synonymous codon changes designed to introduce the S80A 
mutation, a HindIII restriction site, and to abolish the PAM site. Prior to 
transfection, HEK293T cells were treated with 200ng/ml nocodazole (Sigma) for 
16 h. Following treatment, cells were washed twice with media, trypsinised and 
cell density was determined. Cells were washed with Mg2+ and Ca2+ free PBS, and 
re-suspended in Neon buffer R (Invitrogen) at a density of 5x107 cells/ml per 
transfection. 100µl of cells were co-transfected with pPGKpuro (a gift from 
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Rudolf Jaenisch, Addgene plasmid # 11349), pX458 Cas9/sgRNA vector and ssODN 
(1:2:2 ratio) by electroporation. Transfected cells were plated into a 10cm dish 
containing 10ml media and recovered overnight in culture. Transfected cells 
were then selected for ~3 days with 3µg/ml of puromycin. After selection, 
puromycin media was removed and cells washed and incubated in fresh media. 
Serial dilution of selected cells was performed to isolate single cell clones in 96-
well plates. For clone screening, genomic DNA was extracted from cells using 
the DNeasy Blood & Tissue Kit (QIAGEN) according to the manufacturer’s 
instruction. DNA was amplified by PCR using primers (F: 5’-
ACCTGGCTTTTTAGCCATATCT-3’; R: 5’-TTCAGCTTAGGAGCGAAGGC-3’) and 
HotStarTaq Master Mix Kit (QIAGEN) according to the manufacturer’s 
instructions. Intitial screens were performed by HindIII (NEB) restriction digest of 
PCR products purified using QIAquick PCR Purification Kit (QIAGEN), according to 
the manufacturer’s instructions. Gene editing of selected clones was confirmed 
by Sanger sequencing (GATC-Biotech). 
4.3.6 Transcriptomic and bioinformatic analysis 
For RNA-sequencing, total RNA was extracted from cells using RNeasy kits 
(QIAGEN), according to the manufacturer’s instructions. Triplicate independently 
generated samples for each condition were sequenced to a read depth of 
20million using Illumina NextSeq™ 500 platform. Single-end 75bp reads were 
aligned to human reference sequence iGenome NCBI GRCh38 using HISAT (Kim et 
al., 2015). Aligned reads were counted using HTseq-count (Anders et al., 2015). 
The above analyses were performed using the University of Glasgow Galaxy 
server. Differentially expressed genes were calculated and visualised using an in-
house RNA-seq analysis pipeline which utilises DESeq2 (Love et al., 2014). 
Induced genes with adjusted p value <0.05 were included in this study. Heat 
maps of gene groups were produced using DESeq2 mean normalised counts, 
visualised using the online tool Morpheus (Broad Insitute). For real-time 
quantitative PCR, total RNA was extracted from cells using RNeasy kits 
(QIAGEN), according to the manufacturer’s instructions. Isolated RNA was 
primed with random hexamer oligonucleotides and reverse transcribed using 
Primer Design precision nanoScript reverse transcription kit. PCR was performed 
with SYBR Green master mix and QuantiTect primers (QIAGEN). All data were 
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normalised to TBP. Gene expression changes were calculated using the 2-ΔΔCT 
method. 
4.3.7 Motif analysis 
Motif analysis was based on the GREAT approach (McLean et al., 2010), which 
incorporates both proximal and distal regulatory regions for enrichment 
analyses. Regulatory regions for genes were obtained from the Ensembl 
Regulatory Build (Zerbino et al., 2015). Genomic locations were obtained using 
the “fetch closest non-overlapping feature” tool. JASPAR Position Weight Matrix 
MA0105.1 was used to identify the best matching NFKB1 binding sites in 
regulatory regions using the “FIMO” tool. These analyses were performed using 
the University of Glasgow Galaxy server. Sequence logos were generated using 
WebLogo (Crooks et al., 2004). Transcription factor binding site shape analysis 
was performed using the TFBSshape online tool (Yang et al., 2014). 
4.3.8 DNA affinity binding assay (DAPA) 
5’-biotinylated and unlabelled single-stranded oligonucleotides containing a 
central ĸB site flanked either side a by 7-bp spacer were purchased from 
Eurofins Genomics (5’-AGTTGAGGGGNNTTTCCCAGGC-3’; 3’-
TCAACTCCCCNNAAAGGGTCCG-5’, where N represents -2 -1 ĸB site variation per 
assay). Oligonucleotides were annealed to create 5’-biotinylated, and unlabelled 
double-stranded duplexes. DAPA reactions were prepared by mixing 1.5µg of 5’-
biotinylated double stranded oligo with 150µg of nuclear extract and 15µl 
streptavidin-agarose beads (Sigma) in a total of 500 µl DAPA buffer (10mM Tris 
HCl pH 7.5, 50mM NaCl, 1mM DTT, 5% glycerol, 1mM EDTA, 1mM NaF, 1mM 
Na3VO4, 1mM PMSF, 1µg/ml leupeptin, 2µg/ml aprotinin, 2µg/ml pepstatin). 
Unlabelled double stranded oligonucleotides were added in 10-fold excess to 
confirm binding specificity. Reactions were incubated at room temperature on a 
rotator for 1 hour. Beads were washed 3 times in 500µl DAPA buffer. To elute 
DNA-bound proteins, beads were resuspended in 20µl of 2X SDS sample buffer, 
and incubated at 95ºC for 5 mins. Eluates were resolved on SDS-PAGE gels and 
analysed by western blot. 
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4.3.9 Luciferase assays 
Promoters containing 4 sequential copies of defined ĸB sites (5’-GGGAATTTCC-
3', 5’-GGGACTTTCC-3', 5’-GGGGATTTCC-3', 5’-GGGGCTTTCC-3') were cloned into 
the pTAL-Luc vector (Clontech). WT and NFKB1S80A HEK293T cells were co-
transfected with 100ng pTAL-(4xĸB) Luc vector and 10ng Renilla luciferase 
expression vector pRL-TK (Promega). 24 hours post transfection, cells were 
cultured with or without 10ng/ml TNFα for 8 hours before harvest. Luciferase 
activities of whole cell lysates were analysed using the Dual-Luciferase® 
Reporter Assay System (Promega). The ratio of firefly to Renilla luciferase 
activity was used to normalise for transfection efficiency across all samples. 
4.3.10 Limited Proteolysis 
Whole cell lysates were generated from cells suspended in RIPA buffer lacking 
protease inhibitors. Limited proteolysis was performed by adding varying ratios 
of trypsin (Sigma) to 50µg of whole cell lysate, and incubating the reaction 
mixture for 30 mins at 37°C. Proteolysis was terminated by adding 5X SDS 
sample buffer to the reaction and heating at 95°C for 5 mins. Samples were 
resolved by SDS/PAGE and analysed by western blot analysis. 
  
100 
 
4.4 Results 
4.4.1 IKKβ phosphorylates NF-ĸB p50 
The phosphorylation of NF-ĸB subunits is strongly linked to the activation of the 
NF-ĸB pathway. Indeed, in addition to IĸBα, IKKβ also phosphorylates other 
components of the NF-ĸB pathway including p65 and p105 (Christian et al., 
2016). To determine if IKKβ may also phosphorylate p50, we initially performed 
in vitro kinase assays using constitutively active IKKβ (IKKβSSEE) 
immunoprecipitated from transiently transfected HEK293T cells and employing 
purified recombinant GST-p50 as substrate. These assays revealed that active 
IKKβ phosphorylates p50 in vitro (Figure 4.1A). Kinase assays incorporating 
immunoprecipitated kinase dead IKKβ (IKKβK44M) and purified recombinant GST 
established that p50 phosphorylation was due to IKKβ kinase activity (Figure 
4.1A). Similar results demonstrating the phosphorylation of p50 by IKKβ were 
obtained using in vitro kinase assays incorporating purified recombinant IKKβ 
(Figure 4.1B). Co-immunoprecipitation of p50 and constitutively active IKKβSSEE 
in transfected cells demonstrated that IKKβ and p50 interact (Figure 4.1C). Of 
note, p50 interacted with the active but not a kinase dead form of IKKβ 
indicating that IKKβ activity is required for interaction with p50 (Figure 4.1C). 
These data establish the p50 subunit of NF-ĸB as a novel substrate of the IKKβ 
kinase. 
101 
 
 
Figure 4.1: IKKβ phosphorylates NF-ĸB p50. 
(A) HEK293T cells were transfected with FLAG-IKKβK44M (kinase dead) or FLAG-IKKβSSEE 
(constitutively active) as indicated. IKKβ was immunoprecipitated from whole cell lysates with anti-
FLAG antibody and incorporated in a kinase assay using recombinant GST-p50 or recombinant 
GST, with [γ-32P] ATP as a co-substrate. Samples were resolved by SDS-PAGE and visualised by 
autoradiography. (B) In vitro kinase assay employing recombinant IKKβ and recombinant GST-p50 
or GST, with [γ-32P] ATP as a co-substrate. Samples were resolved by SDS-PAGE and visualised 
by autoradiography. (C) HEK293T cells were co-transfected with Myc-p50 and FLAG-IKKβSSEE or 
FLAG-IKKβK44M as indicated. p50 was immunoprecipitated (IP) from whole cell lysates with anti-
Myc antibody and analysed by western blot (WB) using the indicated antibodies. 
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4.4.2 Serine 80 is the IKKβ phosphorylation site of NF-ĸB p50 
To identify the specific amino acids of p50 phosphorylated by IKKβ we employed 
an in vitro kinase assay using a peptide array representing the entire amino acid 
sequence of p50. A series of 30 18-amino-acid-long peptides were SPOT 
synthesised on nitrocellulose, with each peptide overlapping by 3 residues to 
generate a p50 peptide array. The p50 array was subjected to in vitro kinase 
assays using recombinant IKKβ as previously described (Kiely et al., 2009). This 
analysis identified four putative IKKβ phosphorylation sites in p50; S73, S74, S80 
and T315 (human p50 amino acid numbering used) (Figure 4.2A). To further test 
the putative sites of IKKβ phosphorylation we next performed in vitro kinase 
assays incorporating recombinant IKKβ and recombinant GST-p50 in which S73, 
S74, S80 and T315 are mutated to alanine. This analysis revealed that IKKβ could 
still phosphorylate p50 when S73, S74, and T315 are mutated to alanine, but not 
when S80 is mutated to alanine (Figure 4.2B). These data identify S80 of p50 as 
the site of IKKβ phosphorylation. Analysis of the available crystal structure of 
p50 homodimer bound to DNA revealed that S80 of p50 is located in an extended 
loop of the RHD and therefore available for phosphorylation (Figure 4.2C). To 
further confirm IKKβ phosphorylation of p50 in vivo, we next generated an 
antibody raised against the S80 phosphorylation site of p50. This anti-phospho-
S80 p50 antibody recognised IKKβ dependent phosphorylation of p50 but not a 
p50S80A mutant in transiently transfected cells, demonstrating the 
phosphorylation of p50 S80 by IKKβ in cells (Figure 4.2D). Unfortunately, this 
antibody was not of sufficient affinity to generate a specific signal in cell lysates 
of non-transfected cells and so was not of further use in investigating p50 S80 
phosphorylation. 
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Figure 4.2: IKKβ phosphorylates NF-ĸB p50 at S80. 
(A) In vitro IKKβ kinase assay using a peptide array of immobilised, overlapping 18-mer peptides 
the entire p50 sequence. Black spots represent IKKβ-phosphorylated peptides. Peptide 
sequences, amino acid number (mouse p50) and putative phosphosites (bold) are shown. (B) In 
vitro IKKβ kinase assay using recombinant GST, wild type and mutated recombinant GST p50 as 
indicated. (C) Image from the X ray crystal structure of p50 homodimer bound to DNA (1NFK) 
indicating the location of S80 in an extended loop of the Rel Homology Domain. (D) HEK293T cells 
were co-transfected with or without FLAG-IKKβSSEE and with either XP-p50 or XP-p50S80A as 
indicated. p50 was immunoprecipitated (IP) from whole cell lysates with anti-XP antibody and 
analysed by western blot (WB) using anti-phospho-serine 80 (p-S80) antibody. 
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4.4.3 S80 phosphorylation is not required for NF-ĸB activation 
Following the identification of S80 as a novel phosphorylation site on the p50 
subunit, we next sought to investigate its role in regulating NF-ĸB activity. To 
achieve this we utilised CRISPR/Cas9 genome editing techniques to generate 
NFKB1S80A knock-in HEK293T cells (Figure 4.3A). The p50 subunit of NF-ĸB is 
generated from the proteasomal processing of the p105 precursor which requires 
the IKKβ mediated phosphorylation at the C-terminus of p105 (Heissmeyer et al., 
1999, Heissmeyer et al., 2001, Salmeron et al., 2001, Lang et al., 2003). To 
determine whether S80 plays a role in the processing of p105 we analysed 
p105/p50 protein levels in whole cell lysates from wild type (WT) and cells by 
western blot. This revealed equivalent levels of p105/p50 in WT and NFKB1S80A 
demonstrating that S80 is not required for the processing of p105 to p50 (Figure 
4.3B). To determine the effect of S80 mutation on the activation of the NF-ĸB 
pathway we next stimulated WT and NFKB1S80A cells with TNFα and assessed the 
phosphorylation and degradation of IĸBα by western blot. This analysis 
demonstrated equivalent levels of IĸBα phosphorylation and degradation in WT 
and NFKB1S80A cells stimulated with TNFα (Figure 4.3C). Nuclear translocation of 
p50 and p65 in TNFα stimulated WT and NFKB1S80A was assessed by immunoblot 
analysis of nuclear and cytoplasmic fractions. This demonstrated equivalent 
levels of NF-ĸB translocation to the nucleus following TNFα stimulation (Figure 
4.3D). Together, these data demonstrate that upstream signalling and nuclear 
translocation of NF-ĸB following TNFα stimulation is unaffected by the p50 S80A 
mutation. To investigate the effect of S80 mutation on p50 interaction with p65 
we performed an immunoprecipitation assay using anti-p50 antibody. Western 
blot analysis of immunoprecipitates showed that equivalent levels of p65 co-
purified with p50 in both WT and NFKB1S80A cells demonstrating that p50 S80A 
mutation does not alter the interaction of p50 and p65 (Figure 4.3E). 
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Figure 4.3: S80 phosphorylation is not required for NF-ĸB activation. 
(A) Schematic of the CRISPR/Cas9 targeting strategy used to edit the NFKB1 target locus, 
highlighting the position of the S80 codon (red); gRNA (yellow); PAM site (blue) and primers used 
for screening (green arrows). The ssODN template including homology arms (dotted line), HindIII 
restriction cut site (green triangles) and synonymous codon changes (bold) are shown. Also shown 
is DNA sequence chromatogram of the NFKB1 target region confirming the S80A point mutation 
(black box). (B) Whole cell lysates extracted from WT and NFKB1S80A HEK293Ts were analysed by 
western blot (WB) with the indicated antibodies. (C) WT and NFKB1S80A HEK293Ts were 
stimulated with 10ng/ml TNFα for the indicated times prior to lysis. Whole cell extracts were 
analysed by western blot to detect levels of phosphorylated and total IĸBα protein. (D) WT and 
NFKB1S80A HEK293Ts were stimulated with 10ng/ml TNFα for the indicated times prior to lysis. 
Nuclear and cytoplasmic extracts were analysed by western blot using antibodies against p65 and 
p105/p50. (E) WT or NFKB1S80A HEK293Ts were left untreated or were stimulated with 10ng/ml 
TNFα for 30 mins prior to lysis. p50 was immunoprecipitated (IP) from whole cell lysates with anti-
p105/p50 antibody and analysed by western blot (WB) with anti-p105/p50 and anti-p65 antibodies 
as indicated. 
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4.4.4 S80 phosphorylation selectively regulates TNFα-induced 
gene expression 
Site-specific phosphorylation of NF-ĸB subunits has previously been shown to 
regulate transcriptional activity (Christian et al., 2016). To determine the role of 
S80 phosphorylation in regulating NF-ĸB target gene expression, we next 
analysed TNFα-induced transcriptional responses in WT and NFKB1S80A cells by 
RNA-seq. WT and NFKB1S80A cells were untreated or treated with TNFα for 3 
hours prior to RNA-seq analysis. This revealed distinct transcriptional profiles of 
differentially expressed genes in WT and NFKB1S80A cells in response to TNFα 
(Figure 4.4A). In particular we identified two TNFα-inducible groups of genes 
composed predominantly of NF-ĸB target genes containing an identifiable NF-ĸB 
binding site in their promoter regions that were differentially regulated by WT 
and NFKB1S80A cells (Figure 4.4B). The expression of genes encoding pro-
inflammatory chemokines and cytokines including TNF, IL8, CXCL2, CXCL1 and 
CXCL10 was dramatically increased in NFKB1S80A cells compared to WT cell 
following TNFα treatment. However, other NF-ĸB target genes predominantly 
encoding for intracellular signalling factors including BCL3, MAP3K8, NFKB1 and 
IRAK1 were expressed at equivalent levels in both WT and NFKB1S80A cells 
following TNFα treatment. Analysis of selected genes from each group by qPCR 
confirmed the gene-selective regulation of transcription by p50 S80 
phosphorylation (Figure 4.4C). Of note, although the expression levels of a 
number of TNF-inducible genes is higher in NFKB1S80A cells than WT cells, there is 
a very high correlation between TNFα induced differentially expressed genes in 
WT and NFKB1S80A cells (Figure 4.4D). This indicates that S80 phosphorylation 
regulates the levels of gene expression induced by TNFα treatment rather than 
the identity of the genes induced. 
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Figure 4.4: S80 phosphorylation selectively regulates TNFα-induced gene expression. 
(A) Triplicate samples of WT and NFKB1S80A cells treated with TNFα for 3 hours (+TNFα) or 
untreated (Unt) were analysed by RNA-seq. The heat map displays differentially expressed genes 
(p.adj <0.05) scaled as per z-score. Genes were clustered using spearman distances and UPGMA 
agglomeration. (B) Box and whisker plots of gene expression level by RNA-seq for selected genes. 
Each dot represents a sample. Boxes show the 25th, 50th and 75 percentile with whiskers showing 
inter-quartile range. (C) WT and NFKB1S80A HEK293Ts were stimulated with 10ng/ml TNFα for the 
indicated times prior to harvest and RNA extraction. Gene expression levels were determined by 
quantitative real-time PCR. Data are mean ± S.E of triplicate samples and are representative of 
three independent experiments. (D) Log2 fold change scatter plot of genes (dots) shown in (B). The 
blue dotted line indicates correlation the between WT TNFα/WT Unt v S80A 0hr/WT Unt fold 
changes (spearman correlation ~0.96). The red line represents linear regression. 
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4.4.5 Specific DNA-binding motifs associated with differential 
regulation of NF-ĸB target genes by S80 
The gene selective effects of S80 mutation on TNFα-induced transcription 
suggested that phosphorylation of S80 may regulate the activity of p50 in a 
promoter specific manner. Binding site sequence preferences differ among NF-
ĸB dimers (Siggers et al., 2011) and suggests a potential mechanism for the 
selective effect of S80 mutation on the transcription of a distinct set of target 
genes. To further explore this possibility, we performed transcription factor 
binding site analysis to search for the most enriched ĸB sites in TNFα-induced 
genes expressed higher in NFKB1S80A cells than WT cells, and those expressed 
equally in both WT and NFKB1S80A cells. The genomic region between the nearest 
upstream and downstream gene was used to search for both proximal and distal 
regulatory features (including promoters and enhancers) for each gene. 
Regulatory features were analysed for occurrences of a 10 base pair NFKB1 
position weight matrix (JASPAR ID MA0105.1). This analysis identified distinct 
DNA binding motifs associated with each group of genes (Figure 4.5A and Figure 
4.5B). Specifically, promoter and enhancer ĸB sites varied at the -1 and -2 
positions (Figure 4.5A and Figure 4.5B). The ĸB sites of genes with increased 
expression in NFKB1S80A cells relative to WT cells, contain an adenine (A) at the -
2 position, and either an adenine or a cytosine (C) at the -1 position (Figure 
4.5A). In contrast, the ĸB sites of genes where expression is unchanged between 
WT and NFKB1S80A cells contain either an A or a guanine (G) at the -2 position 
while there is no enrichment of any particular nucleotide at the -1 position 
(Figure 4.5B). This analysis suggested that S80 phosphorylation may regulate p50 
function in a DNA binding site sequence specific manner. 
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Figure 4.5: Specific κB sites are enriched in genes selectively regulated by S80 
phosphorylation. 
Gene expression values (scaled as per z-score) of selected genes (A) induced to a greater degree 
in NFKB1S80A cells compared to WT cell, and (B) genes expressed equally between WT and 
NFKB1S80A cells. Proximal and distal regulatory regions surrounding each gene were searched for 
occurrences of NFKB1 motifs best matched to JASPAR position weight matrix MA0105.1. 
Sequence logos representing the most enriched ĸB site for each gene set are shown. 
 
4.4.6 S80 phosphorylation reduces p50 affinity for -1A containing 
ĸB sites 
To determine if S80 phosphorylation alters the binding of p50 to specific ĸB 
sequences we next carried out DNA affinity precipitation assays (DAPA) 
incorporating the ĸB sequences identified in our analysis of transcriptomic data 
(Figure 4.5). WT or NFKB1S80A cells were left untreated or treated with TNFα 
prior to extraction of nuclear fractions. Nuclear extracts were incubated with 5’-
biotinylated oligonucleotides representing ĸB sites with base pair substitutions 
at the -1 and -2 positions. The oligonucleotides were designed to represent the 
DNA-binding motifs identified in the gene sets identified by our transcriptomic 
analysis (Figure 4.5A and Figure 4.5B), and differed only in the base pair 
sequence at the -2 and -1 positions of a GGGA(-2)C(-1)TTTCC motif. 
Oligonucleotides representing ĸB sites from genes with enhanced TNFα inducible 
expression in NFKB1S80A cells therefore contained an A at the -2 position and an A 
or C at the -1 position. Since the ĸB sites identified in genes with equivalent 
expression in both WT and NFKB1S80A cells displayed heterogeneity at the -1 
position we generated oligonucleotides with an A or C at the -1 position to 
reflect the previously reported prevalence of A and C at this position of ĸB sites 
(Zabel et al., 1991) and a G at the -2 position. Oligonucleotides and bound 
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protein were precipitated using streptavidin conjugated agarose beads. 
Specificity of protein DNA interaction was verified using control samples 
containing a 10X excess of non-biotinylated oligonucleotide. Precipitated 
proteins were resolved by SDS gel electrophoresis and analysed by western blot 
using antibodies against p50 and p65 and quantified using a digital 
chemiluminescence scanner. These assays demonstrated approximately 2 fold 
greater binding of p50S80A to the GGGA(-2)A(-1)TTTCC ĸB site when compared to 
WT p50 (Figure 4.6). Remarkably, there is also significantly greater binding of 
p65 to this ĸB site in NFKB1S80A cells relative to WT cells, demonstrating that p50 
S80 phosphorylation regulates the DNA binding of p50:p65 heterodimers. The 
requirement of an A at the -1 position for this effect was demonstrated by a 
single base change of -1A to -1C in the GGGA(-2)C(-1)TTTCC ĸB site which 
largely abolished the increased p50S80A binding and completely abolished the 
increased p65 binding seen with the GGGA(-2)A(-1)TTTCC site (Figure 4.6). 
The significance of the -1A nucleotide to p50S80A binding was further 
demonstrated by the increased binding of p50S80A to a GGGG(-2)A(-1)TTTCC ĸB 
sites relative to WT p50 (Figure 4.6). Of note, the levels of p65 binding to this 
site were similar in both p50S80A and WT p50 expressing cells indicating that S80 
phosphorylation may regulate the binding of p50 homodimers but not p50:p65 
heterodimers to ĸB sites with this sequence. This suggested that binding to 
specific ĸB sequences may also be influenced by the composition of p50 
containing dimers. An additional change from A to C in the -1 nucleotide position 
in the GGGG(-2)C(1)TTTCC site further reduces p50S80A binding relative to WT 
p50 as compared to GGGG(-2)A(-1)TTTCC ĸB sites (Figure 4.6). Together, these 
data show that the regulation of p50 binding by S80 is determined primarily by 
the identity of the -1 nucleotide which appears to modify the binding of both 
p50 homodimer and p50:p65 heterodimer complexes. Thus S80 phosphorylation 
reduces the binding of p50 containing NF-ĸB dimers to ĸB sites containing an A 
at the -1 position. 
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Figure 4.6: S80 phosphorylation regulates DNA binding affinity to -1A containing κB sites. 
WT and NFKB1S80A HEK293T were left untreated or treated with 10ng/ml TNFα as indicated for 30 
mins. Equal concentrations of nuclear lysates were incubated with 5’-biotinylated double stranded 
oligonucleotides, with or without a 10X excess of unlabelled competitor double stranded oligo 
indicated. The sequence of the double stranded oligos containing ĸB sites that vary at the -1 and -2 
positions are indicated for each assay (underlined). Precipitated samples were analysed for p50 
and p65 proteins by WB. Relative binding of p50 and p65 protein to DNA was quantified by 
normalising to input. Data shown are representative of 3 individual experiments. 
 
4.4.7 S80 phosphorylation inhibits transcription from -1A 
containing ĸB sites 
The transcriptomic and DNA binding analyses suggest that the increased 
transcription of pro-inflammatory genes in NFKB1S80A cells results from increased 
binding of p50S80A containing NF-ĸB dimers to promoter ĸB sites containing an A 
in the -1 position. We next sought to investigate whether increased DNA-binding 
of p50S80A is sufficient to increase target gene transcription or whether the 
transcriptional outcome observed in TNFα treated NFKB1S80A cells occurs only in 
the context of the gene promoter. We generated 4 different luciferase reporter 
constructs that contained four ĸB site repeats that vary at either the -2 or the -1 
position immediately upstream of a minimal promoter and firefly luciferase 
reporter gene. The 4 reporter plasmids each contained a ĸB site sequence 
identical to each of the sequences employed in the DAPA experiments described 
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above (Figure 4.6). WT or NFKB1S80A cells were transiently transfected with the 
different reporter plasmids along with a constitutive expression vector for 
Renilla luciferase to enable normalisation for transfection efficiency. Luciferase 
reporter activity was measured in untreated and TNFα-treated cells to 
determine the impact of p50S80A on transcription driven by specific ĸB site 
sequences. TNFα-induced luciferase activity from the reporter containing the 
GGGA(-2)A(-1)TTTCC sequence was approximately 2 fold greater in NFKB1S80A 
cells compared to WT cells (Figure 4.7), consistent with the increased DNA 
binding of p50S80A to this sequence observed in the DAPA assays (Figure 4.6). 
Interestingly, TNFα induced reporter activity in both WT and NFKB1S80A cells is 
highest in reporter plasmids containing the GGGA(-2)A(-1)TTTCC site compared 
to the other ĸB sites tested, suggesting that ĸB sites containing an A at the -1 
and -2 position are more potent drivers of gene transcription. The importance of 
the -1 nucleotide is further highlighted by the observed overall decrease in 
luciferase activity in both WT and NFKB1S80A cells when the -1A is changed to -1C 
(Figure 4.7). 
The increased TNFα induced reporter activity from the A(-2)C(-1) ĸB site seen in 
NFKB1S80A cells relative to WT cells (Figure 4.7) is also consistent with the 
observed increased expression levels in NFKB1S80A cells of genes which contain 
either A(-2)A(-1) or A(-2)C(-1) ĸB sites (Figure 4.5A). The relative differences in 
TNFα induced reporter activity between WT and NFKB1S80A cells are much less 
where the ĸB site contains a G(-2)A(-1) and G(-2)C(-1) sequence (Figure 4.7). 
This is consistent with the transcription profiles observed for genes that contain 
either G(-2)A(-1) or G(-2)C(-1) ĸB sites where expression is similar between WT 
and NFKB1S80A cells (Figure 4.5B). Furthermore, DNA binding analysis also showed 
that p65 binding to these sites is either unaffected, or slightly reduced (G(-2)A(-
1) and G(-2)C(-1), respectively) by S80 phosphorylation which correlates with the 
reporter activity (Figure 4.6). The reporter activity for all four ĸB sequences 
tested were equivalent between untreated WT and NFKB1S80A cells, consistent 
with TNFα dependent activation of IKKβ as a requirement for p50 
phosphorylation. Taken together, these data show that S80 phosphorylation 
regulates NF-κB transcriptional activity in a ĸB sequence specific manner and 
that binding site sequence differences are sufficient to determine transcriptional 
outcome following S80 phosphorylation. Specifically, S80 phosphorylation acts to 
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limit the NF-ĸB mediated transcription of genes containing a -1A ĸB site 
nucleotide. 
 
Figure 4.7: S80 phosphorylation regulates transcription in a κB sequence specific manner. 
WT and NFKB1S80A HEK293T cells were transfected with pTAL-NFKB reporter constructs with four 
identical tandem ĸB sites that vary at the -1 and -2 positions as indicated (underlined). 24 hours 
post transfection, cells were either left untreated or treated with TNFα for 8 hours before luciferase 
activity was measured. The Renilla luciferase expression vector pRLTK was used as an internal 
control to normalise transfection efficiency across all samples. Reporter activity is represented as 
fold increase over untreated WT cells. Data shown are mean ± S.E. of quadruplicate samples. 
Statistical significance between treated WT and NFKB1S80A cells was determined by Student’s t 
test. **p≤0.01; ***p≤0.001; ****p≤0.0001. 
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4.5 Discussion 
In this study, we have identified S80 as a novel phosphorylation site on the NF-ĸB 
p50 subunit. The phosphorylation of S80 by the IKKβ kinase also identifies p50 as 
a novel substrate for this kinase. Our data demonstrates that the 
phosphorylation of p50 at S80 selectively regulates TNFα-induced transcription 
by regulating the DNA binding of p50 at ĸB sites in a sequence specific manner. 
Thus, phosphorylation of S80 reduces p50 DNA binding to ĸB sites with a -1A, and 
thereby limits the expression of gene under the control of regulatory elements 
bearing this sequence. The regulation of p50 DNA binding by S80 phosphorylation 
occurs both in the context of p50:65 heterodimers and p50 homodimers, 
revealing the regulation of the transcriptional activity of the p65 subunit in trans 
through the modification of p50. 
In addition to the central role of IKKβ as an activator of the NF-ĸB pathway 
through the phosphorylation of IĸBα, IKKβ also phosphorylates a number of other 
components of the NF-ĸB pathway (Christian et al., 2016). This includes NF-ĸB 
p105, which is phosphorylated by IKKβ at the C-terminus to promote its limited 
proteasomal degradation to generate the p50 subunit of NF-ĸB. NF-ĸB p65 is also 
phosphorylated by IKKβ at S468 (Schwabe and Sakurai, 2005) and S536 (Schwabe 
and Sakurai, 2005, Sakurai et al., 1999, Sizemore et al., 2002, Haller et al., 
2002, Yoboua et al., 2010) which serves to regulate p65 transcriptional activity. 
Our identification of p50 as an IKKβ substrate places p50 alongside these other 
components of the NF-ĸB pathways as a regulatory target of IKKβ kinase activity. 
Of note, the regulation of sequence specific p50 DNA binding by IKKβ 
phosphorylation reveals a novel mechanism of IKKβ-mediated control of NF-ĸB 
activity. The phosphorylation of p65 at S468 and S536 by a number of other 
kinases in addition to IKKβ (Buss et al., 2004) suggests that S80 of p50 is also 
likely to be phosphorylated by other kinases. The future identification of 
additional S80 kinases will shed further light on the role of S80 phosphorylation 
in the regulation of NF-ĸB dependent transcriptional responses in the context of 
different cellular stimuli. 
The NF-ĸB barcode hypothesis proposes that post-translational modifications of 
NF-ĸB subunits, either alone or in combination, generate distinct functional 
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states that direct transcription in a gene specific manner (Moreno et al., 2010). 
This hypothesis has largely been generated from studies of p65 phosphorylation 
which indicate that individual sites of p65 phosphorylation may regulate the 
expression of distinct subsets of NF-ĸB target genes (Moreno et al., 2010). The 
molecular basis for such gene specific effects of p65 phosphorylation are not 
clear is many cases. Although studies have demonstrated that S468 
phosphorylation promotes the ubiquitination of p65 by enhancing interaction 
with an E3 ligase complex containing COMMD1, GCN5, Cullin2 and SOCS1 at 
certain promoters (Geng et al., 2009), it is not understood what directs this 
interaction at these specific promoters. In this study we establish that the gene-
specific transcriptional effects of S80 phosphorylation are mediated by the 
differential binding of phosphorylated p50 with ĸB sites containing an A 
nucleotide at the -1 position. Importantly, p50 S80 phosphorylation primarily 
affects the binding of p50:p65 heterodimers at these sites to inhibit gene 
transcription. While our data does not identify S80 phosphorylation as a 
regulator of p50 homodimer function, further analysis will be required to 
determine whether cell or signal specific factors control dimer specific effects of 
S80 phosphorylation. Phosphorylation of p50 at S328 has previously been 
demonstrated to inhibit the binding of p50 to ĸB sites containing a C nucleotide 
at the -1 position (Crawley et al., 2013). This study, together with our data, 
identifies the -1 position of ĸB sites as a critical factor in determining the 
transcriptional consequences of p50 phosphorylation. These data also establish 
ĸB site sequence as an additional and important component to be considered in 
further developing the NF-ĸB barcode hypothesis. 
DNA binding sites can act as allosteric regulators of transcriptional regulators 
(Lefstin and Yamamoto, 1998). Distinct DNA conformations adopted by particular 
ĸB sequences provides a potential mechanism to explain why single nucleotide 
variations affect DNA binding of NF-ĸB dimers. In support of this an in silico 
transcription factor binding site shape analysis of the ĸB sites employed in our 
experiments predicts a unique conformation for each ĸB site (Yang et al., 2014) 
(Supplementary Figure 1). Previous studies have revealed that phosphorylation 
of p65 induces conformational changes that may influence the transcriptional 
outcome following DNA binding (Milanovic et al., 2014). Using similar approaches 
we assessed conformational differences between p50WT and p50S80A by limited 
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proteolytic digestion (Supplementary Figure 2). This analysis showed different 
sensitivities to digestion between p50WT and p50S80A, indicating that S80 
phosphorylation may induce a conformational change that could modify the 
binding of p50 dimers to ĸB sites containing an A nucleotide in the -1 position. 
Such conformational changes may modify the transactivating potential of NF-ĸB 
dimers by modifying DNA binding to specific sites, but also possibly by modifying 
interaction with other factors that in turn affect DNA binding. 
Our data demonstrate that the interaction of S80 phosphorylated p50 with ĸB 
sites containing an A at the -1 position is sufficient to inhibit DNA binding and 
gene transcription of associated genes and does not necessarily require the 
context of a promoter. Interestingly, our data also show that individual ĸB 
sequences have different capacities to drive transcription as measured by 
reporter assays incorporating ĸB sequences upstream of a minimal promoter. 
These analyses identified -2A, -1A ĸB sites as more potent drivers of 
transcription than other sites tested. Remarkably, the increased transcription 
from reporter vectors containing these ĸB sites is also reflected in TNFα 
stimulated cells where genes regulated by these sites are induced at 
significantly higher levels than genes regulated by other ĸB sites. Indeed, these 
ĸB sites appear to be enriched in the regulatory regions of genes encoding pro-
inflammatory cytokines and chemokines, including TNFα, IL8 and the chemokines 
CXCL1 and CXCL2. The enrichment of specific ĸB sites in a functional class of 
genes provides strong evidence that NF-ĸB phosphorylation and ĸB sequences 
may establish regulatory networks to coordinate stimulus-specific transcriptional 
programmes. 
In conclusion, this study describes a novel site of IKKβ phosphorylation of the 
p50 subunit that regulates TNFα induced transcriptional responses in a gene-
selective manner. Our data demonstrates that the gene selective effect of S80 
phosphorylation on transcription is encoded in the ĸB sequence, specifically by 
the -1 nucleotide position. The results of this study contributes further to our 
understanding of the regulation of transcriptional programmes by NF-ĸB. Future 
research may enable the prediction of transcriptional outcome based on an 
understanding of the phosphorylation status of NF-ĸB and DNA binding site 
sequence. 
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4.6 Supplementary data 
 
 
Supplementary Figure 1: Transcription factor binding site shape analysis 
Predicted DNA shape values for (A) minor groove width (MGW), (B) propeller twist (ProT), (C) roll 
and (D) helix twist (HelT) are displayed as heat maps. Each κB site analysed has the 10bp format 
GGG(-2)(-1)TTTCC, with nucleotide variations at the -2 and -1 position (indicated). 
 
 
 
 
Supplementary Figure 2: S80 affects proteolysis of p50 
(A) HEK293T cells were transfected with either p50WT-XP or p50S80A-XP plasmids as indicated. 
Whole cell lysates were either left untreated (Unt) or treated with varying trypsin:lysate (w/w) ratios 
as indicated. p50 protein degradation levels were analysed by western blot (WB) using anti-Xpress 
antibody. (B) Whole cell lysates extracted from TNFα treated (10ng/ml) WT or NFKB1S80A cells 
were left untreated (-) or treated with trypsin at a 1:9 ratio of trypsin:lysate (w/w). p50 protein 
degradation levels were analysed by western blot (WB) using anti-p50 antibody. 
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Chapter 5 
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5 NFKB1S80A THP-1 profiling analyses 
5.1 Abstract 
The NF-ĸB p50 subunit is a critical regulator of inflammatory gene expression, 
however, its regulation by phosphorylation is not well studied. NFKB1 is one of 
the most highly expressed transcription factors in macrophages, and is central to 
regulating gene expression in macrophages. Therefore, understanding the 
mechanisms regulating p50 function is key to understanding essential 
inflammatory responses. In this chapter, NFKB1S80A THP-1 cells generated using 
CRISPR/Cas9 genome editing were utilised to investigate the role of p50 S80 
phosphorylation in a human macrophage model. It was found that S80 selectively 
regulates LPS-induced gene expression, in particular, the expression of pro-
inflammatory genes. Transcription factor binding site analysis of LPS-induced 
gene promoters identified an enriched κB site within a distinct cluster of genes 
with elevated expression in NFKB1S80A THP-1s compared to WT THP-1s. As a 
consequence, NFKB1S80A THP-1 cells have an enhanced pro-inflammatory 
phenotype, supported by enrichment of gene sets related to inflammatory 
processes. In addition, the possibility of predicting the outcome of gene 
expression based on specific NF-κB binding sites was explored. 
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5.2 Introduction 
The importance that the NF-κB p50 subunit has in regulating the immune 
response is clear from a number studies utilising Nfkb1-/- mouse models 
(described in section 1.4.1), and genome wide studies implicating NFKB1 
polymorphisms in human inflammatory diseases (Sun and Zhang, 2007). 
However, the particular role that p50 plays in the regulation of immune cells 
such as macrophages is becoming more apparent. A screen of human monocyte-
derived macrophages treated with a number of different stimuli identified a 
broad spectrum of transcriptional profiles associated with macrophage activation 
(Xue et al., 2014). Within these transcriptional profiles, NFKB1 was identified as 
one of the most highly expressed transcription factors (Xue et al., 2014). In fact, 
it has been estimated that there are 30,000 p50 homodimers in the nuclei of 
resting bone marrow derived macrophages (BMDMs) (Cheng et al., 2011), 
suggesting that p50 plays an important role in regulating gene expression at 
basal level. Furthermore, p50 homodimers are important repressors of 
inflammatory gene expression, and their stability is crucial for limiting pro-
inflammatory gene expression and establishing Toll-like Receptor tolerance in 
macrophages (Carmody et al., 2007, Yan et al., 2012). These studies implicate 
p50 as an important regulator of gene expression in macrophage. Therefore, 
identifying the mechanisms regulating p50 function in macrophages is essential 
to understanding transcriptional profiles controlling major processes of the 
immune response. 
While studies of p50 function could be performed in mouse macrophage cell 
lines such as RAW264.7 or murine BMDM, it has been reported that there are 
substantial differences in TLR4-regulated gene expression between mice and 
humans (Schroder et al., 2012). Therefore, the transcriptional profiles of murine 
and human macrophages are not suitable for comparison. Although primary 
human macrophages could be cultured, their short in vitro life span and 
potential heterogeneity in inflammatory response limit the benefits of their use 
(Gordon et al., 2014). The most widely used cell line for investigating primary 
human macrophage function in vitro is the human leukaemia-derived monocytic 
cell line, THP-1. THP-1 cells can be differentiated into macrophage-like cells 
using stimuli such as phorbol 12-myristate-13-acetate (PMA), 1α, 25-
dihydroxyvitamin D3 (vD3), or macrophage colony stimulating factor (M-CSF). 
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However, PMA-stimulated differentiation is generally preferred for generation of 
cells with similar phenotypic and functional characteristics of human peripheral 
blood mononuclear cell (PBMC) monocyte-derived macrophages (Chanput et al., 
2014). Therefore, THP-1 cells are an appropriate model for studying human 
macrophage functions, mechanisms and signalling pathways. THP-1 cells have 
previously been used to study the LPS-induced NF-κB response, where expression 
profiles were similar to PBMC monocyte-derived macrophages, supporting use of 
THP-1s cells as a good model for inflammatory gene expression (Sharif et al., 
2007). For this reason, NFKB1S80A THP-1 cells were generated using CRISPR/Cas9 
genome editing technology (Chapter 3) to be used as model to study S80 
phosphorylation in human macrophage. While mutation of NFKB1 S80 will 
provide insight into the role of NF-κB p50 phosphorylation in the regulation of 
inflammatory gene expression in human macrophages, it is important to consider 
how mutation of NFKB1 might affect other signalling pathways in THP-1 cells. 
This is due to the ability of NFKB1 to crosstalk with other transcription 
regulatory networks.  
For example, ERK1/2 activation may be affected in THP-1 cells as a result of 
NFKB1 mutation. While TNFα does not induce ERK1/2 phosphorylation in HEK293 
cells (Bladh et al., 2009, Tu et al., 2014) ERK1/2 activation is induced by LPS in 
macrophages, regulated by the interaction of p105 with the kinase TPL-2. In 
macrophages, all detectable TPL-2 is associated with a pool of p105, inhibiting 
TPL-2 induced ERK1/2 activation (Beinke et al., 2003). Activated ERKs 
phosphorylate and activate a number of downstream targets, including 
transcription factors, which coordinate the regulation of a large number of genes 
involved in many biological processes (Roskoski, 2012). It has been shown in 
macrophages that following LPS-induced p105 processing, liberated TPL-2 
specifically mediates activation of ERK1/2, and not other MAPKs such as p38 
(Dumitru et al., 2000). Therefore, if p105 processing is impaired by S80A 
mutation, ERK1/2 activation may be defective, which in turn will affect 
expression of genes regulated by this pathway. The importance of NFKB1 in 
regulating ERK1/2 activation has been demonstrated using macrophages from 
Nfkb1-/- mice and Nfkb1SSAA mice (Waterfield et al., 2003, Banerjee et al., 2006, 
Yang et al., 2012). Nfkb1SSAA mice are defective in LPS-induced p105 processing 
due to mutation of IKKβ target sites from serine to alanine residues. Nfkb1-/- 
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macrophages are defective for TPL-2 activation of ERK1/2 signalling, which 
impairs production of IL-10 and COX2 (Waterfield et al., 2003, Banerjee et al., 
2006). Similarly, Nfkb1SSAA macrophages are defective for TPL-2 activation of 
ERK1/2, impairing expression of Il6 and Csf2 (Yang et al., 2012). In addition, it 
has been shown that NF-κB is capable of regulating a subset of interferon (IFN)-
stimulated genes (Pfeffer, 2011). Moreover, p50 homodimers have been shown 
to binds to a subclass of IFN response elements (IRE) to repress IFN-inducible 
gene expression in macrophages (Cheng et al., 2011). Therefore, mutation of 
p50 S80 may have an effect on IFN gene expression. 
The aims of this chapter were to: 
1. Utilise CRISPR/Cas9 generated NFKB1S80A knock-in THP-1 cells to 
investigate p50 S80 phosphorylation-driven transcriptional profiles in 
response to LPS. 
2. Investigate mechanisms controlling LPS-induced selective gene 
expression. 
3. Explore the phenotype of NFKB1S80A knock-in THP-1 cells in an 
inflammatory context. 
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5.3 Results 
5.3.1 NF-κB activation unaffected despite reduced p105/p50 
protein levels in NFKB1S80A THP-1 cells 
Following the generation of NFKB1S80A THP-1 cells (Figure 3.7, clone 10), the role 
of S80 phosphorylation in regulating NF-κB activity in human monocyte-derived 
macrophages was investigated. Immunoblot analysis of p105/p50 protein 
expression in whole cell lysates from undifferentiated wild type (WT) and 
NFKB1S80A THP-1 cells revealed a slight reduction in both p105 and p50 protein 
levels in NFKB1S80A cells (Figure 5.1A). This result was surprising, given that 
p105/p50 protein levels were equivalent between WT and NFKB1S80A HEK293T 
cells (Chapter 4), suggesting a cell type-specific effect of the S80 mutation. To 
investigate the effect of S80 mutation on the activation of the NF-ĸB pathway, 
WT and NFKB1S80A THP-1 cells were differentiated with 25ng/ml PMA for 3 days. 
Following a 4 day rest period, WT and NFKB1S80A THP-1 cells were stimulated 
with 10ng/ml LPS, and IĸBα phosphorylation and degradation by was assessed by 
immunoblot. This analysis demonstrated slightly lower levels of IĸBα 
phosphorylation in NFKB1S80A cells stimulated with LPS, compared to WT THP-1s 
(Figure 5.1B). However, the kinetics of IĸBα phosphorylation are comparable 
between WT and in NFKB1S80A THP-1s. Nuclear translocation of p50 and p65 in 
response to LPS was assessed in PMA-differentiated WT and NFKB1S80A THP-1 
cells. Immunoblot analysis of nuclear and cytoplasmic fractions demonstrated 
that p50 and p65 translocation to the nucleus following LPS stimulation is similar 
between WT and NFKB1S80A THP-1 cells. Together, these data demonstrate that 
despite the slight reduction in p105/p50 protein levels in NFKB1S80A THP-1 cells, 
the ability of p50 to translocate to the nucleus is not impaired. 
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Figure 5.1: S80 phosphorylation is not required for NF-ĸB activation in THP-1 cells 
(A) Whole cell lysates extracted from WT and NFKB1S80A THP-1s were analysed by western blot 
(WB) to detect endogenous p105/p50 protein levels. (B) WT and NFKB1S80A THP-1s were 
differentiated with 25ng/ml PMA for 3 days, and were stimulated with 10ng/ml LPS after 4 days rest 
for the indicated times prior to lysis. Whole cell extracts were analysed by WB to detect levels of 
phosphorylated and total IκBα protein. (C) WT or NFKB1S80A THP-1s were differentiated with 
25ng/ml PMA for 3 days, and were stimulated with 10ng/ml LPS after 4 days rest for the indicated 
times prior to lysis. Nuclear and cytoplasmic extracts were prepared and analysed for p50 and p65 
proteins by WB. 
 
5.3.2 ERK1/2 activation is increased in NFKB1S80A THP-1 cells 
Since p105 undergoes TLR-inducible processing to generate p50, the levels of 
p105/p50 protein in PMA-differentiated WT and NFKB1S80A THP-1 cells were 
assessed in response to LPS treatment. Immunoblot analysis revealed a 
significant decrease of p50 protein levels in NFKB1S80A THP-1 cells compared to 
WT THP-1 cells (Figure 5.2A). While it could be speculated that the S80A 
mutation may have an effect on LPS induced p105 processing, p50 protein levels 
in untreated NFKB1S80A THP-1 cells are also reduced. The effect of impaired 
p105/p50 protein levels on the activation of the ERK1/2 MAPK pathway was next 
investigated. Immunoblot analysis revealed significantly increased levels of 
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phosphorylated ERK1/2 in both unstimulated and stimulated NFKB1S80A THP-1 
cells compared to WT THP-1 cells (Figure 5.2A). This effect was surprising, given 
that ERK1/2 activation has been shown to be dependent on p105 processing in 
murine macrophages (Yang et al., 2012). To investigate the effects of the S80A 
mutation on other MAPK signalling pathways, the p38 pathway was also 
examined (Figure 5.2A). Levels of phosphorylated p38 are comparable between 
WT and NFKB1S80A THP-1 cells, suggesting that S80A mutation may specifically 
effect activation of ERK1/2, and not other MAPK pathways such as p38. 
It has been shown that the period of rest following PMA exposure can influence 
some phenotypic properties and functional characteristics of THP-1 cells (Lund 
et al., 2016). In Figure 5.2A, THP-1 cells were stimulated with LPS immediately 
following PMA treatment. In order to rule out rest period as a factor that 
influences p105/p50 protein levels and upregulation of ERK1/2 signalling 
pathways, immunoblot analyses were repeated, however THP-1 cells were rested 
in culture for 4 days following PMA differentiation (Figure 5.2B). This analysis 
revealed a reduction in p105/p50 protein levels in NFKB1S80A THP-1 cells 
compared to WT THP-1s (Figure 5.2B), consistent with the results observed in 
undifferentiated THP-1 cells (Figure 5.1A). However, the total level of p105/p50 
protein in differentiated NFKB1S80A THP-1 cells appears to be less compared to 
undifferentiated NFKB1S80A THP-1 cells. The level of p50 protein in NFKB1S80A 
THP-1 cells rested for 4 days is higher in comparison to NFKB1S80A THP-1 cells 
that were not rested in culture (Figure 5.2B and Figure 5.2A). This analysis 
suggests that the S80 mutation affects endogenous p105/p50 protein levels in 
differentiated THP-1 cells, and that THP-1 differentiation protocol appears to 
have an effect on p105/p50 protein ratios. 
This analysis also revealed that ERK1/2 activation is still increased in NFKB1S80A 
THP-1 cells following a 4 day rest period (Figure 5.2B). However, the kinetics of 
ERK1/2 activation are different in both WT and NFKB1S80A THP-1 cells. With 0 
days rest, ERK1/2 activation is only visible in WT THP-1 cells after 60 min LPS 
stimulation, whereas in NFKB1S80A THP-1 cells there is constitutive activation 
(Figure 5.2A). However, following 4 days rest, ERK1/2 activation in WT THP-1 
cells peaks after 15 mins. In NFKB1S80A THP-1 cells, ERK1/2 activation also peaks 
after 15 mins, but is sustained (Figure 5.2B). While levels of phosphorylated p38 
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appear reduced in NFKB1S80A THP-1 cells, the kinetics of p38 activation are 
comparable to that of WT cells, and reflect the findings of Figure 5.2A. Lower 
phosphorylated p38 levels observed are perhaps due to reduced levels of total 
p38 protein (Figure 5.2B). Together, these data suggest that the shorter 
differentiation protocol appears to exaggerate differences in p105/p50 protein 
level and ERK1/2 activation observed in NFKB1S80A THP-1 cells. Therefore, the 7 
day differentiation protocol (3 days PMA differentiation followed by 4 days rest) 
was utilised for further analyses such as RNA-seq and qPCR described in the next 
section (5.3.3). 
 
 
Figure 5.2: p105/p50 protein levels and ERK1/2 activation altered in differentiated NFKB1S80A 
THP-1 cells 
WT and NFKB1S80A THP-1 cells differentiated with 25ng/ml PMA for 3 days and were either treated 
with 10ng/ml LPS after 0 days rest (A) or 4 days rest (B) for the indicated times prior to lysis. Whole 
cell lysates extracted from WT and NFKB1S80A THP-1s were analysed by western blot (WB) to 
detect endogenous p105/p50 protein levels and levels of phosphorylated and total ERK1/2 and p38 
protein. 
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5.3.3 Transcriptomic analysis of NFKB1S80A THP-1 cells 
5.3.3.1 RNA-seq analysis workflow 
In order to investigate the role of S80 phosphorylation in regulating NF-κB target 
gene expression, LPS-induced transcriptional responses in WT and NFKB1S80A THP-
1 cells were analysed by RNA-seq. WT and NFKB1S80A THP-1 cells were left 
untreated or treated with LPS for 3 hours prior to RNA-seq analysis. RNA-seq 
data was analysed using two different pipelines (Schematic shown in Figure 
5.3A). Differentially expressed genes were identified by using two different 
methods. CuffDiff is a well-established method which calculates differential 
expression at transcript level. However, it has been reported that this method 
can produce slightly more false positive results compared to other methods such 
as DESeq2 (Rapaport et al., 2013, Seyednasrollah et al., 2015, Schurch et al., 
2016). Therefore, a combination of both CuffDiff and DESeq2 methods were 
utilised to ensure robust analysis of RNA-seq data. 
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Figure 5.3: p50 S80 phosphorylation selectively regulates gene expression in THP-1s 
(A) Workflow of RNA-seq analysis including CuffDiff and DESeq2 methods of calculating 
differentially expressed genes. (B) A representative per-base sequence quality plot generated by 
FastQC. The central red line represents the median value. The yellow box represents the inter-
quartile range (25-75%). The upper and lower whiskers represent the 10% and 90% points. The 
blue line represents the mean quality. The background of the graph divides the y axis into quality of 
called: very good (green), reasonable (orange), and poor (red). (C) Principal component analysis 
(PCA) of DESeq2 analysed RNA-seq data, showing the first two components. Samples are 
represented by dots. The percentage of total variation explained by each component is given. (D) 
Triplicate samples of WT and NFKB1S80A THP-1 cells treated with LPS for 3 hours (+) or untreated 
(-) were analysed by RNA-seq. The heat maps display differentially expressed genes calculated by 
DESeq2 (p.adj <0.01, replicates shown). Normalised read counts are scaled as per z-score. (E) 
WT and NFKB1S80A THP-1s were stimulated with 10ng/ml LPS for the indicated times prior to 
harvest and RNA extraction. Gene expression levels were determined by quantitative real-time 
PCR. Data are mean ± S.E of triplicate samples and are representative of three independent 
experiments. 
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The FastQC tool was used to check the per-base sequence quality of raw RNA-
seq data (Anders et al., 2015). All samples passed this quality control check, 
with high quality scores across all bases. A representative per-base sequence 
quality plot is shown in Figure 5.3B. Principal component analysis (PCA) was also 
performed to investigate the distribution of RNA-seq samples (Figure 5.3C). The 
PCA plot shows clear separation between each of the RNA-seq samples, and tight 
clustering of replicates, indicating little variation between each replicate. 
5.3.3.2 S80 phosphorylation selectively regulates gene expression 
RNA-seq analysis revealed distinct transcriptional profiles in both WT and 
NFKB1S80A THP-1 cells (Figure 5.3D). Two distinct groups of differentially 
expressed genes were identified: LPS-independent and LPS-dependent. Within 
the LPS-independent group, there are genes expressed in WT THP-1 cells which 
are not expressed in NFKB1S80A THP-1 cells. Similarly, there are genes expressed 
in NFKB1S80A THP-1 cells which are not expressed in WT THP-1 cells. The 
transcriptional profiles of unstimulated cells suggests that S80 phosphorylation 
regulates the ability of p50 to control gene expression at basal level, potentially 
as part of a p50 homodimer. Within the LPS-dependent group, genes are both 
upregulated and downregulated in both WT and NFKB1S80A THP-1 cells. Upon 
further inspection of LPS-inducible genes, the magnitude of gene expression 
differs between WT and NFKB1S80A THP-1 cells (Figure 5.3). For example, while 
the expression of some genes remains equivalent between WT and NFKB1S80A 
THP-1 cells, expression levels of other genes are upregulated to a greater extent 
in NFKB1S80A THP-1 cells in comparison to WT THP-1s. This suggests a selective 
effect of the NFKB1 S80A mutation, and indicates that S80 phosphorylation might 
regulate p50 as part of a p50:p65 heterodimer in THP-1 cells. 
To validate RNA-seq results, expression of selected genes with an identifiable κB 
site in their promoter region were independently measured by qPCR (Figure 
5.3E). This analysis confirmed evidence of selective gene regulation identified by 
RNA-seq. Of note, the expression of pro-inflammatory chemokines and cytokines 
is regulated in a selective manner. Expression of CCL2 and TNFα is similar 
between WT and NFKB1S80A THP-1 cells, whereas expression of CSF1, CXCL2 and 
IL8 is much higher in NFKB1S80A THP-1 cells compared to WT cells. In contrast, 
IL6 expression is dramatically increased in WT THP-1 cells compared to NFKB1S80A 
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THP-1 cells (Figure 5.3). These data suggest that S80 phosphorylation regulates 
LPS-induced transcriptional responses in a gene-selective manner. These results 
are consistent with those in Chapter 4, which analysed TNFα-induced gene 
expression in HEK293T cells. However, the expression pattern of TNFα differs 
between HEK293T cells and THP-1 cells, suggesting cell type or ligand specific 
expression patterns of certain genes. In addition, S80 phosphorylation appears to 
selectively regulate the expression of NF-κB modulators. Expression of BCL3 is 
higher in NFKB1S80A THP-1 cells than in WT THP-1s, whereas MAP3K8, NFKB1, and 
NFKB2 expression is equivalent (Figure 5.3). Of note, NFKB1 expression is slightly 
higher in NFKB1S80A THP-1 cells, suggesting that differences in p105/p50 protein 
levels in NFKB1S80A THP-1 cells may be controlled post-translationally. Together, 
these data indicate that S80 phosphorylation selectively regulates LPS-induced 
gene expression, including pro-inflammatory genes. 
Although RNA-seq analysis identified a number of LPS-independent genes, these 
genes were not further analysed as part of this thesis. However, it is important 
to note that the unstimulated transcriptional profiles of WT and NFKB1S80A THP-1 
cells may provide insight into how S80 phosphorylation regulates expression of 
genes at basal level. Specifically, it suggests that S80 phosphorylation may 
regulate the activity of p50 as part of a p50 homodimer, thereby controlling 
gene expression in unstimulated macrophages. Due to the findings that p50 S80 
phosphorylation predominantly regulates transcription through p50:p65 
heterodimers to limit NF-κB driven pro-inflammatory gene expression (Chapter 
4), further analyses in this chapter were focussed on LPS-induced genes. 
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5.3.4 Transcription factor and binding site enrichment analyses 
5.3.4.1 NF-κB is the core regulator LPS-induced gene expression in 
NFKB1S80A THP-1s 
To verify that NF-κB is the core transcription factor responsible for LPS-induced 
transcriptional profiles in NFKB1S80A THP-1 cells, upstream regulator enrichment 
analysis was performed. This analysis was used to identify the upstream 
transcriptional regulators that explain observed gene expression changes within 
LPS-induced WT THP-1 (Figure 5.4A and B) and LPS-induced NFKB1S80A THP-1 
(Figure 5.4D and E) datasets. Upstream regulator analysis is based on prior 
knowledge of expected effects between transcriptional regulators and their 
target genes, available from the TRRUST database (Han et al., 2018). Enriched 
upstream regulators are calculated based on significant overlap between dataset 
genes and known targets controlled by a transcriptional regulator (overlap p-
value). An activation score for each transcriptional regulator is calculated based 
on comparing the predicted directionality against the observed directionality of 
expression of each gene controlled by the upstream regulator (z-score). This 
analysis revealed a similar enrichment profile between LPS-induced WT and 
NFKB1S80A THP-1 cells (Figure 5.4C and Figure 5.4F). Importantly, NF-κB 
transcription factors such as RELA, NFKB1 and REL are significantly enriched 
within LPS-induced genes in both WT and NFKB1S80A THP-1 cells. This suggests 
that NF-κB driven gene transcription is not impaired in NFKB1S80A THP-1 cells, 
despite reduced p50 protein levels. In addition, it confirms that NF-κB is a strong 
contributor to the LPS-induced transcriptional profile observed NFKB1S80A THP-1 
cells. If the transcriptional profile of NFKB1S80A THP-1 cells was predominantly 
caused by increased ERK1/2 activation, it would perhaps be expected to observe 
enrichment of more ERK1/2 activated transcription factors such as ELK1 
(Roskoski, 2012). In addition, it might be expected that ERK1/2 activated 
transcription factors have a higher enrichment score than NF-κB transcription 
factors in NFKB1S80A THP-1 cells. For example, JUN and SP1 are only slightly 
more enriched in NFKB1S80A THP-1 cells in comparison to WT THP-1s (Figure 5.4F 
and Figure 5.4C). In addition, while SP1 is enriched, its activation is not 
significant in WT THP-1 cells or in NFKB1S80A THP-1 cells. While the slightly 
higher enrichment of JUN and SP1 in NFKB1S80A THP-1 cells may be an effect of 
increased ERK1/2 activation in NFKB1S80A THP-1 cells, JUN and SP1 enrichment is 
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not more prominent than RELA and NFKB1. These data confirm that NF-κB is 
central to the LPS-induced transcriptional profiles observed in both WT and 
NFKB1S80A THP-1 cells, and that NF-κB transcription is functional in NFKB1S80A 
THP-1 cells. 
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Figure 5.4: Upstream regulator enrichment analysis of LPS-induced genes 
The heat maps display differentially expressed genes calculated by DESeq2 (p.adj <0.01, 
replicates shown). Normalised read counts are scaled as per z-score for LPS treated WT THP-1 
cells (A) and LPS treated NFKB1S80A THP-1 cells (D). The number and directionality of LPS-
induced genes is indicated for WT THP-1 cells (B) and NFKB1S80A THP-1 cells (E). Upstream 
regulator enrichment analysis of LPS-induced genes from WT THP-1 cells (C) and LPS-induced 
genes from NFKB1S80A THP-1 cells (F). Upstream regulators were ranked by enrichment score 
(overlap p-value (–log10 p-value)) and by activation score (z-score). Red bars indicate both 
significant enrichment score (p-value <0.05) and significant activation score (significant z-score 
>2). Blue bars indicate significant enrichment (p-value <0.05), but not significant activation score 
(z-score <2). 
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5.3.4.2 Specific κB site enrichment within a distinct cluster of LPS-induced 
genes 
Having identified NF-κB transcription factors as enriched upstream regulators, 
enrichment of specific NF-κB binding sites was next explored. Specificity of NF-
κB binding sites provides a mechanism to explain the potential selective effects 
of the S80 phosphorylation on LPS-induced transcription in THP-1 cells. Firstly, K 
means clustering of differentially expressed genes was performed to identify 
groups of genes which share similar expression profiles. This initial analysis 
revealed 20 clusters consisting of both LPS independent and LPS dependent 
genes (Figure 7.2). LPS-inducible gene clusters were combined based on the 
directionality of gene expression, creating groups of upregulated and 
downregulated genes. Genes were then categorised by magnitude of expression. 
This created 6 distinct groups of LPS-inducible genes, where expression was 
either up/downregulated to a greater extent in either WT or NFKB1S80A THP-1 
cells, or where gene expression was equivalent between WT and NFKB1S80A THP-1 
cells. In order to identify enriched NF-κB sites within each group of selectively 
regulated genes, transcription factor binding site analysis was performed using 
the de novo binding motif discovery program HOMER (Heinz et al., 2010). The 
promoters of genes belonging to each group were searched for de novo binding 
motifs +300bp/-50bp relative to the transcription start site. The most highly 
enriched DNA binding motif for each group of genes analysed is displayed in 
Figure 5.5 and Figure 5.6. In addition, the transcription factor best matched to 
the enriched de novo motif predicted by HOMER is shown. 
Interestingly, interferon-sensitive response elements (ISRE) are enriched in the 
promoters of genes upregulated to a greater extent in WT THP-1 cells compared 
to NFKB1S80A THP-1 cells (Figure 5.5B) and in the promoters of genes upregulated 
to an equivalent level in WT and NFKB1S80A THP-1 (Figure 5.5C). Although LPS is 
not the best suited stimulus to investigate the induction of IFNs, these results 
indicate a potential role for S80 phosphorylation in the transcriptional control of 
IFN response. Of note, there are sequence differences in the enriched motifs in 
promoters of genes expressed higher in WT THP-1s compared to NFKB1S80A THP-
1s (Figure 5.5B) and between genes expressed equivalently (Figure 5.6C). These 
differences can be observed at the -6,-3,-2 and -1 positions of the binding site. 
While the promoters of genes expressed higher in WT THP-1s compared to 
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NFKB1S80A THP-1s contain motifs that are ambiguous at these positions (-6G/C, -
3T/G, -2G/C, -1A/G) (Figure 5.5B), the promoters of genes expressed 
equivalently between WT THP-1s and NFKB1S80A THP-1s contain motifs that 
appear to be enriched with specific nucleotides at these positions (-6G, -3T, -2C, 
-1A) (Figure 5.5C). This suggests that regulation of p50 at these sites could be 
sequence specific. In addition, the promoters of genes upregulated equivalently 
between WT and NFKB1S80A THP-1 cells are also enriched with an NF-κB binding 
site. However, the κB site has a high degree of degeneracy, and is not 
specifically enriched with particular bases at each position of the DNA binding 
site (Figure 5.5C). 
Promoters of genes highly upregulated in NFKB1S80A THP-1 cells compared to WT 
THP-1 cells are also enriched with an NF-κB binding site (Figure 5.5A). This de 
novo motif contains a specific 10 base pair κB site (consensus G-5G-4G-3A-2A-
1T0T1T2C3C4). Expression of genes enriched with this κB site in their promoters 
are enhanced in NFKB1S80A THP-1 cells, suggesting S80 phosphorylation regulates 
p50 activity in a κB site-specific manner. This is in contrast to the degenerate 
motif found to be enriched in promoters of genes expressed equivalently 
between WT and NFKB1S80A THP-1 cells. Therefore, this analysis suggests that 
there are specific DNA-binding motifs associated with differential regulation of 
NF-ĸB target genes by S80. Of note, this 10bp κB site is identical to one of the 
most enriched motifs found in a gene cluster with the same expression profile in 
HEK293T cells (Chapter 4). The 10bp κB site G-5G-4G-3A-2A-1T0T1T2C3C4 was 
identified as being enriched in the promoters of gene highly expressed in 
NFKB1S80A HEK293T cells in comparison to WT HEK239Ts (Chapter 4). This results 
validates the enrichment of the specific κB site G-5G-4G-3A-2A-1T0T1T2C3C4 within 
promoters of genes regulated in the same manner genes across two different cell 
types, and two different stimuli. In Chapter 4, S80 phosphorylation was shown to 
regulate the affinity of p50 to -1A containing κB sites, limiting gene 
transcription. The THP-1 κB site enrichment analysis suggests that the selective 
effect of the S80 mutation on NF-κB target gene expression in response to TNFα 
treatment in HEK293T cells may also regulate LPS-induced NF-κB target gene 
expression THP-1 cells. 
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Figure 5.5: Transcription factor binding site analysis of LPS-induced upregulated genes 
LPS-induced upregulated genes were categorised into 3 groups: (A) Expression upregulated to a 
greater extent in NFKB1S80A THP-1s compared to WT THP-1s (B) Expression upregulated to a 
greater extent in WT THP-1s compared to NFKB1S80A THP-1s. (C) Expression upregulated to 
similar level in WT and NFKB1S80A THP-1s. The heat maps display the average FPKMs of LPS-
induced genes calculated by CuffDiff (scaled as per z-score). Promoters of genes from each cluster 
were analysed using HOMER motif analysis software. Significantly enriched de novo motifs (p-
value <0.001) and best matched transcription factors are shown. 
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Genes which are downregulated in response to LPS do not appear to have NF-κB 
binding sites enriched in their promoters (Figure 5.6). Promoters of genes 
downregulated to a similar extent in WT and NFKB1S80A THP-1 cells, and to a 
greater extent in NFKB1S80A THP-1 cells compared to WT THP-1s are enriched 
with motifs that are similar to those bound by zinc-finger containing 
transcriptional regulators GFI1B and ZFP161, respectively (Figure 5.6A and 
Figure 5.6C). Promoters of genes downregulated to a greater extent in WT THP-1 
cells compared to NFKB1S80A THP-1s are enriched with motifs similar to the ETS1 
transcription factor site (Figure 5.6B). 
 
Figure 5.6: Transcription factor binding site analysis of LPS-induced downregulated genes 
LPS-induced downregulated genes were categorised into 3 groups: (A) Expression downregulated 
to a greater extent in NFKB1S80A THP-1s compared to WT THP-1s (B) Expression downregulated 
to a greater extent in WT THP-1s compared to NFKB1S80A THP-1s. (C) Expression downregulated 
to similar level in WT and NFKB1S80A THP-1s. The heat maps display the average FPKMs of LPS-
induced genes calculated by CuffDiff (scaled as per z-score). Promoters of genes from each cluster 
were analysed using HOMER motif analysis software. Significantly enriched de novo motifs (p-
value <0.001) and best matched transcription factors are shown. 
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5.3.5 Gene set enrichment analysis (GSEA) 
5.3.5.1 Enhanced pro-inflammatory phenotype of NFKB1S80A THP-1 cells 
To further characterise the phenotype of the transcriptional profile of NFKB1S80A 
THP-1 cells, gene set enrichment analysis was performed. Differentially 
expressed genes from LPS stimulated WT THP-1 cells vs NFKB1S80A THP-1 cells 
(WT + vs S80A +) were ranked by fold change expression value. Genes expressed 
higher in NFKB1S80A THP-1s compared to WT THP-1s feature at the top of the list, 
and genes expressed higher in WT THP-1s compared to NFKB1S80A THP-1s feature 
at the bottom of the list. The ranked gene list was searched for enriched gene 
sets from the Molecular Signatures Data Base (MSigDB), using the GSEA online 
tool (available at http://software.broadinstitute.org/gsea/msigdb/index.jsp). 
GSEA calculates an enrichment score (ES) which reflects how overrepresented a 
gene set is at the top or bottom of a ranked list. A positive ES indicates gene set 
enrichment at the top of the ranked list (gene expression higher in NFKB1S80A 
THP1s compared to WT THP-1s), and a negative ES indicates gene set 
enrichment at the bottom of the ranked list (gene expression higher in WT THP-
1s compared to NFKB1S80A THP-1s). 
The ranked gene list was first searched for enrichment of the hallmark gene sets 
on MSigDB. The GSEA hallmark collection provides refined gene sets derived from 
multiple founder gene sets, providing robust enrichment analysis results 
(Liberzon et al., 2015). The top 3 significantly enriched hallmark gene sets for 
the top and bottom of the ranked gene list are shown in Figure 5.7A and Figure 
5.7B, respectively. 
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Figure 5.7: Enriched hallmark gene sets in LPS-treated WT vs NFKB1S80A THP-1 cells 
Gene set enrichment analysis of WT + vs S80A + ranked gene list (CuffDiff). Enrichment plots 
show the enrichment profile (green curve) across the ranked gene list. Black lines represent the 
genes which contribute to the enrichment profile. Peak enrichment scores (ES) and p-values are 
shown. (A) Top 3 significantly enriched hallmark gene sets at the top of the ranked gene list, 
indicated by positive enrichment score (expression higher in NFKB1S80A THP-1s compared to WT 
THP-1s). (B) Top 3 significantly enriched hallmark gene sets at the bottom of the ranked gene list, 
indicated by negative enrichment score (expression higher in WT THP-1s compared to NFKB1S80A 
THP-1s). 
 
Significantly enriched gene sets at the top of the ranked list (gene expression 
higher in NFKB1S80A THP-1s compared to WT THP-1s) include TNFα signalling via 
NF-κB and inflammatory response. Although THP-1 cells were stimulated with 
LPS, enrichment of these gene sets indicates that the induction of the 
inflammatory response in NFKB1S80A THP-1s is coordinated by NF-κB gene 
expression. In addition, genes expressed higher in NFKB1S80A THP-1s compared to 
WT THP-1s are enriched with the epithelial mesenchymal transition gene set. 
This hallmark collection is comprised of genes sets associated with 
reorganisation of the extracellular cellular matrix, and expression of matrix 
metalloproteinases and integrins (Liberzon et al., 2015). Expression of these 
genes could be associated with important processes performed by active 
macrophages such as migration, adhesion, phagocytosis and tissue repair (Wynn 
and Vannella, 2016). Enrichment of this gene sets suggests that S80 
phosphorylation could regulate genes involved in these important inflammatory 
processes. Significantly enriched gene sets at the bottom of the ranked list (gene 
expression higher in WT THP-1s compared to NFKB1S80A THP-1s) are related to 
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progression through the cell cycle and cell proliferation, indicated by the 
enrichment of E2F and MYC transcription factor targets, and genes involved in 
the G2/M checkpoint. Of note genes expressed higher in WT THP-1s compared to 
NFKB1S80A THP-1s were enriched with the interferon gamma response and 
interferon alpha response hallmark gene sets (Figure 7.3). This indicates that 
genes expressed higher in WT THP-1s compared to NFKB1S80A are involved in 
mediating a response to IFNγ. This is consistent with the transcription factor 
binding site enrichment analysis, which revealed enrichment of ISRE motifs in 
promoters of genes expressed to a greater extent in WT THP-1s compared to 
NFKB1S80A THP-1s (Figure 5.7B). 
In order to further explore the phenotype of NFKB1S80A THP-1 cells, pathway 
analysis was performed using Kyoto Encyclopedia of Genes and Genomes (KEGG) 
gene sets available on MSigDB (Figure 5.8). Genes expressed higher in NFKB1S80A 
THP-1s compared to WT THP-1s are associated with the lysosome pathway, 
indicating a potential increase in the phagocytic ability of NFKB1S80A THP-1 cells 
(Figure 5.8A). In addition, enriched gene sets include focal adhesion and 
regulation of actin cytoskeleton, indicating that NFKB1S80A THP-1 cells have the 
potential to be motile (Figure 5.8A). It is important to note that MAPK signalling 
was an enriched pathway associated with genes expressed higher in NFKB1S80A 
THP-1s compared to WT THP-1s (Figure 7.3), which may be a result of increased 
ERK1/2 activation in this cell line. Enriched pathways associated with genes 
expressed higher in WT THP-1s compared to NFKB1S80A THP-1 cells include 
spliceosome and ribosome, which are related with gene transcription and 
translation processes, respectively (Liberzon et al., 2015). Enrichment of the 
Parkinson’s disease pathway relates to oxidative stress (Liberzon et al., 2015), 
which may be induced by LPS treatment. Overall, these analyses indicate that 
NFKB1S80A THP-1 cells express genes that regulate inflammatory processes to a 
greater extent compared to WT THP-1 cells, indicating an enhanced pro-
inflammatory phenotype of NFKB1S80A THP-1 cells. In contrast, WT THP-1 cells 
express genes that regulate the cell cycle, suggests that WT THP-1 cells have a 
proliferative phenotype. 
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Figure 5.8: Enriched KEGG pathways in LPS-treated WT vs NFKB1S80A THP-1 cells 
Gene set enrichment analysis of WT + vs S80A + ranked gene list (CuffDiff). Enrichment plots 
show the enrichment profile (green curve) across the ranked gene list. Black lines represent the 
genes which contribute to the enrichment profile. Peak enrichment scores (ES) and p-values are 
shown. (A) Top 3 significantly enriched KEGG pathways at the top of the ranked gene list, 
indicated by positive enrichment score (expression higher in NFKB1S80A THP-1s compared to WT 
THP-1s). (B) Top 3 significantly enriched KEGG pathways at the bottom of the ranked gene list, 
indicated by negative enrichment score (expression higher in WT THP-1s compared to NFKB1S80A 
THP-1s). 
 
5.3.5.2 Validation of A(-2)A(-1) κB enrichment within distinct sets of gene 
sets 
In order to investigate a possible link between the enhanced pro-inflammatory 
phenotype of NFKB1S80A THP-1 cells and increased expression of pro-
inflammatory genes, the genes enriched in hallmark MSigDB gene sets were 
further explored. Genes expressed higher in NFKB1S80A THP-1s compared to WT 
THP-1s cells that contributed to TNFα signalling via NF-κB and inflammatory 
response hallmark enrichment profiles were utilised for transcription factor 
binding site analysis. Using the GSEA-derived results provides a refined list of 
genes known to be specifically upregulated as a result of NF-κB signalling, and 
specifically involved in the activation of the inflammatory response, thus 
reducing potential noise from genes upregulated independently of NF-κB. Gene 
promoters were analysed using HOMER, which identified enriched de novo κB 
sites. The consensus κB site G-5G-4G-3A-2A-1T0T1T2C3C4 was enriched in the 
promoters of genes that contribute to the GSEA hallmark TNFα signalling via NF-
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κB profile (Figure 5.9A). A similar κB site was enriched in the promoters of genes 
that contribute to the GSEA hallmark inflammatory response profile, with 
consensus sequence G-5G-4G-3A-2A-1W0T1T2C3C4 (W represents A or T) (Figure 
5.9A). These κB site identified are extremely similar to the most enriched motif 
found in a much larger, less refined list of genes highly expressed in NFKB1S80A 
THP-1 cells (G-5G-4G-3A-2A-1T0T1T2C3C4) (Figure 5.5A). These analyses demonstrate 
that the κB site G-5G-4G-3A-2A-1T0T1T2C3C4 is enriched in the promoters of distinct 
sets of genes. In particular, promoters containing A(-2)A(-1) κB sites regulate a 
number of pro-inflammatory chemokines and cytokines indicated on the heat 
maps (Figure 5.9A and Figure 5.9B). These results are also consistent with 
transcription factor binding site analysis performed in Chapter 4 with HEK293T 
cells, which also demonstrated that pro-inflammatory genes with A(-2)A(-1) κB 
sites are expressed higher in NFKB1S80A HEK293T cells compared to WT HEK293T 
cells. 
 
Figure 5.9: -A(-2)A(-1) κB site enrichment in GSEA refined gene sets 
The heat maps display the average FPKMs calculated by CuffDiff (scaled as per z-score) of genes 
derived from (A) hallmark TNFα signalling via NF-κB and (B) hallmark inflammatory response 
GSEA enrichment profiles. Pro-inflammatory genes with an identifiable κB site are highlighted. 
HOMER promoter analysis of genes from (A) and (B) identifying significantly enriched de novo 
motifs (p-value <0.001) and best matched transcription factor. 
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5.3.6 κB site-based prediction of gene expression 
The κB site G-5G-4G-3A-2A-1T0T1T2C3C4 has been consistently enriched in the 
promoters of genes with a distinct expression pattern. Genes containing this κB 
site are expressed much higher both NFKB1S80A THP-1 (Figure 5.6A and Figure 
5.9) and NFKB1S80A HEK293T cells (Chapter 4) compared to WT cells. In 
particular, S80 mutation had the greatest effect on p50 DNA binding to κB sites 
containing an A at the -2 and -1 position compared to other the κB sites tested 
(Chapter 4). As a result, reporter activity from A(-2)A(-1) κB sites was increased 
the most compared to the other κB sites tested (Chapter 4). The presence of 
specific κB sites within distinct groups of genes indicates that S80 
phosphorylation regulates p50 activity in a κB site-specific manner. Therefore, it 
might be possible to predict which genes are regulated by p50 phosphorylation 
based on κB site sequence. Searching for genes containing A(-2)A(-1) κB sites 
might provide insight into which NF-κB target are regulated by p50 S80 
phosphorylation. In order to test this hypothesis, transcription factor binding site 
analysis was performed using the de novo motif finding program HOMER (Heinz 
et al., 2010). LPS-induced genes from WT THP-1 cells were searched for the 
following motif in their promoter region: G-5G-4R-3A-2A-1T0Y1Y2Y3Y4 (where R 
represents a purine and Y represents a pyrimidine) (Figure 5.10A). This κB site 
motif was designed to have a degree of degeneracy to include mismatches at 
particular bases, for example G-5G-4G-3A-2A-1T0C1T2T3C4. A total of 286 genes were 
identified as having A(-2)A(-1) κB sites, 236 of which were upregulated and 50 of 
which were downregulated. Since the mechanism by which S80 phosphorylation 
regulates transcription of genes containing A(-2)A(-1) κB sites was elucidated by 
analysing upregulated genes (Chapter 4), downregulated genes were not 
included in further analysis. 
The expression of 150/236 genes containing A(-2)A(-1) κB sites was higher in 
NFKB1S80A THP-1s compared to WT THP-1s (Figure 5.10B). Therefore, the 
transcriptional outcome of 64% of genes regulated by S80 phosphorylation was 
predicted based on κB site sequence alone. However, of the 236 genes analysed, 
88 genes contained multiple κB sites. It is unknown how S80 phosphorylation 
selectively regulates the expression of genes multiple κB sites. To circumvent 
this, genes with only one A(-2)A(-1) κB site were analysed. Expression of 97/148 
genes was higher in NFKB1S80A THP-1s compared to WT THP-1s (66%) (Figure 
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5.10C). Removing multiple κB site containing genes only increased the prediction 
of transcriptional outcome by a small margin (2%). Overall, this analysis suggests 
that the expression of genes regulated by phosphorylated p50 could potentially 
be predicted by κB site sequence alone, to a certain extent. 
 
 
Figure 5.10: Prediction of p50 S80 regulated gene expression based on κB site sequence 
(A) Position weight matrix (PWM) of the motif used to search LPS-induced genes from WT THP-1 
cells for A(-2)A(-1) κB sites using the HOMER motif analysis program. The heat maps display the 
average FPKMs calculated by CuffDiff (scaled as per z-score) of (B) genes containing A(-2)A(-1) 
κB sites and (C) genes containing single A(-2)A(-1) κB sites (C). The percentage of genes 
upregulated in NFKB1S80A THP-1 cells are indicated. 
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5.4 Discussion 
In this chapter, the role of p50 S80 phosphorylation in a human macrophage cell 
line model was investigated utilising CRISPR/Cas9 generated NFKB1S80A THP-1 
cells. Western blot analysis of NFKB1S80A THP-1 cells revealed some surprising 
effects of the NFKB1 S80 mutation. The endogenous level of p105/p50 protein in 
NFKB1S80A THP-1 cells is slightly reduced in comparison to WT THP-1 cells. This 
difference was not observed in HEK293T cells, where p105/p50 protein is 
expressed equivalently in WT and NFKB1S80A HEK293T cells (Chapter 4). This 
suggests that reduction in protein levels could be a cell type-specific effect of 
the NFKB1 S80 mutation. The transcript levels of NFKB1 are similar in WT and 
NFKB1S80A THP-1 cells, suggesting a post-translational effect of the S80 mutation. 
It is possible that mutation of S80 may reduce p105/p50 translation or affect 
protein stability. 
Previous studies utilising macrophages from Nfkb1-/- mice have established a link 
between p105 and ERK1/2 activation (Beinke et al., 2003, Waterfield et al., 
2003, Dumitru et al., 2000, Banerjee et al., 2006). It has been reported that 
ERK1/2 activation is dependent on LPS-induced processing of p105, which 
liberates TPL-2 kinase, specifically mediating activation of ERK1/2. p105 also 
functions to maintain the integrity of TPL-2 since it is very unstable. Therefore, 
Nfkb1-/- macrophages are defective in LPS induced ERK activation due to the 
reduced steady state levels of TPL-2 (Waterfield et al., 2003, Beinke et al., 
2003). Since NFKB1S80A THP-1 cells have slightly less p105 protein compared to 
WT THP-1s, it might be expected that ERK1/2 activation is impaired in NFKB1S80A 
THP-1s. However, phosphorylation of ERK1/2 is increased in NFKB1S80A THP-1 
cells compared to WT THP-1s, indicating that ERK1/2 activation is elevated in 
NFKB1S80A THP-1 cells. This suggests that NFBK1 S80 mutation does not have a 
direct effect on ERK1/2 signalling through this mechanism. 
It is possible that ERK1/2 activation could be upregulated by an intrinsic 
feedback loop. Perhaps a factor secreted by NFKB1S80A THP-1s could upregulate 
and potentially sustain ERK1/2 signalling. For example, untreated and LPS-
treated NFKB1S80A THP-1 cells express more cytokines such as CSF1 and IL1β 
compared to WT THP-1 cells. CSF1 (also known as M-CSF) stimulates macrophage 
development through activation of ERK1/2 pathways (Richardson et al., 2015). 
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IL1β signals through interleukin-1 receptors (IL-1R), related to the TLR family. 
Both receptor families share the cytoplasmic TIR domain, and consequently 
utilise overlapping components for downstream signalling. IL1β triggers signalling 
through the MyD88 dependent pathway (detailed in Chapter 1), which can 
activate components of the MAPK pathway, including ERK (Janssens and Beyaert, 
2002). Increased pools of these cytokines in NFKB1S80A THP-1 cells before and 
after LPS stimulation may explain the increase ERK1/2 signalling. 
It is important to note that the phenotypes of NFKB1S80A THP-1 cells appear to be 
exaggerated by the THP-1 differentiation protocol. In undifferentiated NFKB1S80A 
THP-1 cells, p105/p50 protein level is slightly reduced compared to WT THP-1 
cells. However, PMA-differentiated NFKB1S80A THP-1 cells appear to have less 
p105/p50 protein levels compared to undifferentiated NFKB1S80A THP-1 cells. To 
date, the role that NFKB1 plays in differentiation of THP-1 monocytes to 
macrophages is currently unknown. Furthermore, p50 protein levels were further 
affected depending on how many days NFKB1S80A THP-1 cells were left to rest in 
culture following PMA differentiation. NFKB1S80A THP-1 cells utilised immediately 
following PMA differentiation appeared to have drastically reduced p50 levels 
compared to NFKB1S80A THP-1 cells rested for 4 days. In addition, ERK1/2 
activation kinetics were affected by rest period following PMA differentiation. 
Inclusion of a 4 day rest period reduced constitutive activation of ERK1/2 
observed in NFKB1S80A THP-1 cells. It is necessary to allow differentiated THP-1 
macrophages to recover in culture without PMA in order to restore a resting 
phenotype (Chanput et al., 2014). The level of p50 protein in NFKB1S80A THP-1 
cells appears to recover during the 4 day rest period following PMA treatment, 
further suggesting a role for NFKB1 in the differentiation of human macrophages, 
in particular p50. Given that p50 homodimers are important suppressors of gene 
expression by occupying the promoters of target genes in unstimulated 
macrophages (Carmody et al., 2007), perhaps p50 homodimers repress genes 
necessary for differentiation. The reduction in p50 protein during differentiation 
might be explained by degradation of p50 homodimers in order to remove 
repressive complexes from target gene promoters, allowing initiation of the 
transcriptional profile necessary for differentiation. 
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Despite reduced p105/p50 levels and increased ERK1/2 activation, NF-κB is the 
core regulator of LPS-induced gene expression in NFKB1S80A THP-1 cells. RNA-seq 
analysis revealed a distinct transcriptional profile in NFKB1S80A THP-1 cells, 
suggesting evidence of selective gene expression regulated by S80 
phosphorylation. Mechanisms regulating selective gene expression were 
previously explored in Chapter 4, and it was shown that S80 phosphorylation 
regulates p50 activity in a κB site sequence specific manner. Therefore, it was 
speculated that S80 phosphorylation might regulate p50 activity in THP-1 cells by 
a similar mechanism. Transcription factor binding site analysis identified G-5G-4G-
3A-2A-1T0T1T2C3C4 as an enriched κB site in the promoters of genes expressed 
much higher in NFKB1S80A THP-1 cells compared to WT THP-1 cells. Of note, 
genes containing this κB site include chemokines and cytokines, suggesting that 
S80 phosphorylation regulates expression of pro-inflammatory genes in THP-1 
cells. These data indicate that S80 phosphorylation regulates p50 activity in a κB 
site-specific manner as part of a p50:p65 heterodimer, consistent with the 
findings reported in Chapter 4. Consistent results across two cell types 
stimulated with different inflammatory stimuli indicates that regulation of p50 
affinity towards specific κB sites by S80 phosphorylation is a conserved 
mechanism of selectively regulating gene expression.  
Understanding the phosphorylation status of NF-ĸB and interaction with 
particular ĸB sites may enable the prediction of transcriptional outcome of 
genes regulated by a particular phosphorylation in other cell types. For example, 
genes containing a A(-2)A(-1) ĸB site are regulated by S80 phosphorylation which 
correlates with gene elevated expression in NFKB1S80A HEK293T and THP-1 cells 
compared to WT cells. 66% of LPS-induced genes from WT THP-1 cells containing 
A(-2)A(-1) ĸB were expressed higher in NFKB1S80A THP-1s compared to WT THP-
1s. This suggests that transcriptional outcome of the majority of genes 
containing a particular κB site sequence can be predicted based on κB site 
alone. However, it is important to consider that κB site sequence is not the only 
determining factor for gene expression. Gene expression may be regulated by 
other mechanisms, different NF-κB dimers or modulated by co-factors. In 
addition not all κB site containing genes are regulated by NF-κB. 
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This was recently demonstrated by Tong et al. (2016) who revealed that the 
expression of a group of genes containing strong NF-κB promoter motifs 
(associated with RelA ChIP-seq peaks) was induced in Rela-/- fetal liver-derived 
macrophages, implicating other factors in their regulation (Tong et al., 2016). 
Gene set enrichment analysis supported the concept that S80 phosphorylation 
regulates a pro-inflammatory transcriptional profile. Genes expressed higher in 
NFKB1S80A THP-1 cells compared to WT THP-1 cells were more associated with 
inflammatory processes compared to WT. In contrast, genes expressed higher in 
WT THP-1 cells compared to NFKB1S80A THP-1 cells were more associated with 
cell proliferation. This suggests that NFKB1S80A THP-1 cells are more “active” and 
have an enhanced pro-inflammatory phenotype, correlating with elevated levels 
of pro-inflammatory genes. In particular, NFKB1S80A THP-1 cells have a 
phenotype similar to that of an LPS-activated macrophage (Wu et al., 2009), 
whereby genes associated with processes involving motility and phagocytosis are 
expressed higher in comparison to WT THP-1 cells. However, to experimentally 
determine the enhanced pro-inflammatory phenotype of NFKB1S80A THP-1 cells, 
functional assays such as migration assays or chemokine/cytokine secretion 
assays would have to be performed in order to confirm hypotheses generated 
from GSEA results. 
In addition to κB sites, transcription factor binding site analysis of LPS-induced 
genes identified enrichment of DNA binding motifs belonging to transcription 
factors other than NF-κB. Enrichment of DNA binding motifs belonging to other 
transcription factors indicates that S80 phosphorylation of p50 may be required 
for interaction with proteins from other gene regulatory networks. In particular, 
p50 interaction (directly or indirectly) with other transcription factors may be 
required for downregulation of distinct sets of genes in response to LPS. Of note, 
ISRE motifs were identified as enriched DNA binding sites in LPS-induced 
transcriptional profiles of THP-1 cells. Given that p50 homodimers are able to 
bind to a subclass of IFN response elements (Cheng et al., 2011), it is possible 
that S80 may regulate p50 binding to ISRE motifs to regulate IFN gene expression 
in THP-1s. In particular, p50 binding to ISRE motifs may be regulated in a 
sequence specific manner, potentially revealing a previously unidentified 
consequence of p50 phosphorylation.
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6 General discussion 
Phosphorylation of NF-κB is an important regulatory mechanism for the control 
of transcription. Despite the importance of NF-κB p50 in the regulation of 
inflammation, phosphorylation of p50 is not well studied. In this thesis, 
CRISPR/Cas9 genome editing techniques were utilised to generate NFKB1S80A 
HEK293T and THP-1 cell lines in order to investigate the role of a novel p50 
phosphorylation of S80, in the regulation of inflammatory gene expression. 
Transcriptomic analyses revealed that phosphorylation of p50 at S80 selectively 
regulates gene expression in response to inflammatory stimuli such as TNFα and 
LPS. The data shows that selective gene expression is regulated in a DNA 
sequence specific manner, due to the enrichment of specific κB sites within 
distinct subsets of NF-κB target genes including pro-inflammatory chemokines 
and cytokines. DNA binding analyses demonstrated that S80 regulates the 
binding of p50 to NF-κB binding sites in a sequence specific manner. Specifically, 
phosphorylation of S80 reduces the affinity of p50 for κB sites that have an 
adenine at the -1 position, and thereby limits the expression of genes under the 
control of regulatory elements containing -1A κB sites. The regulation of p50 
DNA binding by S80 phosphorylation occurs both in the context of p50:65 
heterodimers and p50 homodimers, revealing the regulation of the 
transcriptional activity of the p65 subunit in trans through the modification of 
p50. 
The kinase responsible for the phosphorylation of S80 was discovered to be IKKβ, 
identifying NF-κB p50 as a novel substrate for this kinase. IKKβ is most well-
known for its role as an activator of the canonical NF-κB pathway by 
phosphorylation of IκBα. However, IKKβ is capable of phosphorylating other 
components of the NF-κB pathway such as p105. To date, the majority of 
p105/p50 phosphorylation sites identified are located in the C-terminal region of 
p105, and are required for p105 processing to generate the p50 subunit. 
However, phosphorylation of the N-terminal region of p105 (i.e. p50) is much 
less well understood (described in 1.4.3.2). In addition, it has been previously 
reported that IKKβ phosphorylates p65 at S468 (Schwabe and Sakurai, 2005) and 
S536 (Schwabe and Sakurai, 2005, Sakurai et al., 1999, Sizemore et al., 2002, 
Haller et al., 2002, Yoboua et al., 2010), proposing a role for IKKβ-mediated 
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regulation of NF-κB subunit activity. However, the mechanisms regulating 
transcriptional activity were not elucidated. This thesis reveals the regulation of 
sequence specific p50 DNA binding by IKKβ phosphorylation as a novel 
mechanism of IKKβ-mediated control of NF-ĸB transcriptional activity. It is 
important to note that phosphorylation of particular residues of p65 are 
regulated by a number of kinases (Christian et al., 2016). In particular, S536 has 
been reported to be phosphorylated by 4 other kinases in addition to IKKβ (Buss 
et al., 2004). It is therefore possible that p50 S80 could be phosphorylated by 
other kinases, regulating transcriptional responses in the context of different 
cellular stimuli. It may also be possible that S80 phosphorylation occurs in the 
resting state. p65 S468 phosphorylation by GSK3β in unstimulated cells acts to 
negatively regulate p65 basal activity. This suggests that S80 could be 
phosphorylated by other kinases under resting conditions, regulating p50 activity 
at basal level. Identification of additional p50 S80 kinases will provide insight 
into the role of S80 phosphorylation in the regulation of NF-ĸB driven 
transcriptional control, depending on physiological context. In addition, the 
subcellular location of IKKβ kinase activity on p50 is not known. IKKβ 
phosphorylation of p65 at S468 and S536 appears to take place in the cytosol 
while it is bound to IκB (Schwabe and Sakurai, 2005). However, it has been 
reported that IKKβ is present in the nucleus (Tsuchiya et al., 2010, Anest et al., 
2003). This suggests that IKKβ may phosphorylate p50 in the nucleus, although 
the status of its kinase activity in the nucleus is yet to be confirmed. 
The ability of NF-κB subunits to be phosphorylated at multiple sites by different 
kinases, and at the same site by multiple kinases adds a layer of complexity to 
NF-κB transcriptional regulation. Combinatorial phosphorylation events could 
result in heterogeneous populations of phosphorylated NF-κB protein. Indeed, it 
has been demonstrated that phosphorylated p65 protein accumulates in distinct 
subcellular locations. S536 phosphorylated p65 is predominantly cytosolic, 
whereas S468 is localised to nuclear speckles (Moreno et al., 2010). This led to 
the proposal of the NF-κB barcode hypothesis which suggests that post-
translational modifications of NF-κB subunits, alone or in combination, generate 
distinct functional states that direct transcription in a gene specific manner 
(Moreno et al., 2010). Rather than “one modification, one effect”, 
phosphorylation by multiple kinases may regulate NF-κB in different manners. 
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The barcode hypothesis provides an explanation as to how individual stimuli 
activating NF-κB leads to the specific induction of distinct sets of genes. 
However molecular mechanisms regulating NF-κB interaction with specific gene 
promoters remain unclear. This thesis established a mechanism for the selective 
regulation of gene expression by the p50 subunit. It was revealed that that gene-
specific transcriptional effects of S80 phosphorylation are mediated by the 
differential binding of phosphorylated p50 with ĸB sites containing an A 
nucleotide at the -1 position (Chapter 4). In addition, p50 S80 phosphorylation 
primarily affects the binding of p50:p65 heterodimers at these sites to inhibit 
gene transcription from promoter constructs containing -1A κB sites. The 
importance of the -1 κB site position has been previously reported in the context 
of DNA damage. Phosphorylation of p50 S328 has been shown to attenuate the 
binding of p50 towards κB sites containing a -1C. This study together with this 
thesis identifies the -1 position of NF-κB binding sites as a critical regulator of 
p50-DNA binding. Therefore, κB site sequence can also be considered as an 
important factor contributing to the NF-κB barcode hypothesis. 
The work of this thesis focussed on the impact that p50 S80 phosphorylation has 
on the regulating p50:p65 heterodimer driven transcription. However, it is 
important to consider the dimer specific effects of the S80 mutation. While this 
thesis does not fully explore S80 phosphorylation as a regulator of p50 
homodimer function, there is data to suggest specific p50 homodimer effects. 
RNA-seq analysis of THP-1 cells revealed that expression of a number of genes 
were altered in the resting state in NFKB1S80A cells (Chapter 5). This suggests a 
possible role for S80 phosphorylation in regulating the expression of genes at 
basal level, perhaps controlled by p50 homodimers. Previous studies have shown 
that there is a large number of p50 homodimers present in the nuclei of 
unstimulated macrophages (Cheng et al., 2011), and that the p50 subunit was 
exclusively present at NF-κB target gene promoters in unstimulated 
macrophages, indicating the presence of p50 homodimer binding (Carmody et 
al., 2007). Upstream regulator analysis of unstimulated THP-1 cells revealed 
NFKB1 as a significantly enriched transcription factor (Figure 7.4). Together, this 
indicates that p50 may also play a critical role in controlling the basal expression 
of NF-κB target genes, regulated by S80 phosphorylation. However, the 
mechanisms controlling the specificity of p50 homodimer affinity to specific 
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promoters is currently unknown. DNA binding analyses in this thesis revealed 
increased binding p50S80A to a specific κB site (G-5G-4G-3G-2A-1T0T1T2C3C4) relative 
to WT p50, however p65 binding to this site was similar in both p50S80A and WT 
p50 expressing HEK293T cells. This indicates that S80 phosphorylation may 
regulate the binding of p50 homodimers but not p50:p65 heterodimers to ĸB 
sites with this sequence. However, further analysis into the mechanisms of 
dimer specific phosphorylation is required. 
Given that ubiquitin regulated stability of p50 homodimers has previously been 
shown to be critical for acting to threshold pro-inflammatory gene expression 
(Carmody et al., 2007, Cheng et al., 2011), it is important to consider 
ubiquitination and proteasomal degradation as a mechanism of p50 homodimer 
regulation, which may involve S80 phosphorylation. S80 phosphorylation may be 
involved in recruiting ubiquitination machinery to specific target gene promoters 
bound by p50 homodimers, triggering proteasomal degradation and thus clearing 
promoters. Phosphorylation-dependent ubiquitination of the p65 subunit, 
resulting in proteasomal degradation and promoter clearance, has been 
demonstrated (Lawrence et al., 2005, Mao et al., 2009). In particular, p65 
phosphorylated at S468 by IKKβ was preferentially ubiquitinated by an E3 ligase 
complex containing COMMD1 (Mao et al., 2009). 
Transcription factor binding site analysis revealed enrichment of both ISRE and 
NF-κB DNA binding motifs in the transcriptome of LPS-stimulated THP-1 cells 
(Chapter 5). In particular, genes containing specific NF-κB motifs are inhibited 
by S80 phosphorylation, whereas genes containing specific ISRE motifs are 
activated by S80 phosphorylation (Chapter 5). This further suggests how S80 
phosphorylation might regulate p50 as part of a p50:p65 heterodimer and p50 
homodimer respectively, regulating different functional outcomes. This analysis 
supports a previous study reporting that p50 homodimers bind to a subclass of 
IFN response elements to repress IFN-inducible gene expression in macrophages 
(Cheng et al., 2011). It is possible that S80 may regulate p50 homodimer binding 
to ISRE motifs to regulate IFN gene expression in THP-1s. In particular, p50 
homodimer binding may be regulated in a sequence specific manner (Chapter 5). 
These data suggest that S80 phosphorylation modulates p50:p65 heterodimer 
activity to regulate pro-inflammatory gene expression, whereas S80 
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phosphorylation of p50 homodimers may regulate anti-viral gene expression. This 
indicates a potential new role of p50 phosphorylation in the regulation of anti-
viral responses. In order to further investigate this, NFKB1S80A THP-1 cells could 
be stimulated with type 1 IFNs such as IFN-α or IFN-β to assess induction of anti-
viral transcriptional programmes. 
DNA binding sites can act as allosteric regulators of transcription factors (Lefstin 
and Yamamoto, 1998). Distinct DNA conformations adopted by particular ĸB sites 
provide a potential mechanism to explain why single nucleotide variations affect 
DNA binding of NF-ĸB dimers. Transcription factor binding site shape analysis of 
the ĸB sites investigated in this thesis were analysed for differences in DNA 
shape configurations that are important in protein-DNA recognition (Yang et al., 
2014). This in silico analysis predicts a unique conformation for specific ĸB sites 
(Chapter 4). In particular, the G-5G-4G-3A-2A-1T0T1T2C3C4 κB site has a narrower 
minor groove width, and higher degree propeller twist at the -1 position, 
compared to other κB sequences analysed (Chapter 5). A narrow minor groove 
width increases the negative electrostatic potential of DNA, offering favourable 
conditions for interaction with positively charged proteins (Rohs et al., 2009). 
Higher degrees of propeller twist provide opportunity to form an additional 
hydrogen bond in the major groove, important for the recognition of specific 
DNA sequences by proteins (Rohs et al., 2009). Phosphorylation of S80 may lead 
to the addition of a negative charge to p50, reducing affinity to DNA with narrow 
grooves such as G-5G-4G-3A-2A-1T0T1T2C3C4 κB sites, predicted to have a high 
negative charge (Chapter 4). 
Phosphorylation of S80 may also induce conformational change of p50, which 
could affect transcriptional outcome following DNA binding. Previous studies 
have revealed that phosphorylation of p65 induces conformational changes 
resulting in changes to ubiquitination status and differential protein interactions 
(Milanovic et al., 2014). Using similar approaches, conformational differences 
between p50WT and p50S80A were assessed by limited proteolytic digestion, which 
revealed different sensitivities to digestion between p50WT and p50S80A (Chapter 
4). This indicates that S80 phosphorylation may induce a conformational change 
that could modify the binding of p50 dimers to -1A containing ĸB sites. 
Conformational changes may modify the transactivating potential of NF-ĸB 
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dimers by regulating DNA binding to specific κB sites, but also possibly by 
modifying interaction with other factors that in turn affect DNA binding. In 
addition, it has been reported that single nucleotide differences in κB site 
sequences are critical for the recruitment of specific co-activators required for 
NF-κB target gene expression (Leung et al., 2004). This study suggests that κB 
sites impart specific properties to the bound NF-κB dimer, thereby determining 
co-activator recruitment, highlighting the importance of κB site sequence for 
specific gene expression. This fits with the hypothesis that S80 phosphorylation 
could affect the interaction of p50 with other factors, ultimately altering DNA 
binding affinity to specific κB sites. 
S80 phosphorylation of p50 is sufficient to inhibit DNA binding which limits gene 
transcription from κB sites containing an A at the -1 position. Of note, individual 
ĸB sequences have different capacities to drive transcription as measured by 
reporter assays (Chapter 4). These analyses identified A(-2)A(-1) ĸB sites as more 
potent drivers of transcription than other sites tested. Interestingly, the 
increased transcription from reporter vectors containing these ĸB sites is also 
reflected in both TNFα and LPS stimulated HEK293T and THP-1 cells 
respectively, where genes regulated by these sites are induced at significantly 
higher levels than genes regulated by other ĸB sites. These ĸB sites appear to be 
enriched in the regulatory regions of genes encoding pro-inflammatory cytokines 
such as TNFα and IL8 and the chemokines CXCL1 and CXCL2. Many NF-κB target 
genes contain multiple κB sites in their regulatory regions, which may contribute 
towards specific gene activation. Previous research on the cooperative 
interaction between two κB-sites has suggested that that one site is dominant 
over the other (Leung et al., 2004) which could relate to affinity of NF-κB 
towards certain sites. It will be interesting in the future to explore the 
cooperation of A(-2)A(-1) κb sites with other κB sites within the same reporter 
construct, exploring any dominant effects that A(-2)A(-1) κB sites might have. 
The enrichment of specific ĸB sites in a functional class of genes provides strong 
evidence that NF-ĸB phosphorylation and ĸB sequences may establish regulatory 
networks to coordinate specific transcriptional programmes. Indeed, analyses of 
LPS-inducible genes in THP-1 cells revealed that A(-2)A(-1) κB sites are enriched 
within genes important for the induction of the inflammatory response, and are 
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associated with particular biological pathways important for active macrophage 
function (Chapter 5). These analyses suggest that the distinct transcriptional 
profiles driven by p50 S80 phosphorylation could potentially co-ordinate specific 
processes in macrophages. Further analysis of the physiological roles of S80 
phosphorylation will be key to understanding how p50 regulates the immune 
response by acting as a critical regulator of gene expression in macrophages. 
Identifying κB sites that correlate with specific transcriptional responses allows 
the potential for prediction of transcriptional outcome based on the 
phosphorylation status of p50. For example, by using a simple PWM to search for 
genes containing A(-2)A(-1) κB sites, the transcriptional outcome of 66% of 
analysed genes regulated by S80 phosphorylation was predicted based on κB site 
alone (Chapter 5). Future research may enable the outcome of gene 
transcription to be predicted based on knowledge of the phosphorylation status 
of NF-ĸB and DNA binding site sequence using a systems approach. For example, 
by integrating RNA-seq data with large-scale protein-DNA binding data generated 
from PBMs, a database identifying κB site binding preferences of specific 
phosphorylated forms of p50 correlated with distinct transcriptional outcome 
could be created. Combining high-throughput analyses could generate PWMs 
with strong predictive power. This may allow the functional consequences of 
site-specific p50 phosphorylation to be predicted across a range of different cell 
types, such as B-cells and T-cells, further investigating the contribution of p50 to 
immune cell function. Prediction of promoter binding with associated 
transcriptional outcome could also be extended to in vivo models. The 
functional and biological effects of p50 phosphorylation could be predicted and 
assessed in mouse models, elucidating the significance of p50 phosphorylation 
during development. Ultimately, this approach could be utilised to predict the 
consequences of modulating p50 phosphorylation in human inflammatory 
disease. 
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7 Appendix 
7.1 CRISPR/Cas9 targeting of NFKB1 
 
Figure 7.1: CRISPR/Cas9 targeting of NFKB1 
Schematic representation of the human NFKB1 gene highlighting the position of the gRNA utilised 
for CRISPR/Cas9 genome editing (yellow allow) relative to exon 5 (blue arrow) containing the S80 
codon (red box). The sequence and binding sites of PCR primers designed for screening are 
shown (green arrows). 
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7.2 Clustering analysis of differentially expressed THP-1 
genes 
 
Figure 7.2: Clustering analysis of differentially expressed genes in THP-1 cells 
Clustering analysis of differentially expressed genes (CuffDiff calculated: p.adj <0.05, fold induction 
ratio >2) was performed using the Bioconductor package CummeRbund with default options (K-
means clustering with Jensen-Shannon distance), producing 20 clusters. Line plots display the 
average FPKMs of WT and NFKB1S80A genes + or – LPS as indicated. 
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7.3 THP-1 clustering analysis 
Upregulated: S80A Upregulated: WT Upregulated: 
Similar 
GADD45B 
NFKBIA 
PEAK1 
IL1RAP 
CYLD 
SEPSECS-AS1 
SLC43A2 
AHR 
LOC102723779 
BTC 
NEURL3 
LINC00346 
HCAR3 
IDO2 
HCAR2 
IDO1 
RP11-
701P16.5 
CXCL2 
LAMP3 
LOC102724012 
LOC101928783 
LOC101927369 
TNIP3 
CXCL3 
BX255923.3 
BIRC3 
AC058791.1 
IL1A 
GCNT4 
PLAT 
CXCL6 
IFNL1 
MB21D2 
TRAF1 
CXCL1 
KCNA3 
BDKRB2 
ELOVL7 
IL32 
ITGB3 
OCSTAMP 
LINC00622 
MMP10 
FGF18 
LOC729040 
PDGFB 
ITGB8 
EFNB2 
UNC13A 
COL5A3 
CTHRC1 
CTGF 
NKX3-1 
CYS1 
EDN1 
SEMA6D 
CAMK2A 
CACHD1 
ICAM5 
TFPI2 
FLT1 
SPSB4 
STEAP4 
FGF2 
MMP12 
VEGFC 
TMCC2 
LEPREL1 
GPRC5A 
EVA1A 
C2CD4B 
AMPD3 
CPEB4 
KIF21A 
TMEM64 
TNFRSF10D 
CYP7B1 
VAX2 
BCAR1 
CCSER2 
LOC101928487 
ZBTB38 
GIMAP8 
RNF2 
KLHL5 
CDC37L1 
PRKCH 
PPP3CC 
PDLIM5 
KIF1B 
EMR2 
PDE8A 
BCL2L11 
KLF9 
KLF6 
ARHGAP10 
CDKN1A 
LOC101927759 
SLC4A7 
USP9X 
HDAC9 
BCL6 
ADAM17 
IER3 
APLF 
C11orf96 
BAMBI 
CRIM1 
PCDH9 
S100A3 
IL1R1 
LINC01004 
KLF5 
MAMLD1 
IL1B 
NHSL1 
DUSP5 
LOC101928716 
LOC102724792 
CSF1 
FAM49A 
SERPINE2 
ZNF697 
OR2B11 
RPE65 
ACKR3 
JHDM1D-AS1 
MAFF 
RASGEF1B 
GLIS3 
ERRFI1 
LTB 
RP11-37B2.1 
PGM2L1 
BCL2A1 
HS3ST3A1 
SMPD5 
THAP2 
LOC100507403 
LOC100132831 
RP4-553F4.6 
LOXL2 
DUSP1 
ATF3 
STARD4 
FNDC3B 
NFIL3 
EN2 
SNN 
TNFAIP1 
TBC1D10A 
FAM222A 
PLXNC1 
TECPR2 
WT1 
FEM1C 
PVR 
PIK3R5 
ABHD17C 
FOSL2 
HIF1A 
ITGA6 
PNRC1 
LOC102723863 
RP1-249H1.4 
MALAT1 
RFX2 
SPATA5L1 
KLF7 
LCP2 
KLF10 
POGLUT1 
ZFC3H1 
MARCKS 
NEAT1 
ZNF674-AS1 
DAPK1 
RAB8B 
TWISTNB 
IGSF8 
USP43 
PDHX 
JDP2 
ABCA1 
MESDC1 
ZNF267 
TNFRSF10A 
LYSMD2 
BACH1 
DUSP22 
PPARD 
TPRA1 
SYT4 
KCNN2 
PNPLA8 
RASSF5 
SRFBP1 
MGLL 
PFKFB3 
CDK6 
TMEM140 
CREM 
CLIC4 
B3GNT5 
RUNX1 
JAK1 
RHOF 
TMEM106A 
AEBP2 
FZD9 
NLRP3 
TCEB3 
RCN1 
TLR2 
ZC3H7B 
VSNL1 
ORM1 
INHBE 
PTAFR 
ANKRD18DP 
LINC01136 
KLF2 
TMEM171 
EGR4 
FAM167A 
ALDH1A1 
LOC286186 
LOC102723959 
HIST1H3I 
NUDT9P1 
TEX19 
LOC100996717 
MYBPC3 
CLUHP3 
SIM1 
LOC102724608 
NAV3 
PLLP 
CXCL14 
NOTCH2NL 
APOL3 
CNTNAP1 
SYNGR3 
TNFSF13B 
BMPER 
SFRP2 
ABCA6 
PPP1R17 
C6orf58 
FDCSP 
CLEC4D 
MIR3945 
ACSM1 
OXTR 
BCL2L14 
LOC102723429 
CCM2L 
LAD1 
CCR7 
GPR31 
IL27 
TEX41 
AQP9 
ANKRD66 
HAPLN3 
LOC102724443 
PNPLA1 
GPR37 
GAL3ST2 
CGN 
GBP5 
SLAMF7 
AMOTL2 
THBS1 
RHOH 
NFE2L3 
KCNJ2-AS1 
IFIT2 
CHST2 
FAM134B 
NBPF19 
EGR1 
MAP3K8 
CXCL10 
NFKB2 
GCH1 
OASL 
MX1 
NOD2 
MT1M 
NBPF14 
VILL 
LILRB2 
BATF3 
TLX3 
CFB 
GRIN3A 
STAT4 
PTGIR 
NBPF10 
NRG4 
ANKRD18A 
LOC344887 
HERC5 
LINC00996 
PSTPIP2 
RP11-
330A16.1 
RSAD2 
CMPK2 
HERC6 
FLVCR2 
TNFSF10 
LAMB1 
HESX1 
LINC00528 
MT2A 
DAPP1 
SLC24A4 
LHX2 
CKB 
BRCA2 
RGL1 
MCOLN2 
MMP25 
XAF1 
FAM201A 
PLAGL2 
IRF7 
MB21D1 
SERPING1 
LOC101927910 
TRIM5 
FRY 
NPTX2 
MX2 
DMXL2 
KCND1 
SAMD9L 
ADA 
IL1RN 
SMAD3 
C20orf112 
TTC39B 
TRIM22 
DENND4A 
MASTL 
CEP120 
PDGFRL 
KCNJ2 
FAM26F 
HCK 
EPSTI1 
SPATA13 
CASP10 
CD70 
PIK3AP1 
SIK3 
MFSD2A 
MSX1 
FOSL1 
CNKSR3 
INO80D 
NABP1 
MAML2 
FFAR2 
CPXM1 
PPP1R15A 
MAP1B 
TRIP10 
NRP2 
ZHX2 
FLJ20021 
MAP3K5 
TPT1-AS1 
ZNFX1 
CD44 
PANX1 
STARD10 
PHLDA2 
WWC2 
XRN1 
CEP85L 
HIVEP3 
GPR84 
FAM117A 
LOC100996740 
RAPGEF2 
BLZF1 
ADAM11 
EXT1 
NAB1 
SMAD7 
C15orf37 
TICAM1 
IL6ST 
SLCO3A1 
TP53INP2 
JUN 
PRDM1 
N4BP1 
JUNB 
BTG2 
RRAS2 
APBA3 
WTAP 
GLYCTK 
ANKRD28 
SKIL 
STK17A 
HUWE1 
PTGER4 
LOC401463 
TP53BP2 
TLR8 
UXS1 
STC2 
BMF 
GCLM 
G0S2 
QPCT 
ZFP36 
PKIG 
NCF1 
RIN2 
APOL2 
RAB21 
AC147651.4 
MXD1 
NINJ1 
PML 
RP11-
806H10.4 
MGC12916 
SOCS3 
LINC00936 
GPRC5B 
CCL4 
SLC7A2 
SSTR2 
CNP 
C6orf62 
SMCO4 
LAP3 
SQRDL 
NUDCD1 
ZBTB17 
SERPINB1 
SFT2D2 
UBE2L6 
CPNE8 
FBRS 
GNB4 
CHD2 
PRKD3 
NDEL1 
ADPRHL2 
SPATA2 
UBE2Z 
TOP1P1 
IFRD1 
ATP2C1 
ARID5A 
GMEB1 
UBR4 
BRWD3 
OAS1 
PPP1R15B 
C1orf122 
SBNO2 
SEC24A 
ADRB1 
GTPBP1 
PHF11 
MLLT6 
EPM2AIP1 
BRPF3 
RAB20 
METTL1 
EAF1 
PANDAR 
USP13 
C19orf66 
STRIP2 
LYN 
ANP32D 
PCGF5 
TFEC 
BATF 
PTRH1 
ACSL5 
MS4A7 
TRADD 
NFKBIB 
ATP11C 
ETS2 
PTPN1 
CNTLN 
NCOA2 
CCNL1 
PVRL2 
CASP7 
NUB1 
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ADAMTS5 
PCDH17 
NTN1 
IL36G 
WNT1 
CYP7A1 
TUBB2B 
CLDN1 
C2CD4A 
SELE 
EFNA1 
PI3 
MEP1A 
INSM1 
VSTM1 
CSF2 
LRRC32 
FRMD7 
C9orf135-AS1 
C1QTNF1 
INHBA 
LOC100288911 
IL18R1 
NUAK2 
XIRP1 
PGLYRP2 
IL2RA 
N4BP3 
CD69 
ANKRD26P3 
RND1 
SRSF12 
CCRN4L 
PPP2R3A 
LINC00854 
PIM1 
RDH10 
DSE 
PXDC1 
BHLHE40 
ELL2 
DNAJB5 
CBR3 
CD58 
ZC3H12D 
LOC100132891 
RICTOR 
CLEC2D 
PLA2G4C 
LOC101928762 
PLAUR 
SLFN5 
ITPRIPL2 
AGO2 
PLAU 
SPHK1 
KIAA0247 
PDLIM4 
RIN3 
IER2 
OTUD4 
BIRC2 
B4GALT1 
SMURF2 
MICALL1 
BCL2L1 
DENND3 
STX12 
RAB12 
SPAG9 
IFNGR2 
DPYSL2 
RAB5A 
EIF1B 
LRP12 
N4BP2L1 
ARHGAP31 
IFFO2 
RND3 
SVIL 
LOC100288175 
FSTL3 
RASSF8 
ACVR2A 
LUCAT1 
RGS16 
TUBB2A 
SLC41A2 
RASL10A 
SFRP1 
ARRDC3 
PLK3 
NFAT5 
CLIP2 
TCHH 
LOC101928054 
RIPK2 
TCF7L1 
BCAR3 
KIRREL2 
PPP4R1L 
ABL2 
ZXDA 
KITLG 
USP12 
IGFBP3 
ATP2B1 
GEM 
OTUD1 
STARD5 
ICAM1 
AREG 
TTC9 
SEMA3C 
CCL20 
BCL9L 
FMNL3 
PMAIP1 
LOC101929796 
IL3RA 
ETV3 
PDCD1LG2 
MEIS2 
ACRC 
MAP2K3 
GBP3 
RBM43 
SNAPC1 
PLEKHF2 
LOC101927686 
B4GALT5 
LOC100505622 
OPTN 
ACSL1 
C4orf32 
E2F7 
RGPD2 
IRAK2 
IL7R 
LOC440934 
ICOSLG 
ICAM4 
DCUN1D3 
TNFSF15 
IL15RA 
ARL5B 
LOC102724428 
ZBTB10 
CDC42EP2 
GRHL1 
PPM1K 
ECE1 
CASP5 
LOC101927902 
TNFAIP3 
WT1-AS 
GBP2 
RARRES1 
RBM17 
MED14 
YRDC 
STK40 
SLC30A7 
NFATC1 
LOC100507217 
SQSTM1 
POLR3D 
BATF2 
CCRL2 
ZC3H12A 
CSRNP1 
CD40 
FCAMR 
MYO10 
CA13 
SNAI1 
CCL22 
FLJ46906 
CD83 
EHD1 
LINC00884 
IL8 
ABTB2 
LOC101928841 
NOC3L 
MPND 
TBX15 
IL18 
LGMN 
PRDM2 
KPNA1 
CASP3 
PPP1R18 
TAB2 
RAP1B 
ARFGAP3 
KCTD20 
PTP4A1 
NCOA4 
UBE2E1 
SAT1 
EIF5 
MSTRG.12754 
RELA 
STXBP5 
VIM 
DYNLT1 
ST3GAL2 
SATB2 
DDX3X 
ARL8B 
FOXD4 
WBP4 
PITPNA 
DENND2D 
ZNF189 
DDX21 
TRIM24 
CEBPD 
AZIN1 
MARK3 
TNIP2 
PITPNB 
SMS 
FZD1 
AAED1 
LITAF 
PIP5K1A 
NFE2L2 
OGFRL1 
ZNRF2 
HMGCS1 
ZCCHC2 
DDX3Y 
PTCHD3P1 
QKI 
ARID4B 
ZCCHC5 
NTNG2 
NCF1B 
CCL7 
SOCS1 
RRAD 
C1orf21 
WNT3 
LFNG 
DST 
EIF3C 
TOR1B 
ZMIZ2 
TMEM194A 
DDIT4 
WARS 
JAK2 
PTPN2 
NBN 
DDX60L 
IL12RB2 
MAP1LC3A 
RNF213 
NAF1 
SP110 
STAT1 
ADPRM 
THUMPD3-AS1 
EYA3 
STAT2 
TRIM21 
MYD88 
SIAH2 
XBP1 
PARP9 
OAS2 
IRF9 
GTF2B 
OAS3 
PARP12 
PHACTR4 
BCL11A 
CD38 
 
C5orf56 
CYB5R2 
GMPR 
C10orf12 
JADE2 
LYRM4 
FBXO6 
ISG15 
VCAM1 
CHI3L2 
ASTL 
LINC00158 
GBP1P1 
MEOX2 
CSF3 
IL6 
SHROOM3 
IL12B 
AC008697.1 
CLEC4E 
C1orf61 
C11orf86 
IL18RAP 
TNFAIP6 
CCL8 
CXCL9 
IL23A 
LILRA6 
MUC1 
NCF1C 
GRAMD1A 
FEZ1 
POU2F2 
SIX5 
NCR3LG1 
FAM95C 
MTF1 
LOC730101 
PIM2 
TRIM36 
MCTP1 
USP18 
HIVEP1 
IRG1 
USP42 
TRAFD1 
AIDA 
ERO1LB 
BTG3 
DOT1L 
CRISPLD1 
CSNK1G3 
LACTB 
IKBKE 
RIPK1 
ZBTB42 
METTL21B 
PLEK 
FAM177A1 
SRXN1 
TANK 
CDYL2 
OSGIN1 
BBC3 
PRRG1 
IL10RA 
ROBO1 
TMEM39A 
FAM129A 
RNF145 
NFKBIE 
GPR137B 
SLC31A2 
RBM7 
ST8SIA4 
CDC42EP3 
LIMK2 
ANKLE2 
LRRC3 
MED13 
IRF2 
SSSCA1-AS1 
CBLN3 
ADTRP 
LOC102723996 
SLC16A9 
DIXDC1 
DDX58 
CCL2 
PLEKHA4 
STX11 
NR4A2 
KIAA1644 
PNMA2 
C12orf61 
DNAJB4 
SLC35G1 
TNFSF9 
LOC101927402 
F3 
REL 
NKX2-2 
CYP27B1 
LINC01181 
ISG20 
MSC 
SRC 
CCL3L3 
KDM6B 
GBP4 
BCL3 
HS3ST3B1 
GBP1 
PELI1 
IFIT5 
LOC284648 
RNF19B 
ARAP2 
TFAP2A 
PDE4B 
TNF 
CD300E 
SGPP2 
SLC11A2 
ZNF140 
CEBPB 
SGTB 
ZBTB5 
EDEM1 
APOL1 
TAP1 
SLC25A28 
IFIT1 
MIRLET7BHG 
CCL5 
TAF4B 
SLC7A11 
HELZ2 
IFIH1 
APOL6 
C17orf96 
IFIT3 
SLC2A6 
DDX60 
KMT2E-AS1 
TRAF3IP2 
NFKB1 
TBX3 
SOD2 
KYNU 
DRAM1 
TIFA 
IER5 
F8A1 
LINC00477 
DENND5A 
DHX58 
CCDC71L 
TRIM69 
C7orf60 
FOXD4L1 
GPR132 
ZC3HAV1 
TNIP1 
SAMD9 
RELB 
IRF1 
NRIP3 
SLC12A7 
GSAP 
LONRF1 
VEGFA 
PIM3 
DTX4 
DCP1A 
IKZF1 
TWIST1 
IFI44 
HSPA6 
RP3-
399L15.3 
SLC4A5 
EMP2 
ZNF101 
TRAF3 
DTX3L 
EIF2AK2 
PLSCR1 
INSIG1 
LINC00641 
PNPT1 
RAB39A 
MEFV 
PARP14 
SPACA6P 
RTP4 
LSS 
PI4K2B 
CAMK1G 
CD80 
CXCL11 
MGAT4C 
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SAV1 
LOC374443 
RFTN1 
FAM132B 
MIR22HG 
ZC3H12C 
ZFY 
TNFRSF10B 
PHLPP2 
TLR7 
ZBTB43 
JADE3 
GPC5 
ADPRH 
 
DUSP16 
DUSP2 
IL10 
CXCL12 
CCL3 
EBI3 
OLR1 
GPR157 
SYNPO2 
NAMPT 
LINC00421 
SDC4 
GRAMD3 
FAM171A1 
 
DNAJB6 
IFI16 
UBTD2 
CD82 
SESTD1 
CPD 
ARMCX1 
NXPH4 
TNFAIP8 
MST4 
STAT5A 
NRARP 
TBC1D2B 
MOB3C 
 
ANKRD33B 
GPX3 
NR4A1 
PTGS2 
PTGER2 
TNFRSF9 
CCL4L1 
RASL11A 
HES4 
 
 
RNF144B 
FOXF1 
PTX3 
SCN1B 
SERPINB9 
HIVEP2 
DLL4 
ETV3L 
CCDC147-
AS1 
 
 
Table 7.1: Groups of upregulated genes utilised for transcription factor binding site analysis 
using HOMER 
 
Downregulated: S80A Downregulated: WT Downregulated: similar 
GJC2C5orf55 
SLMO1 
SIX3 
NAP1L3 
ZNF836 
PGPEP1 
MIR600HG 
ARHGEF3 
CALHM2 
AVPI1 
CIPC 
FN3K 
SUFU 
KLHL30 
USP2 
GREB1 
OR2W3 
LINC00920 
KLHDC8B 
GPRC5C 
PDK4 
LOC100507642 
AC011899.9 
CAMKK1 
TLX1 
SNORD3A 
LINC00663 
CARD10 
RAB11FIP4 
MTUS1 
GDPD1 
PGF 
DLX3 
RGS4 
ZNF280A 
VPS37D 
LOC101928230 
PKDCC 
MAGEE1 
DPF3 
C15orf52 
ID3 
TMEM86A 
KIF25-AS1 
HOXB7 
MGC57346 
CEMP1 
FAM171A2 
SNAI3 
LOC101927863 
LOC102724386 
LOC101929666 
SH2D3C 
P2RY1 
USP51 
ARHGAP30 
CD244 
MTMR12 
AAK1 
ADCY9 
EVI2A 
ACAD8 
ZNF740 
ANKS1A 
HDAC5 
UAP1L1 
FRRS1 
ZNF425 
ESCO1 
VANGL1 
TMEM187 
CD1D 
TEX2 
CFL2 
EPOR 
PPCDC 
RGS14 
SETD8 
XYLT2 
SNX21 
C1orf226 
TOB1 
TRAK1 
LY9 
TBXA2R 
MERTK 
GPRIN3 
PRR5L 
FAM102A 
SESN1 
ZCCHC24 
RCBTB2 
PRKACB 
ZNF469 
FILIP1L 
PPP1R3F 
SLC38A1 
DKK2 
TGFBR2 
MTSS1L 
PDLIM7 
ZNF281 
CAB39 
ST3GAL1 
PIAS2 
KANK2 
LOC101928429 
DENND1B 
LINC00984 
MIOS 
FAM13A 
LOC102723993 
SEMA3G 
KCNF1 
LOC101928228 
GPR55 
GPR82 
CEBPA-AS1 
PPFIA4 
FAM117B 
GMCL1P1 
CEBPE 
TMEM38A 
PIGR 
CHN2 
SLC46A3 
MTM1 
TMEM177 
MAPK14 
IKBIP 
KLHL18 
NT5DC2 
RAB11FIP1 
NAGK 
TRMT5 
WDR91 
CPPED1 
GRAMD4 
FAM134A 
EXOC3 
TLK1 
LEPROTL1 
UBXN2B 
ARHGAP18 
LOC400548 
 
ATP6V0E2 
DHX57 
USP4 
TREML1 
MRPL34 
C20orf194 
SPIN1 
GIMAP4 
KCNK13 
OTUB2 
NISCH 
RTKN 
PQLC2 
SOCS6 
LOC102724791 
LOC100287896 
LINC00094 
ANKRD39 
ZADH2 
DGCR2 
RFPL1S 
STX6 
TMEM9 
ZFYVE21 
C6orf211 
VPS8 
AKAP11 
LGI2 
ABI3 
CCDC132 
MICALCL 
LOC100506985 
LAMB2P1 
RASL11B 
CCDC170 
 
CD180 
C11orf21 
SIT1 
ZNF815P 
GPR65 
RAB3A 
CUX2 
TMEM169 
EPHB3 
LCNL1 
LOC102723672 
RNF125 
SLC46A1 
TFAP4 
C19orf35 
LOC100996246 
PAQR7 
LINGO3 
TMEM37 
ATOH8 
NLRC4 
EEPD1 
FRAT1 
MBLAC2 
PDE7B 
LRRC25 
LOC101929536 
CORO2A 
CAMSAP3 
HHEX 
DBP 
SLC40A1 
KCTD7 
ZFP30 
ZNF395 
B3GNT8 
C3orf62 
PXMP4 
SOX12 
RP11-426L16.8 
ZNF33B 
HERC2P9 
MAP6D1 
LYL1 
ZNF10 
PARD6A 
C16orf54 
ZNF74 
PDP2 
C11orf24 
ARV1 
SPATC1L 
FAM168A 
RMND1 
EVI2B 
FRAT2 
FAM174B 
MNT 
PPP1R3E 
DHRS4-AS1 
PUS7L 
EHMT2 
NR2F6 
PPP1R3G 
ZNF589 
UBL4A 
SLC45A4 
ZNF174 
MRPS26 
LOC100507054 
LEPREL4 
LDLRAP1 
DAG1 
RSAD1 
ANKMY2 
SASH3 
ZNF318 
ARMC7 
FAM203A 
CCL28 
AKNA 
RGS19 
FUT10 
FAM53B 
CEP250 
ZFP64 
SETDB2 
DIRAS1 
PLD6 
MIEF2 
ZFP92 
PDCD2L 
GMCL1 
ZNF786 
C17orf59 
ZNF362 
PP7080 
WDR92 
DGKZ 
ARHGAP35 
RGS12 
AP3M2 
BAIAP2-AS1 
PPAPDC3 
RNF166 
ZNF768 
PACSIN3 
ARID3B 
LOC101927070 
PNPLA3 
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RHOBTB2 
HTR1B 
AC098823.3 
ARX 
FAM212A 
HOXA7 
NKX6-3 
FGD3 
THEM6 
WNT9A 
CDK5R1 
LMX1B 
SNX18 
IGIP 
KIAA1614 
LINC00324 
MLNR 
NHLRC4 
TNFSF14 
ST3GAL5 
CASP9 
ACOT11 
PSMG3-AS1 
TBL2 
PER1 
PWWP2B 
TRAM2 
LRRC4 
ATG16L1 
TRIM58 
ZNF561 
DUSP7 
PCDHB8 
MBP 
RAB11FIP5 
ZFPM1 
ZNF490 
CABIN1 
GIMAP6 
RAB3IL1 
STOX2 
CEACAM21 
ZBTB4 
RASGRP3 
MAF 
C9orf172 
CYTH4 
FAM45B 
SLC35F6 
FAM219B 
GLTPD1 
ZNF251 
GLCCI1 
EIF2AK4 
FAM214B 
ARRDC2 
TCEAL8 
MADD 
DLX4 
TUBA4A 
LRFN4 
MTA3 
RBM38 
MPI 
KCNE3 
ARL11 
ZNF70 
CCDC103 
MAP10 
ZC3HAV1L 
RNF168 
GJD3 
GCNT1 
ETV5 
GPAM 
ZNF252P 
IPCEF1 
ETV5 
GABRG2 
FLJ44313 
PCDHB16 
ADRB2 
C3orf58 
KLF4 
HPS3 
PLEKHA2 
PPP1R12B 
XKR8 
MFSD9 
NSD1 
FADD 
PRR12 
RPRD2 
FAM84B 
NRROS 
AMIGO1 
FBXL18 
TNRC18 
MAFG-AS1 
FLJ20464 
SH2B2 
DCLRE1A 
NUDT18 
EEF2K 
SWSAP1 
ZNF852 
LOC101929523 
BOLA1 
ZNF780A 
SLC35C1 
SCAMP5 
CXorf64 
ZYG11B 
GIT2 
ADCK2 
SH3BP5L 
SMIM15 
INPP5D 
WIPF1 
XPC 
GRK6 
NAA40 
PEX6 
LZTS2 
TK2 
APBB3 
USP21 
MFSD5 
SLC7A6 
TANGO2 
CBR1 
DOK2 
FUT8 
PRKAB1 
COMMD9 
SLC25A38 
GDE1 
KIAA1715 
C2orf43 
SNAPC2 
CSK 
IRX3 
WDR55 
ARHGEF7 
SEPHS2 
DBT 
KIAA0930 
NCF4 
AGO4 
BAZ1B 
ICMT 
MLX 
MCAT 
C10orf91 
RASSF7 
FANCF 
PGBD2 
KLHL35 
BCDIN3D 
RTN4R 
DOK3 
TMEM223 
ZNF439 
TCHP 
WNT6 
MVK 
ZNF280B 
WDR81 
MTHFR 
THAP11 
THRA 
POLRMT 
ZNF696 
FITM2 
ARL4C 
CAMK2G 
TBC1D13 
LRRC37BP1 
ZNF616 
ABHD8 
ANKRD13D 
TRIM32 
SLA 
KRBA1 
LSM14B 
ZFP62 
SLITRK5 
KLF16 
ABHD6 
ALDH3A2 
HDHD3 
ORAI3 
MPV17L2 
CLEC3B 
VPS26B 
RITA1 
TMEM206 
ZFP69 
TMEM55A 
MAGEF1 
AASDH 
GCLC 
ASB13 
KLF13 
SIGLEC9 
GPATCH11 
MGME1 
HEATR3 
SFMBT2 
NAT14 
TBC1D14 
PIP4K2B 
SDHAF1 
SUOX 
MAP3K1 
HLTF 
TTC5 
NAT8L 
FAM78A 
LOC100289656 
OSBPL7 
LOC93622 
RPP25 
Table 7.2: Groups of downregulated genes utilised for transcription factor binding site 
analysis using HOMER 
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7.4 GSEA enrichment plots 
 
Figure 7.3: GSEA enrichment plots: LPS-treated WT vs NFKB1S80A 
Gene set enrichment analysis of WT + vs S80A + ranked gene list (CuffDiff). Enrichment plots 
show the enrichment profile (green curve) across the ranked gene list. Black lines represent the 
genes which contribute to the enrichment profile. Peak enrichment scores (ES) and p-values are 
shown. (A) 5th and 6th most significantly enriched hallmark gene sets at the bottom of the ranked 
gene list, indicated by negative enrichment score (expression higher in WT THP-1s compared to 
NFKB1S80A THP-1s). (B) 6th most significantly enriched KEGG pathway at the top of the ranked 
gene list, indicated by positive enrichment score (expression higher in NFKB1S80A THP-1s 
compared to WT THP-1s). 
  
165 
 
7.5 Upstream regulator analysis of untreated THP-1 cells 
 
Figure 7.4: Upstream regulator enrichment analysis of untreated THP-1 cells 
Upstream regulator enrichment analysis of DESeq2 calculated differentially expressed genes (p.adj 
<0.01) in unstimulated cells (WT – vs NFKB1S80A –). Upstream regulators were ranked by 
enrichment score (overlap p-value (–log10 p-value)) and by activation score (z-score). Red bars 
indicate both significant enrichment score (p-value <0.05) and significant activation score 
(significant z-score >2). Blue bars indicate significant enrichment (p-value <0.05), but not significant 
activation score (z-score <2). 
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